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Abstract
Viruses are the cause of many severe human diseases such as Hepatitis C,
Dengue fever, AIDS, Influenza and even cancer. In consequence of viral dis-
eases several millions of people die every year all over the world. Due to the
rapid evolution of viruses their drug development and treatment are especially
difficult. The present work aims at getting a better understanding of the ongo-
ing signaling processes of certain diseases. To do this, methods for the analysis
and network inference of RNA interference (RNAi) data are presented.
Recent biological and technological advances in the field of RNAi enable the
knockdown of individual genes in a high-content high-throughput manner.
Thereby, a detailed quantification of perturbation effects on specific pheno-
types can be assessed using multiparametric imaging. This in turn allows the
identification of genes which are involved in certain biological processes such
as virus-host factors used in the viral life-cycles. However, hit lists of already
published RNAi screens show only a small overlap, even for studies of the
same virus. This may be due to insufficient data analysis where the potential
of microscopic screening data is not fully tapped since individual cell mea-
surements are not taken into account for data normalization and hit scoring.
This thesis shows that for RNAi data studying Hepatitis C and Dengue virus
the phenotypic effect after a perturbation is highly influenced by each cell’s
population context. Therefore, novel methodologies are proposed which use
the individual cell measurements for the data analysis and statistical scoring.
This results in an increased sensitivity and specificity in comparison to already
existing methods where these factors are disregarded. The method proposed
here allows the identification of already existing as well as new hit genes which
are significantly involved in the respective viral life-cycles.
The spatial and temporal placement of these hits, however, still remains un-
known, and the ongoing signaling processes are only poorly understood. To
understand the underlying biology from a system wide view it is necessary to
infer the signaling cascade of involved factors in detail. One of the challenges
of network inference is the exponentially increasing dimensionality with an in-
creasing number of nodes. The method proposed in this thesis is formulated as
a linear optimization problem which can be solved efficiently even for large data
sets. The model can incorporate data of single or multiple perturbations at the
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same time. The aim is to find the network topology which best represents the
given data. Based on simulated data for an small artificial five-node example
the robustness of the model against noisy or incomplete data is demonstrated.
Furthermore, for this small as well as for larger networks with 10 to 52 nodes
it is shown that the model achieves superior results than random guessing. In
addition, the performance and the computation time of large networks are bet-
ter than another approach which has been recently published. Moreover, the
network inference method presented here has been applied to data measuring
the signaling of ErbB proteins. These proteins are associated with the develop-
ment of many human cancers. The results of the network inference show that
already known signaling cascades can be successfully reconstructed from the
data. Additionally, newly learned protein-protein interactions indicate that
there are several still unknown feedback and feedforward loops. The proteins
of these loops may serve as potential targets to control ErbB signaling. The
knowledge about these factors is an important step towards the development
of new drugs and therefore,this helps to fight ErbB related diseases.
Zusammenfassung
Viren sind die Ursache von vielen schweren Krankheiten, wie zum Beispiel Hep-
atitis C, Dengue Fieber, AIDS, Influenza und auch Krebs. Mehrere Millionen
Menschen sterben durch die Folgen von viralen Krankheiten jedes Jahr auf der
ganzen Welt. Aufgrund der schnelle Weiterentwicklung von Viren ist deren Be-
handlung und die Entwicklung von Medikamenten besonders schwierig. Durch
die vorliegende Arbeit sollen ablaufende Prozesse bei bestimmten Krankheiten
besser verstanden werden. Dafu¨r werden Methoden zur Analyse und Netzw-
erkinferenz von RNA Interferenz (RNAi) Daten vorgestellt.
Neueste biologische und technologische Fortschritte auf dem Gebiet der RNA
Interferenz ermo¨glichen das Herrunterregulieren von einzelnen Genen in einem
hochaufgelo¨sten Hochdurchsatzverfahren. Dadurch kann mit Hilfe von multi-
parametrischen Bildgebungsverfahren eine detailierte Quantifizierung von Per-
turbationseffekte auf bestimmte Pha¨notypen durchgefu¨hrt werden. Dies er-
laubt wiederum die Identifizierung von Genen, die in bestimmte biologische
Prozesse involviert sind, wie zum Beispiel Virus-Wirts-Faktoren, die im vi-
ralen Lebenszyklus genutzt werden. Hitlisten von bereits publizierten RNAi
Studien zeigen jedoch nur eine geringe U¨bereinstimmung, sogar fu¨r Studien
die den gleichen Virus untersuchen. Der Grund hierfu¨r kann eine unzure-
ichende Datenanalyse sein, bei der das Potential von Mikroskopie-Daten nicht
voll ausgescho¨pft wird, da Einzelzellmessungen bei der Normalisierung und
beim Hitscoring nicht beru¨cksichtigt werden. Diese Arbeit zeigt, dass fu¨r
RNAi Daten, die sich mit dem Hepatitis C und Dengue Virus befassen, der
pha¨notypische Effekt nach einer Perturbation stark von dem Populationskon-
text jeder einzelnen Zelle beeinflusst wird. Deshalb werden neue Methoden
vorgestellt, die die Messungen auf einzelnen Zellen fu¨r die Analyse und statis-
tische Auswertung beru¨cksichtigen. Dadurch wird eine erho¨hte Sensitivita¨t
und Spezifizita¨t im Vergleich zu bereits vero¨ffentlichten Methoden, welche diese
Faktoren unbeachtet lassen, erreicht. Die hier pra¨sentierte Methode erlaubt
die Identifizierung von bereits existierenden sowie neuen Hit-Genen, welche in
den jeweiligen viralen Lebenszyklen signifikant involviert sind.
Die ra¨umliche und zeitliche Anordnung dieser Hits bleibt dabei jedoch
ungekla¨rt und die laufenden Signalprozesse sind bislang nur wenig verstanden.
Um die zu Grunde liegende Biologie systemu¨bergreifend zu erfassen, ist es
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notwendig, die Signalkaskaden von involvierten Faktoren im Detail zu rekon-
struieren. Eine der Herausforderungen beim Lernen von Netzwerken ist die ex-
ponentiell anwachsende Dimensionalita¨t fu¨r eine steigende Anzahl an Knoten.
Die Methode, die in dieser Arbeit vorgestellt wird, ist als lineares Opti-
mierungsproblem formuliert, das sogar fu¨r große Datensa¨tze effizient lo¨sbar
ist. Das Modell kann Daten mit einzelnen oder mehreren Perturbationen gle-
ichzeitig beru¨cksichtigen. Ziel ist es, eine Netzwerktopologie zu finden, welche
die Daten am Besten repra¨sentiert. Mit Hilfe von simulierten Daten fu¨r ein
kleines ku¨nstliches Fu¨nf-Knoten Beispiel wird die Robustheit des Modells gen-
genu¨ber verrauschten und unvollsta¨ndigen Daten aufgezeigt. Desweiteren wird
fu¨r dieses kleine, sowie fu¨r gro¨ßere Netzwerke mit 10 bis 52 Knoten gezeigt,
dass das Modell bessere Ergebnisse als Raten liefert. Daru¨ber hinaus sind die
Resultate und die Rechenzeit bei großen Netzen besser als bei einem anderen
Verfahren, das ku¨rzlich publiziert wurde. U¨berdies wurde die hier vorgestellte
Netzwerkinferenzmethode auf Daten, die die Signal-Prozessierung von ErbB-
Proteinen untersuchen, angewandt. Diese Proteine werden mit der Entstehung
von vielen humanen Krebsarten assoziiert. Die Ergebnisse der Netzwerkin-
ferenz zeigen, dass bereits bekannte Signal-Kaskaden erfolgreich aus den Daten
rekonstruiert werden ko¨nnen. Zusa¨tzlich deuten neu gelernte Protein-Protein
Interaktionen darauf hin, dass es noch einige bisher unbekannte “Feedforward”-
und “Feedback”- Schleifen gibt. Die gelernten Faktoren in diesen Schleifen
ko¨nnen als Ziele dienen um die ErbB-Signalgebung zu kontrollieren. Das Wis-
sen u¨ber diese Proteine ist ein wichtiger Schritt zur Entwicklung von Medika-
menten und dies tra¨gt somit zur Beka¨mpfung von Krankheiten, die mit ErbB
in Zusammenhang stehen, bei.
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Chapter 1
Introduction
In the recent years, technical developments enabled a facilitated measurement
of biological high-throughput data. This results in both, a qualitative and
quantitative improvement of the generated data and offers the potential to
get a better understanding of complex biological systems. RNA interference
(RNAi), for example, is used to study the role of various genes in different
biological processes like virus-host interactions during virus entry, replication
and release.
The general aim of this type of experiments is to gain new insights in
the spatial and temporal placement of individual genes in the cell. While
RNA interference is an easy and fast way to screen genes in a high-content,
high-throughput manner, the inference of signal transduction networks from
this data is a challenging task [MS06].
In this thesis, we are particularly interested in the inference of gene sig-
naling networks from high-throughput RNAi screening data. Since in biology,
experimental measurements are never completely exact, we want to diminish
noise in the data to extract the real biological signal optimally. Whereas there
exist various methodologies for the analysis of Microarray data, there are only
some basic techniques for RNAi data [RKEK09a]. The recent advances in the
technical field of image recognition of RNAi screens offer the possibility to
perform measurements which are very detailed. Microscopy-based read-outs
for example allow the quantification of several phenotypic effects of each
individual cell. However, the state of the art method up to now is to use
only a summarization of the numerous cell measurements and many of the
phenotypic effects such as morphological changes or each cell’s population
context are in most cases ignored [RRB+11, BHS+10, WRBB08, BBH06].
Since the overlap of hit genes identified by already published RNAi screens
is very low even for the same viruses [Gof08], we will show that this effect is
at least partially due to the fact that individual cell measurements are not
taken into account for the analysis up to now. This is supported by a recent
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publication from Snijder and colleagues, who showed that the cell context
is largely influencing viral infection [SSR+09]. In this thesis, we develop an
analysis method which decreases the false positive and false negative rate
of controls in two given data sets to a minimum. The true biological signal
can be extracted and this allows the identification of hit genes significantly
involved in the phenotypes of interest.
After the identification of genes which are involved in certain processes,
the next step is to study how they interact with each other to understand
the underlying biology in a much broader context. Getting a better insight
of the ongoing processes, may enable the identification, for example, of key
factors involved in individual diseases. Thereby, the development of new drug
targets which influence different disease pathways such as the life cycle of
viral infections can be enhanced.
Although, RNAi screening data have a high potential to give new insights in
signaling pathways, the network inference is a challenging task. The number
of possible network topologies, for instance, is increasing exponentially
with the number of genes and therefore, a complete enumeration of the
solution space is computationally not tractable for high dimension problems
[KDZ+09, MBS05]. However, in biology signaling process are most often
mediated via dozens or hundreds of genes. We present a method which is able
to solve even large-scale problems efficiently and thus, this enhances the use
of network inference in real biological problems significantly.
Organization of the Thesis
This thesis is structured into two parts. In the first part, the whole process
of RNA interference and the analysis of RNAi screening data is discussed
in detail. We start with explaining the biological background of RNAi data
and the experimental setup. Furthermore, we introduce RNAi data analysis
and hit identification methods by giving an overview of already existing
approaches. Thereafter, we describe new normalization and statistical
scoring approaches which have been developed in this thesis. Based on the
measurements of each individual cell, we show that the phenotypic effect after
single perturbations is highly influenced by each cell’s context. Our approach
takes, beside some technical parameters, the cell context for normalization
and for the calculation of significance scores. Thereby, we achieve much
higher sensitivity and specificity values in comparison to existing methods on
RNAi screening data of two data sets studying Hepatitis C and Dengue virus
infection.
The second part describes the challenge of inferring networks from
3perturbation data. First, we discuss already existing methods, and then
give the mathematical background of linear programming which is a basis
of the model presented here. The proposed model assumes that the signal
transduction within a network is given as an information flow. The silencing
effect of a gene on the measured output is therefore propagated down the path
in the underlying graph. Preceding genes influence the effect of genes which
are further down in the network. We present a linear program to find the
network topology and the corresponding parameters which are best reflecting
the data.
By formulating the inference task as a linear optimization problem it can
be solved efficiently using the simplex algorithm [Sch99]. This allows to re-
construct networks of 10 nodes using simulated data in less than ten minutes
which is significantly outperforming an existing method called DEPN pub-
lished by Froehlich et al. [FSA+09] which takes almost an hour. In addition,
our results show a much higher performance in terms of sensitivity, specificity
and precision than the DEPN approach. Furthermore, we show based on sim-
ulated data of a small five-node network that our approach is able to deal with
noisy and missing data as well as with single and double perturbations at the
same time.
Finally, we use a real data set studying ErbB signaling to reconstruct the inter-
actions of the involved genes. We learned already known interactions as well
as new ones which indicate for example, that there are feedback loops which
have not been discovered yet.
Structure of the Thesis
The different Chapters within this thesis are organized as follows: This
Chapter gives a general introduction of the topic. The Chapters 2 and 3
belong to the first part of the thesis. Chapter 2 introduces the biological
background of RNA interference and viruses. Then, RNAi experiments
and data generation are reported. Furthermore, existing strategies for the
normalization and statistical analysis of RNAi data are explained.
In Chapter 3 we describe the newly developed strategy of processing RNAi
screening data based on individual cell measurements. First, we describe the
data on Hepatitis C and Dengue virus which is used to evaluate our methods
and then, we discuss two already existing analysis approaches. Thereafter,
we explain our approach and present results of the two data sets. Finally, we
compare the results and discuss them in detail.
The next four Chapters (Chapter 4 to 7) form the second part of this
thesis. In Chapter 4 an introduction on graphs and networks in biology is
given. Then, the problem of inferring networks from perturbations data is
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discussed and previously published methods are presented.
Chapter 5 explains the theory of optimization problems to give a background
knowledge of linear problems and solvers. This is important for the model
developed in this thesis and which is explained in Chapter 6. Here, we
formulate the network inference task as a linear problem which can be solved
efficiently using the simplex algorithm. At the end of Chapter 6, we describe
a strategy to assess the performance of network inference methods.
Finally, in Chapter 7 we present results on simulated data as well as on real
data using our model for the network inference. We use simulated data of a
small five-node toy example and larger problems with networks of 10 to 52
nodes to assess and compare the performance of our approach with a recently
published method and random guessing. Furthermore, using real data, we
infer a network of 16 nodes involved in ErbB signaling.
Finally, Chapter 8 summarizes and concludes the whole thesis and gives an
outlook.
Part I
RNAi Data
5
Chapter 2
Biological Background
This Chapter gives a background of the underlying biology and technology.
It is separated into three different Sections. First, the concept of knockdowns
using short interfering RNAs (siRNAs) is explained and viruses are introduced
in general. The two virus types Dengue and Hepatitis C, which both belong
to the family Flaviviridae, we discuss in more detail.
The second Section describes the methodology of RNA interference experi-
ments using RNAi-based cell arrays and microwell plates. Furthermore the
process of image-acquisition and -recognition is introduced. Finally, in the
third Section, we explain methods commonly used for the RNAi data analysis,
including approaches for the quantification of the data quality, normalization
strategies and methods for the hit calling.
2.1 Biological Background
Systems biology aims at understanding biological processes when looking at
the system as a whole. The goal is to describe complex interactions and to
gain a systemic view of biological systems. During the last years, various
technologies have been developed and enhanced to model cell function with
the help of global cell measurements [CHI10]. For example RNA interference
offers the determination of genes which are important for specific phenotypes
by looking at the cell response after silencing them [PCL+09]. A multitude of
different possible applications exist, but especially for treating several diseases,
such as virus infections, the identification of target genes offers new possibilities
for drug development [AHP+10] and thus, this is of great importance.
2.1.1 RNA Interference
RNAi is a process mediated by double-stranded RNA (dsRNA) molecules
which enable sequence-specific, post-transcriptional gene silencing in a high-
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throughput fashion. RNAi was first discovered in Caenorhabditis elegans (C.
elegans) when dsRNA was injected into worm and the silencing of specific
genes could be observed [FXM+98].
Figure 2.1 shows the basic steps of RNAi: After the introduction of dsRNA
into the cytoplasm of the cell, the enzyme dicer (an endoribonuclease of the
RNase III family) cuts it into siRNAs of about 21 to 28 nt in length [MT04].
These duplexes consist of a guide and a passenger strand, represented in red
and yellow, respectively, in Figure 2.1. While the passenger strand is ejected
and degraded, the guide strand is incorporated into the RNA-induced silenc-
ing complex (RISC) where it allows, since it is unwound, binding to the target
mRNA of perfectly complementary sequence [CS09, MS02]. This leads to the
RISC cleavage of the mRNA and thus, its translation is avoided and the pro-
duction of the protein is blocked.
Figure 2.1: The RNAi mechanism [BEWS04]. First dsRNA is transfered to
the cell which then is cutted by a DICER into duplexes. These are directed to
the RISC complex which leads to the degradation of the homologous mRNA.
(For more details see text.)
Using long dsRNA is historically the most common method for gene
silencing in worms, flies and plants. In the case of C. elegans dsRNA is
possibly transported into the cell by SID-1 (Systemic RNA Interference
Defective) which is an RNA transporter [FH03]. Other possibilities are the
direct microinjection into the animal or soaking the animals in a medium
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which contains the dsRNA [BEWS04].
In mammals an interferon anti-viral response is induced when using dsRNAs
longer than 30 nt. This results in a non-specific degradation of mRNA
sequences. Elbashir and co-authors found in 2001 [EHL+01] that this can be
avoided using chemically synthesized siRNA duplexes of 20 to 23 nt length,
which are in their structure similar to dicer-processed dsRNA.
The siRNAs are directly transfered into the cytoplasm either by normal
transfection or through vectors which are expressing the siRNAs. Thereby,
the successful targeting of specific mRNAs in mammalian cells is enabled
and the non-specific inhibition of protein synthesis is circumvented. The
used vectors are DNA strands encoding short hairpin RNAs (shRNAs)
which are cleaved by dicer. The vectors are often used for transfection since
siRNA-mediated RNAi is of transient nature and they allow the control of
the shRNAs by a promoter. This is particularly useful if genes involved in
cell growth, differentiation or apoptosis pathways are targeted. See [KM06]
for more details.
The RNAi technology offers many advantages in contrast to gene knock-
downs: it is post-transcriptional and therefore reduces the risk of compensatory
gene regulation. Furthermore, it is fast and less expensive and because of its
temporary effect, the experimenter can control the time frame of the knock-
down to an amount of 24 to 72 hours after siRNA delivery.
Thus, the discovery of RNAi offers a great potential, not only for the
systematic elucidation of gene function and gene involvement in biologi-
cal processes, but also for drug target identification in different diseases
[BEWS04, DS09, WM09]. The RNAi technique is nowadays routinely used
in biological experiments and allows high-throughput screens, for example fo-
cusing on genes involved in mitosis [NWH+10], immune response [MKG+05] or
viral infection [BDB+08, LBN+09]. A genome-wide targeting is enabled and
thereby, all candidate genes of a specific phenotype can be identified.
Nevertheless, there are some disadvantages. For example off-target effects
which are due to sequence homology within a protein family or common do-
main. The choice of the target mRNA sequence is an important step in the
design of an RNAi experiment. Choosing three to four regions within the tar-
get mRNA is recommended, and several siRNAs should be used to target the
same gene [MS06, TB10, KCT+07]. In addition, regions which have at least
11 nt in common should be avoided, since they can affect off-target mRNAs
[JBS+03].
The undesired effects can be uncovered by performing validation experiments
such as gel-based real-time PCR or RNAi experiments with a high-content
low-throughput screening.
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2.1.2 Viruses
A virus is a subcellular infectious agent which can survive only if it interacts
with factors of the replication mechanisms of a living cells organism. They
do not have an own metabolism or a cellular structure and are not able to
reproduce outside of a host cell.
The cell morphological structure of different viruses show high diversity. The
virions (virus particles) are very small, between 10 and 300 nm, and have
a very simple structure, consisting of only two parts: the genetic material
and a protein coat (capsid). The capsid consists of identical protein subunits
(capsomers) which are encoded by the viral genome and serves as a physical
protection for the genetic material. Some viruses are additionally enveloped
by lipids which are surrounding the capsid when it is outside of a cell. No
matter whether they are enveloped or not, standard light microscopes cannot
visualize the virions, so transmission electron microscopes are used.
Different viral species show a broad spectrum of different genomic
structures. The genomic material is either RNA, DNA or both (retrovirus).
Whether a retroviral genome is DNA or RNA depends on the different stages
in the viral life cycle.
The viral genome is shaped circular, linear or segmented (genome is divided
into separate parts), irrespective of the type of the nucleic acid. Single-
(unpaired nucleic acid) or double-strands (two complementary paired nucleic
acids) are possible. For the formation of the strands it does not matter
whether it is RNA or DNA and some viruses even have a combination of
single- and double-stranded genomes.
Although there are millions of virus types which differ broadly in their viral
life cycle, five basic stages can be summarized for all of them:
1. Attachment:
The viral capsid interacts with specific receptors located on the cell sur-
face of the host cell.
2. Penetration:
Depending on the virus type, the virions can enter the cell either using
receptor-mediated endocytosis, or the viral and cellular membrane fuse
and thereby the viral entry is enabled.
3. Uncoating:
The viral capsid is removed and viral genomic material is released into
the cytoplasm of the cell.
4. Replication:
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The viral genome is replicated using both host and viral proteins which
have been synthesized in advance using cellular processes.
5. Release:
The new viral genome is coated by newly synthesized capsomers which
self-assemble into capsids. Then the virus is released from the cell and a
new replication cycle can start and new cells can be infected.
All organisms - animals, plants and bacteria - can be infected by viruses and
numerous diseases (e.g Influenza, AIDS, Dengue fever, Hepatitis) are caused
by viral infection. In the following, a more detailed description of Dengue virus
and Hepatitis C virus is given.
Dengue Virus
The Dengue virus causes the Dengue fever, which is also known as breakbone
fever. It is transmitted by the mosquito Aedes aegypti and affects around 50
million people per year in tropical and sub-tropical areas [Wor09]. Typical
flu-like symptoms include fever, headache, patechial rashes and muscle pain.
A severe course of the disease can lead to Dengue hemorrhagic fever or Dengue
shock syndrome which are both life-threatening. There exists no vaccine
against it up to now. The the transmission can be limited by reducing the
number of mosquitoes.
The Dengue fever virus (DENV) belongs to the family Flaviviridae and
there exist four serotypes, DENV-1 to DENV-4. The viral genome is com-
posed of a single, positive strand RNA molecule with about 11 kb length. It is
packaged by dimeric virus capsid proteins in a host-derived lipid-bilayer and
enveloped by glycoproteins. After receptor-mediated endocytosis, the viral
RNA is released into the cytoplasm and uncoated [MKR05].
Then, the genome is translated into a single poly-protein using viral and host
factors and replication takes place in membrane-bound vesicles on the cell’s
endoplasmic reticulum (ER). Once the newly synthesized RNA and the struc-
tural proteins bud together in the lumen of the ER, virus assembly takes
place. The resulting particles are still non-infectious and have to be trans-
ported through the trans-Golgi network (TGN) where they are cleaved by the
host protease furin. Only the mature and infectious virions are released by
exocytosis [UIPT+10, MKR05].
Hepatitis C Virus
Hepatitis C is one of five known Hepatitis viruses (labeled from A to E).
Symptoms of the acute phase (first six months after infection) are similar
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to flu symptoms. Up to 70% of infected people do not have symptoms at
all. In the chronic phase (Hepatitis C virus infection exists for more than
six months), Hepatitis C is affecting the liver. Although it is mostly still
asymptomatic, a once established chronic infection can cause severe liver
failures. Fibrosis, cirrhosis or liver cancer are possible consequences. It is
transmitted by blood-to-blood contact and according to the World Health
Organization [Wor11] about three percent of the world’s population are
infected and five to ten million people in Europe. Currently, no vaccine is
known but a persistent infection can be medicated in some patients.
Like the Dengue virus, the Hepatitis C virus (HCV) belongs to the family
Flaviviridae and it is an enveloped, positive sense, single-stranded RNA (9.6
kb long) virus. The life cycle of HCV looks as follows: the HCV particles
attach to the cell surface and this triggers the release into the cell cytoplasm
(Figure 2.2). Among all possible HCV receptors such as CD81, scavenger
receptor B type I (SR-BI), low-density lipoprotein receptor (LDL-R) and
asialoglycoprotein receptor (ASGP-R) [Tan06], CD81 is studied most. It has
been shown that CD81 mediates binding of HCV via its envelope glycoprotein
[PUC+98]. After uncoating of the the viral genome from its capsid it is
translated at the rough ER [BFP04]. Thereafter, genome assembly and HCV
protein expression takes place and the progeny virions are assembled. Little
is known about these steps in detail [Tan06] and the release of the newly
produced virus particles from the host cell is not yet completely understood.
Whereas available broad-spectrum antibiotics are effectively used against
bacterial pathogens, broad-spectrum antiviral therapeutics are hard to
develop. Although viruses harbour a small genome they can reprogram host
cells to promote their own replication. Due to the rapid evolution of viruses
it is particularly difficult to treat infections. A starting point is to identify
essential viral proteins, which can serve as drug targets. However, due to the
high mutation rate of viruses this is a challenging task. Recent advances in
RNAi and high-content screening microscopy facilitate the identification of
new host factors [Che09]. This might provide further insights into the viral
life cycle and aid in the development of new drugs.
2.2 RNAi Experiments
To find genes which are important for the viral life cycle, the technology of
RNAi experiments is used. The viral response can be easily quantified after
gene knockdowns.
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Figure 2.2: The Hepatitis C virus life cycle (modified from [BFP04]). The
viral particle attaches to the cell surface and enters the cell. After uncoating
the viral genome is translated at the rough ER (rER). After replication and
assembly of the progeny virions, the newly produced virus is released from the
cell. For details see text.
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Basically there are two different possibilities for high-throughput RNAi
experiments: RNAi-based cell microarrays on LabTek chambered coverglass
slides and microwell plate based arrayed screening [MS06]. Both methods are
explained in detail in the following two Sections.
2.2.1 RNAi-based Cell Microarrays
The cell microarray is a glass slide (in most cases a LabTek chambered
coverglass slide) which allows transfection with hundreds to thousands of
RNAi reagents at the same time. A typical experiment on RNAi-based cell
Figure 2.3: Workflow for RNAi-based cell microarrays [MS06]. See text for
details.
arrays (see Figure 2.3) starts with the preparation of the transfection solutions
containing the siRNA samples (synthesized siRNAs, enzymatically derived
siRNAs (esiRNAs), plasmid-based shRNAs or virus-based shRNAs) which are
derived from a certain siRNA library. Next, the samples are spotted on the
LabTeks using a microarraying robot.
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After drying and possibly storage of the slides, mammalian cells are seeded on
the LabTeks. Finally, fluorescence microscopes or plate readers are used for
generating the read-out via life cell imaging or imaging using immunostaining
of transfected cell arrays [ENL+07]. Life cell imaging can be done after a
certain incubation time (mostly around 20 hours) without further handling.
The other approach uses fixed and immunostained cells after an incubation
with siRNA for about 48-60 hours depending on the used protocol.
In each spot positioned on the LabTek one siRNA is transfected into the
overlying cells, which results in the knockdown of the respective gene. This so-
called “reverse transfection” often leads to superior efficiency when compared
to conventional formed transfection experiments [CLH+08].
Using cell microarrays allows a high sample density and long-term storage
after the spotting process. This reduces costs and correlations between differ-
ent assays are increased since they can be performed on the same production
day. Nevertheless, there are some disadvantages. The most important one is
the risk of cross-contamination. The individual reagents are physically not
separated and still the total number of spots per array should be maximized
for a high-speed and a parallel data acquisition. However, Reymann and
colleagues presented in 2009 [RBB+09] a 9216-microwell cell array which does
not show cross-contamination. They introduce physically separated cavities
on cell arrays using a titanium coating. Three reference markers at the
borders of the glass slide ensure the precise spot location. Accurate spotting
is of great importance, because it allows the correct detection of the spot
matrix during the scanning process.
A further disadvantage is given by the small number (in comparison to
microwell plate based arrays) of cells per spot. This reduces the statistical
relevance of a single experiment. In addition, no reverse transcriptase-
polymerase chain reaction (RT-PCR) can be performed for validation after
the data analysis and hit selection. This is due to the fact that individual
spots are not physically separated and thus, the individual knockdown
experiments cannot be processed further. All of these problems are solved in
the microwell plate based screening process which is described in Section 2.2.2.
For measuring a phenotypic effect under the influence of a certain virus, cell
seeding has to be followed by infection. After an additional incubation time,
fixation and imaging is possible like in a non-virus based setting. To quantify
the viral signal intensity during the image recognition process, the viral genome
is tagged by a fluorescence protein, for instance the Green Fluorescence Protein
(GFP).
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2.2.2 Microwell Plate based Screening
Microwell plates exist of different sizes (12, 96 or 384 well-plates) of physically
separated wells. In each well different reagents (siRNAs, plasmid shRNAs or
viruses) can be applied.
During the experimental setup, a library of gene-targeting reagents has to be
chosen first. Second, the reagents are arranged on one or several multi-well
plates. Then, infection (if viral shRNAs are used), transfection or reverse
transfection (if cells are added after the reagents) takes place. This results in
a gene-specific silencing of the corresponding targets. For plates with more
than 96 wells reverse transfection [KPH+07] is recommended since it is easier
to handle and it introduces less technical variability [TB10].
In well-plate based screens it is possible to pool reagents by grouping multiple
siRNAs targeting the same gene together in one well [LVHWN10, BH10].
This decreases the number of necessary wells and thereby, this saves costs and
time. However, for these screens it is technically challenging to get uniform
pools of transfected cells. Furthermore, the efficacy of each individual sample
might be negatively affected since highly potent sequences become diluted
[MS06].
After the experimental process, a plate reader or a fluorescence micro-
scope (see Section 2.2.3) is used to extract the phenotypic effect after the
perturbations. A microscopic analysis allows the recording of several images
per well. Thereby, much more cells can be screened in in comparison to
screens performed on LabTeks (around 400-10.000 cells/well for well-plates
and 100-400 cells/spot for LabTek). This enhances the statistical relevance of
the data [ENR+08].
In contrast to the microarray format, wells are physically separated and there-
fore cross-hybridization cannot occur. Moreover, the read-out is simplified
since no spotting-matrix detection is necessary.
A disadvantage of microwell plates is that they cannot be stored as long as
LabTeks. Erfle and co-authors presented in 2008 [ENR+08] a protocol, which
allows solid-phase reverse transfection in multi-well plates. In this method well
plates are dried after adding the siRNA transfection solution into the wells.
This allows the storage of the ready-to-transfect arrays for at least 12 weeks
after production without losing transfection efficiency. This is not as good as
for RNAi microarrays, but it offers a valid alternative if the storage is not the
most important criterion for choosing an RNAi screening platform.
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2.2.3 Image Acquisition
There are basically two different technologies for the image acquisition: plate
readers, which are exclusively used to detect signals in microtiter plates and
fluorescence microscopes, which are used for both microarray and multiwell
plates. Like for DNA microarrays, the plate reader detects for each spot a
single fluorescence read-out representing the phenotype.
Fluorescence microscopes are more sophisticated. They allow the acquisition
of a multi-parametric read-out and therefore a much more detailed phenotypic
classification [EP07]. For high-throughput screens this requires automated
screening systems, offered for example by Olympus. An automatic Olympus
fluorescence microscope quantifies data with its integrated proprietary image
analysis software ScanR. The algorithms of ScanR are undisclosed.
Alternatively, customized software as for instance developed by Petr Matula
[MKW+09] can be used. It takes two-channel images for input: one channel
represents the cell nucleus stained with the DNA-binding fluorescent agent
DAPI (or HOECHST) and the other channel measures the viral protein pro-
duction level using GFP intensities. In short, the software of Dr. Matula works
as follows: first, each siRNA spot is localized by dividing the LabTek images
into rectangles if LabTeks are used. For well-plates this step is not necessary.
Then, in each spot the DAPI channel is used to segment the cell nuclei and
the GFP channel to measure the mean virus signal intensity of each cell. The
individual cells are then classified with certain criteria such as size, circularity
or position on the array. See [MKW+09] or Section 3.2.2 for more details.
2.3 RNAi Data Analysis
Measurements in biological experiments are never completely exact. During
the whole experimental setup of RNAi screening and imaging several problems
may occur where noise and errors are introduced. These errors can be purely
due to technical problems such as pipetting, robot, or scanning failures as
well as to an inhomogeneous staining, an inhomogeneous cell growing and a
different transfection or infection efficacy. Moreover, different concentrations
of the solvent solution in the edges of plates or different cell numbers in the
individual positions are frequent. The silencing effect of individual siRNAs
can lead to cell death or cell clumping which might cause background or
saturation effects. Apart from problems occurring during transfection, viral
infection may introduce even more data variation since it can lead to a
different cellular behavior.
Systematic noise which affects entire plates or certain positions can be
modeled and normalized. If the variation of the data is due to stochastic
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errors, replicate measurements are required to find significant hits with the
help of hypothesis testing [MHC+06, GCD+05].
After performing RNAi experiments, the generated data has to be analyzed
to find possible sources of noise and errors, to control and quantify the quality
of the data, to reduce systematic errors and to extract the biological signal.
During my time as a PhD student in the group of Prof. Dr. Lars Kaderali,
I supervised Nora Rieber during her master thesis. She developed a pipeline
for the analysis of RNAi data. The pipeline has been implemented in the
statistical language R [R D09] as the Bioconductor [Bio11b, GCB+04] package
RNAither [RKEK09b, RKEK09a]. The work includes the assessment of the
data quality, data normalization and hit calling. In the following the most
important methods of this pipeline are discussed to give an introduction of the
state-of-the-art analysis methods for RNAi screening data.
2.3.1 Quality Control
In biological experiments the use of controls - positive and negative - helps to
evaluate the quality of the data. Whereas negative controls should not show
phenotypic effects, positive controls are supposed to achieve maximal degree in
difference. For RNAi screens performed using an optimal design, positive and
negative controls are used in a reasonable number on each individual plate.
Controls allows the calculation of several different quality metrics such as the
dynamic range or the Z’ factor.
Dynamic Range (DR)
The ratio between the geometric means of the positive and the negative con-
trols is defined as DR [MHC+06]:
DR =
µneg
µpos
. (2.1)
It quantifies the separability of controls and thus, whether they worked as
expected. For RNAi experiments which assume that the mean intensity of the
positive controls is higher than the mean intensity of the negative controls, a
small (near zero) DR shows a good performance of the data.
Z’ factor
Z’ factor [ZCO99] is comparable to DR, yet it is more sophisticated. It is
defined as the ratio of the separation of the distributions of the negative and
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the positive controls with:
Z ′ = 1− 3 σpos + σneg|µpos − µneg| , (2.2)
where µpos and µneg are mean intensity values of the positive and negative con-
trols, respectively, and σpos and σneg are their standard deviations. According
to Zhang et al. [ZCO99], Z ′ = 1 demonstrates an optimal, 0.5 ≤ Z ′ < 1 a
good and Z ′ ≤ 0.5 a bad separation of controls.
Coefficient of Variation (CV)
Although, controls are essential for quality assessment, they are often not
available or they did not work properly in some screens or at least on individual
plates. The coefficient of variation [TOR+01] does not depend on controls and
measures the data quality based on the reproducibility of results. It is defined
as the ratio of the standard deviation of an siRNA (σsiRNA) and its mean
(µsiRNA):
CV =
σsiRNA
µsiRNA
. (2.3)
The data is better the smaller (near zero) the CV value.
Correlation between Replicates
The correlation coefficient between pairs of replicates measures their relation-
ship. Thus, it gives information about the reproducibility and reliability of the
data. There are several different types to quantify the degree of correlation,
i.e. Pearson’s , Spearman’s rank or Kendall’s rank correlation coefficients (for
details see [SH06]). The correlation coefficient is +1 for perfect correlation
and −1 for perfect anti-correlation. Everything in-between indicates the
degree of the linear relationship with being closer to zero, being less correlated
(or less anti-correlated).
Data Visualization
Apart from assessing the data quality via metrics, data visualization and a
visual evaluation is a good strategy. Most often used plots include:
• Histograms, density plots or boxplots of controls, individual plates or the
whole screen to show the data distribution.
• Plate plots (sometimes also called heatmaps) to visualize the color-coded
distribution of the intensity values on individual plates.
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• Scatterplots of signal intensities versus cell counts or versus position num-
ber on the individual plate to illustrate whether the signal depends on
other factors.
• Scatterplots between pairs of replicates to represent their correlation.
For more details about the individual plots and how to interpret them see for
example [GCD+05].
2.3.2 Normalization
Whereas a huge variety of different methods exist for DNA microarray data
analysis, only some standard normalization techniques are available for the
processing of RNAi data [BBH06, PGB10, RKEK09a]. Basically, normaliza-
tion techniques can be separated into two groups: intra- and between-plate
normalization. The first one aims in reducing systematic errors on individual
plates. Examples are effects due to different cell counts or due to different
positions of siRNAs on the plate (i.e. edge-effects).
The between-plate normalization removes systematic bias which occurs on
different plates. Plates which are, for instance, spotted on distinct days or
measured with a diverse microscopical setting, may have different overall sig-
nal intensities. Since data is varying across specific experimental setups, a
standard normalization strategy which is suitable to all of them cannot be
stated. Often, there is not only one possible solution, and also a combination
of different methods which aim at different features of the data are thinkable
[WRBB08].
Normalization on Controls
The most easiest way to normalize between different plates is to scale the
intensity values based on the controls. Thus, assuming an additive error model,
the mean or median of the controls of a plate is subtracted from each intensity
value x of the same plate and the result is divided by the controls standard
deviation:
norm(x) =
x− µctr
σctr
, (2.4)
where µctr and σctr are the mean (or median) and standard deviation (or me-
dian absolute deviation (MAD), see [SH06]) over all spot intensities of the
controls on a plate. Whether for the normalization the negative or the posi-
tive controls shall be chosen, depends on the type of experiment. For RNAi
data, negative controls are used in most cases.
Although this method is easy in computation and interpretability, it is sensi-
tive to outliers [BSF+09] and as mentioned in Section 2.3.1 controls are not
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always available or show large variations within a screen. In this case, more
sophisticated normalization strategies are recommended.
Normalization with Z-scores
A further data scaling strategy is called z-score normalization [MHC+06]. For
each spot x, the z-score is defined as:
Z(x) =
x− µx
σx
, (2.5)
where µx and σx are the mean and standard deviation (or median and MAD,
for a more robust analysis) over all spot intensities of one plate. This allows
the quantification of the signal of each siRNA relative to the rest and thus,
makes different plates comparable. However, this method can be used only if
the assumptions hold, that most siRNAs in a screen do not have an effect and
that they are equally distributed on the individual plates [BSF+09].
B-score Normalization
The B-score method [BSF+09] is a more robust analog to the z-score normal-
ization. It allows the comparison of different plates since it scales the data
according to the overall plate median. Additionally, it normalizes within a
single plate by removing row and column effects.
It is calculated by subtracting the overall plate, the column and the row median
from each siRNA:
Bscore(xijp) =
xijp − (µp + Cˆjp + Rˆip)
MADp
=
xijp − xˆijp
MADp
=
rijp
MADp
, (2.6)
where xijp is the siRNA x in row i and column j on plate p. xˆijp is the fitted
value computed by a two-way median polish [MT77] that estimates systematic
measurement offsets for each row i (Rˆip) and column j (Cˆjp). Furthermore, µp
is the median of plate p and MADp = median|rijp −median(rijp)| for all i, j
on plate p.
Lowess Normalization
Lowess (locally weighted polynomial regression [Cle79, Cle81]) normalization
performs within-plate corrections. If RNAi data is multi-parametric different
read-outs may depend on each other and these can introduce a systematic bias.
For example positions on plates which show higher cell count may have higher
signal intensities.
In order to remove this systematic error, a polynomial regression function is
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fitted to the data for a given number of intervals. Since the polynomial approx-
imation of data is better the smaller the intervals, a sliding window approach
is used. Data points which are nearer to the estimated fit are weighted higher
than more distant points. Combining the polynomials of each interval results
in a smooth curve which models the data. The normalized signal intensities
are the difference of the signal intensity values and the corresponding point on
this curve.
2.3.3 Hit Calling
After data normalization the hit selection takes place. A commonly used
practice is to use z-score normalized intensities which deviate from the bulk,
so which are greater than or smaller than a certain threshold, as hit criteria.
Often, this is done if there are not enough replicate measurements and thus,
no significance level can be computed. The choices for an optimal threshold
depend on the research aspect. If maximum saturation is of interest, so e.g.
finding all genes involved in a certain pathway, the threshold should be chosen
rather small. By contrast, if the goal is to find most significant hits, the
threshold should be high, to reduce costs and time needed in the validation
screen [WRBB08].
Apart from hits which show a clear difference to the rest, siRNAs with
only small, but at the same time very robust effects are of interest as well.
Therefore, hypothesis testing is used if enough replicated are available. This
allows the distinction between significant phenotypic effects and those due
to mere chance. If hypothesis testing is used for each siRNA, p-values are
calculated and hits can be defined using both criteria: absolute z-scores higher
than a given threshold and p-value smaller than a predefined significance level.
T-test
The t-test is an example of a parametric (assuming normally distributed data)
testing method. It tells if the mean of a normally distributed data set differs
significantly from the mean of a Gaussian distribution (one-sample t-test) or
from the mean of another distribution derived from a normally distributed
data set (two-sample t-test).
Assume that we have n ∈ N samples of a normally distributed data set with
sample mean µ and sample standard deviation σ. If the null hypothesis (H0)
assumes that µ = µ0 with µ0 being a specified value (i.e. zero), then the t-test
calculates:
t =
√
n
µ− µ0
σ
. (2.7)
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H0 is rejected with significance level α if:
|t| > t(1− α
2
, n− 1), (2.8)
with t(1 − α
2
, n − 1) being the (1 − α
2
)-quantile of the t-distribution with n-1
degrees of freedom.
The two-sample t-test, for two data sets having the same sample size, is
calculated as:
t =
µ1 − µ2
σ1,2 ·
√
2/n
, (2.9)
with µ1 and µ2 being the mean of the two sample data sets and σ1,2 =
√
σ21+σ
2
2
2
with σ1, σ2 their standard deviations. The degrees of freedom is 2n − 2 with
n being the number of samples in each set of data.
Furthermore, there are two possible scenarios regarding the variances of the
distributions: the standard t-test assumes equal variances and the Welch’s
t-test different ones. For more details see [SH06].
Mann-Whitney Test
The Mann-Whitney test is a commonly used non-parametric test which does
not assume normal distribution. Originally published in 1945 by Wilcoxon
[Wil46] it has been enhanced by Mann and Whitney in 1947 [MW47].
Chapter 3
RNAi Data Analysis
3.1 Introduction
The combination of RNAi screens and fluorescence microscopy results in
high-dimensional image-based readouts where for each siRNA the viral fluo-
rescence intensity signal of several hundreds of cells is quantified. Figure 3.1
shows an assembly of the raw microscopy images of an example RNAi LabTek
array with 384 spots. In each spot, located in one of the 384 rectangles, one
siRNA has been used to silence the respective gene in the overlying cells. One
image has been taken per spot. The Figure shows overlaying fluorescence
signal intensities of the DAPI (cell nucleus) and GFP (viral signal) channels.
Hundreds of cells can be identified and characterized for each knockdown
using image recognition software like described in Section 2.2.3.
This allows in contrast to siRNA screens using bulk measurements a more
detailed view since for each knockdown a multi-parametric phenotypic
readout can be quantified. The image of the LabTek given in Figure 3.1
clearly shows, that there are spots which have smaller intensities in the
middle of the array. This is most probably due to noise for example based
on an inhomogeneous staining or an inhomogeneous cell growing in some
areas of the plate. To remove these effects an adequate normalization
strategy is necessary. However, analysis methods for this type of data are still
lagging significantly behind experimental developments. If the morphology
or the cell-cycle state of a cell is not of primary interest as for example
in [JCL+09, WKIKG09, NWH+10, FPK+10], only some basic strategies as
discussed in Section 2.3 are used for data analysis on an averaged phenotype.
This results in an information loss of hundreds of individual cell measurements
and thus, in the identification of false hits or a small reproducibility of results.
Moreover, each cell’s population context is not taken into account. This
is in contrast to a recent study by Snijder and co-authors [SSR+09]. The
authors showed that the population context of a cell greatly influences the
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Figure 3.1: Raw microscopy image of an example RNAi LabTek array. On
the array are 384 rectangles arranged in 12 columns and 32 rows. In each
rectangle one siRNA has been spotted to knockdown the corresponding gene in
the overlying cells. Shown are the fluorescence signal intensities of the DAPI
(cell nucleus) and GFP (viral signal) channels together (see Section 2.2.3). In the
middle of the array the rectangles have smaller intensities. This effect is most
probably due to noise artifacts which should be normalized in a subsequent
analysis.
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variation in virus infection, endocytosis and membrane lipid composition.
Therefore, the authors claim that determining each cell’s context like cell size
or cell shape is of great importance for the interpretation of phenotypic effects.
Although, the study by Snijder shows the great need of an analysis based
on individual cell information, only few methods are accounting for this so far.
Suratanee and co-authors [SRM+10] proposed a spatial clustering approach
(see Section 3.4). Fuchs and colleagues used multiparametric phenotypic pro-
files of RNAi screening data [FPK+10] to cluster genes. The approach is based
on morphological changes of individual cells within a cell population and this
is used to identify new gene functions. Using multi-dimensional phenotypic
similarity, the authors identified DONSON as a new component in the DNA
damage. However, none of these methods propose strategies for normalization
of cell signal intensities against the effects due to each cell’s context.
Designing suitable statistical methods for quality control and hit selection
is one of the most fundamental challenges in high-throughput experiments
[Eis06]. The use of analytic metrics to assess and rank the effects of individual
siRNAs in combination with hypothesis testing to control false positive and
false negative rates are main approaches [CZK+08]. However, data analysis
based on individual cell measurements poses new methodological challenges
and no publication addresses this problem so far in its full range. The methods
presented by Fuchs et al. and Suratanee et al. provide a first step towards
the analysis of RNAi screening data based on individual cell measurements,
but they do not use population context for normalization. Thus, they do not
offer a full analysis pipeline including normalization and statistical testing
methods. Therefore, we developed a method where for the first time single
cell measurements are used to normalize data and to define hits.
We present results on two high-throughput, high-content viral screens of
Hepatitis C virus (HCV) and Dengue virus (DENV). We normalize the
measurements of each individual cell based on the population context, and
thus, we are correcting for a population bias present in the data. Furthermore,
within-plate and between-plate normalization methods allow to remove
spatial effects. Borrowing ideas from functional enrichment analysis, we
calculate p-values based on individual cell data. This enables the statistical
identification of significant siRNAs with a higher statistical power than when
using bulk measurements.
This Chapter is structured as follows: First,we explain the experimental
setup and details about the image analysis performed of both screens (Section
3.2). Then, we show how the state-of-the-art analysis method (AVERAGE)
is applied to analyze the HCV data in the Section 3.3. Then, we discuss in
Section 3.4 the strategy introduced by Suratanee et al. (RIPLEY) which has
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also been applied on the HCV screen [SRM+10]. In Section 3.5, we explain
the methods of our newly developed approach (CELL-BASED) and present
results of the HCV and the DENV screen. The Section 3.6 quantifies the
performance of the AVERAGE, RIPLEY and CELL-BASED methods based
on results of the HCV screen. Then, we provide a pathway analysis and a
functional annotation of host dependency factors using our method on the
HCV and DENV data in Section 3.7. Furthermore, we show in Section 3.8
how the population context influences the phenotype in a non-virus RNAi
screen. Finally, we conclude and discuss the whole Chapter in detail in
Section 3.9.
We note, that the data, the methods, some of the Figures as well as parts
of the results presented in this Chapter have been submitted for publication
in BMC Bioinformatics recently [KRK+11].
3.2 Data
In the laboratory of Prof. Dr. Bartenschlager, two different high-throughput,
high-content primary RNAi screens have been performed. Both screens are
targeting the same 719 human kinases. The first screen has been done by Ilka
Rebhan and aims at the identification of host cell factors involved in Hepatitis
C virus replication. Anil Kumar has carried out the second screen where the
effect of each kinase is studied after Dengue virus infection.
3.2.1 Experimental setup
RNAi screening has been performed on LabTek chambered coverglass slides
like described in [RRB+11], respectively [Kum10] for the HCV, respectively
the DENV screen. In short, the experimental setup is as follows: seven
different plates are used to target the 719 different human kinases. Each plate
is repeated twelve (HCV) or six (DENV) times. Furthermore, three different
siRNAs are used to target each kinase using the siRNA library from Ambion
(Silencerr Human Kinase siRNA Library V3 (AM80010V3)). The siRNAs
have been reversely transfected into Huh7.5 cells as described in [ENL+07].
Incubation time of the LabTeks after cell seeding was 36 hours for the HCV
and 48 hours for the DENV screen. Then, cells of the HCV screen were
infected with an HCV GFP reporter virus and 36 hours later immunostained
with an GFP-specific antibody. For the DENV screen a wild type Dengue
virus (New Guinea C strain) was used for infection and an immunostaining
for envelope protein of the virus after 24 hours, to allow the quantification of
the viral infection. Images of each siRNA spot are analyzed using a scanning
microscope (ScanˆR, Olympus Biosystems) with a 10x objective (Olympus,
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cat. no. UPSLAPO 10x).
All siRNA spots with less than 125 cells are omitted from the analysis in
both screens to avoid inaccurate measurements due to too little cell numbers.
Analogously, spots with more than 500 cells are excluded since a too dense
cell population can lead to cell clumping and thus, to a different cell behavior
or saturation effects. Additionally, the quality of the images is controlled
for staining artifacts like out-of-focus images, intensity over-saturation or dirt
particles by eye inspection, resulting in an overall exclusion of 15% of the
images.
3.2.2 Image analysis and quality assessment
Beside the inspection by eye, the automatic image analysis system developed
by Matula et al. [MKW+09] has been used to analyze the image data of both
screens. Here, the DAPI and GFP signal can be quantified for each LabTek.
The first channel (DAPI) is representing the cell nuclei and the second channel
(GFP) the virus signal intensity.
In brief, the algorithm for image analysis designed by Matula and colleagues
contains four main steps:
1. Spot localization of knockdown (for RNAi microarrays)
2. Cell identification using the DAPI channel
3. Calculation of cell specific features
4. Measurement of viral fluorescence signal intensity
In the first step (required only if RNAi microarrays have been used) a
rectangle is manually entered into the first image, which had been marked
in advance. Then, this rectangle is copied to all other images according to a
specific grid matrix. In each rectangle, the software positions a spot according
to maximal difference of virus intensities between inside and outside of the
spot. This represents the knockdown are where the siRNA has been spotted.
In the second step, the DAPI channel is used to segment single cell nuclei by
applying an edge-based approach where a binary image f is calculated from
the input image g. For this, the results of the gradient magnitude and the
Laplacian operator are combined:
f(x, y) =
{
1 if |∇g| > T and |∇2g| < 0
0 otherwise,
(3.1)
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with ∇ being the Nabla operator, |∇g| = √g2x + g2y, ∇2g = gxx + gyy, where
gx, gy, gxx, gyy corresponds to first and second order partial derivatives of
g using an approximation based on Gaussian derivative filters [YGvV+95].
Furthermore, T is a threshold automatically determined using the unimodal
background symmetry method [vGvK11]. All the connected pixels with the
negative Laplacian which contain at least one pixel of the image f are selected.
After removing small connected components, the remaining components are
morphologically closed and holes are filled. Finally, for all segmented objects
several morphological features like size and circularity are calculated to
identify cells [MKW+09].
The objects are then specified further in the third step using the following
parameters:
• Position in spot (X- and Y-coordinates)
• Size of cell
• Size of nucleus
• Percentage of overexposed (saturated) pixels in cytoplasm
• Circularity of cell shape
In step four, the GFP channel is used to compute the virus signal of each cell
by taking the mean intensity inside the nucleus neighborhood. We assume
a direct proportionality between infection / replication efficiency and GFP
signal intensity. The neighborhood is defined as non-overlapping rings around
segmented nuclei (see [MKW+09]).
To quantify the data further, several features for each well or spot are
computed:
• Number of objects
• Number of cells
• Size statistics of cells
• Mean virus signal intensity
• Percentage of overexposed (saturated) pixels in cytoplasm
• Percentage of infected cells
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3.3 Data Analysis using AVERAGE Approach
The commonly used method at the moment, even for detailed microscopic
read-outs, is to calculate the mean or median of virus signal intensities of
all cells given in one well or spot [RRB+11, BHS+10, WRBB08, BBH06].
After summarizing the measurements the quality of individual spots or plates
is assessed using methodologies like described in Section 2.3.1. Thereafter,
standard normalization strategies like b-score, z-score or Lowess are applied
(see Section 2.3.2). Then standard hypothesis testing procedures like t-test
for normally distributed data or the Mann-Whitney Test for non-parametric
testing are used (compare Section 2.3.3) [PGB10, BSF+09, MHC+06, BBH06].
3.3.1 Quality Control
The data of the HCV screen has been analyzed (and published in [RRB+11])
using the AVERAGE method by taking the mean of the GFP signal intensi-
ties of all cells within one spot. Quality analysis on raw HCV data reveals
that positive and negative controls are not perfectly separated within each
replicate. An average DR of 2.8 (σ = 0.41) and an average Z’ factor of -1.23
(σ = 0.71) is observed. Doing the same analysis for the DENV data results in
dynamic range values which are slightly better (DR with µ = 2.15, σ = 1.67)
but mean Z’ factors are even worse with -6.87 (σ = 2.9).
The average coefficient of variation of raw signal intensities results in 0.1
(σ = 0.03) for the HCV and in 0.26 (σ = 0.1) for the DENV screen, showing
that the overall variance is higher for DENV data.
Furthermore, we calculated the mean and standard error of Pearson
correlation coefficient of replicate measurements resulting in 0.2 ± 0.008 for
HCV and 0.15± 0.01 for DENV of raw signal intensities. The large variability
of results between the replicate measurements is not surprising since we have
high number of replicates (twelve (HCV), six (DENV)) versus typically only
two to three for well-plate assays.
3.3.2 Normalization
Exemplary, in Figure 3.2 a scatterplot of mean raw signal intensities of all cells
per spot versus the number of cells in the corresponding spots of a randomly
selected plate of the HCV screen is given (the remaining plates look similar).
This indicates that the number of cells (measured in the DAPI channel) and
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Figure 3.2: Mean raw signal intensities of all cells per spot are plotted against
the number of cells in the corresponding spots of a randomly selected plate of
the HCV screen.
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the viral signal intensities (measured in the GFP channel) are correlated. To
quantify this, we calculated the Pearson correlation coefficient of the mean
virus signal intensities and the number of cells within each spot for all plates
of the HCV and the DENV screen. Results are shown in Figure 3.3. Plates
are enumerated based on the date where experiments have been done. In one
experiment each of the seven LabTeks of the two screens have been performed
once. For the HCV screen all but two of the plates are showing significant
correlations between the two channels (p-value smaller than significance level
of α = 0.05 using two-sided Fisher’s Z transformation test [SH06] on the
null hypothesis that Pearson’s correlation coefficient is equal to zero). In the
DENV screen eight plates are significantly correlated and 16 significantly
anti-correlated (p-value smaller than significance level of α = 0.05 using
two-sided Fisher’s Z transformation). There are several possible reasons for
the converse behavior of some plates in the DENV screen. It may be due,
for example, to different environmental conditions like different temperatures
when performing experiments on different dates. Independently from the
source of the dependency of the two channels, they have to be de-correlated
to unbias the data. For this, we applied the Lowess normalization strategy
(see Section 2.3.2) on the data, to minimize the Pearson correlation coefficient
values of the virus signal intensities and the cell counts in each spot (see
Figure 3.4). We did this for all plates of both screens to ensure a unique
treatment of the data, even if some plates did not show significant correlations
before.
After normalization, none of the plates of the HCV screen show significant
Pearson correlation coefficients with a p-value greater or equal to a significance
level of α = 0.05 using two-sided Fisher’s Z transformation and only two
plates of the DENV screen (p-value of 0.0016 and 0.0168). To conclude, in
general the Lowess normalization successfully de-correlates the two channels
in both screens.
Since the calculations of the DR and Z’ factor showed that controls are not
clearly separated and reliable on all plates, a normalization based on controls
cannot be used for between-plate corrections. As B-score normalization
is more robust than Z-score and it additionally corrects for spatial effects
[MHC+06, BSF+09], we use B-score to normalize all the plates of the DENV
and the HCV screen. Thereby, the high between-plate variations, quantified
with the low Pearson correlation coefficient values between replicate plates,
can be improved. Whereas the Pearson correlation coefficient (PCC) values
averaged to 0.2 ± 0.008 for HCV and 0.15 ± 0.01 for DENV of raw signal
intensities, after normalization they average to 0.28 ± 0.004 (HCV) and
0.23± 0.008 (DENV).
The twelve, respectively six replicate measurements of the HCV, respec-
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Figure 3.3: Pearson correlation coefficients of raw mean signal intensities of
all cells per spot and the number of cells in the corresponding spots of all plates
of the HCV screen (left) and the DENV screen (right). Plates are enumerated
based on the date where experiments have been performed (in one experiment
each of the seven LabTeks of the HCV and DENV screen have been performed
once).
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Figure 3.4: Pearson correlation coefficients of lowess normalized mean signal
intensities of all cells per spot and the number of cells in the corresponding spots
of all plates of the HCV screen (left) and the DENV screen (right). Plates are
enumerated based on the date where experiments have been performed (in one
experiment each of the seven LabTeks of the HCV and DENV screen have been
performed once).
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tively the DENV screen were then summarized by taking their mean. Since
data is normally distributed (p-value< 2.2 · 10−16 for both data sets using a
Kolmogorov-Smirnov test against normal distribution, see [SH06] for details)
the one-sample Welch’s t-test on the null-hypothesis of differential GFP signal
intensity per well has been used to calculate the significance of siRNAs. Then,
a combined thresholding for z-scores > 1.5 and for p-values ≤ 0.05 are applied
for hit identification.
Data analysis was performed using the statistical program R [R D09] and
the RNAither [RKEK09a] package from Bioconductor [Bio11b, GCB+04].
3.4 Data Analysis using the RIPLEY Ap-
proach
The HCV screening data has additionally been analyzed by Suratanee et al.
in the year 2010 [SRM+10]. The authors assume that viral infection is mainly
spread by cell-to-cell contacts and as a consequence of this, infected cells form
cell clusters. By systematically analyzing clustering patterns of individual
knockdowns, the RIPLEY approach aims at detecting knockdowns where in-
fected cells do not form such clusters and thus, the viral infection efficiency is
diminished.
Suratanee and colleagues use microscopy images and the point pattern analysis
method called Ripley’s K-function to define the degree of spatial clustering of
infected and and non-infected cells for each individual siRNA. For this, they
classify cells based on their virus signal into infected and non-infected using
a threshold defined by maximizing the difference in infection rates between
positive and negative controls. Then, the clustering behavior is studied us-
ing the inhomogeneous K-function as described by Baddeley and co-workers
[BMW00]:
Kinhom(r) =
1
|A|
N∑
i=1
N∑
j=1,i 6=j
eijIr(dij)
λ(yi), λ(yj)
, (3.2)
with r > 0 being a pre-given radius and N the number of cells observed in
the given area A (whole image). Furthermore, dij is the Euclidean distance
between cell i and j, and Ir(dij) equals to one if dij < r and zero otherwise.
The edge-correction factor eij is calculated by the border method [Rip81].
Moreover, λ(yi) and λ(yj) are estimated intensities at spots yi and yj using
the Gaussian kernel smoother [BMW00]. The radius range of r has been
chosen with 35% of the shorter side of the image. For the computation of the
clustering score the area between the curves of the inhomogeneous K-function
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and a simulated random distribution is calculated. If the score is positive
the curve of the inhomogeneous K-function is above the curve of simulated
random distribution and this indicates a tendency for clustering. If it is
negative no clustering is given. The authors computed clustering scores for
infected and non-infected cells. The final clustering score is calculated as the
difference of the score of infected and non-infected cells (see [SRM+10] for
details).
The RIPLEY approach has been applied on the HCV screen and cluster-
ing scores have been calculated for each knockdown on raw images without
performing any normalization [SRM+10].
3.5 Data Analysis using the CELL-BASED
Approach
In the AVERAGE approach all signal intensities for one spot are summarized
and individual cell measurements are completely neglected. Although, the
RIPLEY method uses a spatial approach which takes the spatial information
for infected and non-infected cells into account, other features defining each
cell (like cell morphology) are ignored. Thus, neither of the two methods
use individual cell information for normalization and for the identification of
knockdowns.
Since Snijder and colleagues [SSR+09] reported that each cell’s context highly
influences its phenotypic effect, our CELL-BASED approach aims at analyzing
the data based on several technical as well as cell context features. After
normalizing against the effects due to these features, we use an approach based
on the idea of gene set enrichment analysis to define hit siRNAs which are
significantly reducing the viral replication efficiency. For this, we assume that
for each knockdown there are two populations of cells coming from two normal
distributions of infected and non-infected cells.
3.5.1 Gaussian Mixture Model to Define the two Sub-
populations of Infected and Non-Infected cells
Figure 3.5 shows example microscopy images of the fluorescence signals of
the nuclei (DAPI) and the virus (GFP) signal for one negative (scrambled)
and one positive control (CD81, targeting the viral receptor of HCV) of the
HCV screen. We note, that the data in the DENV screen behaves similar
and therefore, the images are not shown explicitly. The Figure shows that
cells have an inhomogeneous virus signal even within the same spot (see GFP
channel of the CD81 control). In addition to the within spot heterogeneity,
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Figure 3.5: Microscopy images of one negative (scrambled) and one positive
(CD81) control in the HCV screen. The left panel shows the nuclei (DAPI)
channel and the right panel the virus signal (GFP).
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both controls clearly show a difference in the expressed GFP signal. As
discussed in Section 3.3.2 the overall viral signal intensity of individual spots
is dependent on the number of cells in that spot. However, this does not
explain the different viral intensity signals in the case of controls, where the
number of cells are almost the same. In numbers, there are on average 326.82
(standard error of 5.44) cells per spot for positive controls which directly
target the viral genome (HCV321 and HCV138) and 338.32 (standard error
of 3.43) cells per spot for negative controls (scrambled). Using a two-sided,
two-sample Welch’s t-test on the cell-counts in the positive and negative
controls, this results in a p-value of 0.11. Therefore,this shows no significant
apoptotic effect of the corresponding knockdowns. The same observation
holds for the DENV screen with 279.81 cells (standard error of 7.64) and
287.0 cells (standard error of 5.3) per positive (DV-NS5 and DV-NS2) and
per negative controls (scrambled), respectively (p-value= 0.46).
However, although in the DAPI channel no significant effect is measured
for controls, Figure 3.5 suggests that the knockdown of CD81 has a clear
effect on the viral replication since the GFP signal is clearly reduced in
comparison to the GFP signal of the negative control. To amplify this, we
show in Figure 3.6 the distribution of log-GFP signal intensity values of each
cell of the negative and positive controls, respectively, for the HCV screening
data (DENV screening data looks similar). The Figure shows that for both
Figure 3.6: Histogram of single cell log-transformed raw GFP intensity sig-
nals for controls (negative control: scrambled; positive control: CD81) in HCV
screen. The brown curve indicates the signal distribution of all cells in the entire
screen.
types of controls the distribution of the signal intensities is bimodal and we
assume that the two populations are reflecting infected and non-infected cells.
The brown curve corresponds to the signal distribution of all cells in the entire
screen and it perfectly matches the behavior of negative controls. The positive
controls instead show pronounced differences concerning the sizes of the two
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subpopulations. This indicates that the knockdown influences the bimodal
distribution where under optimal conditions (perfect transfection, knockdown
and infection efficiency) positive controls would show only background GFP
signal intensities, and negative controls maximal GFP signal intensities.
Thus, we assume that the size of the two distributions (mean and standard
deviation of the two Gaussians) is influenced by viral infection. To quantify
this, we use the Gaussian Mixture Model methodology.
Methodology
Since we aim at distinguishing between infected and non-infected cells of the
given signal intensities measured in the GFP channel of both screens, we divide
the data into two clusters. For this, we perform a model-based clustering using
a Gaussian mixture model with two components of the log-transformed GFP
cell signal intensities x as follows:
f(x) = α1N (x|µ1, σ21) + α2N (x|µ2, σ22), (3.3)
where αk with k ∈ {1, 2} is the probability that an observation comes from
the kth mixture component and αk ∈ [0, 1] with α1 + α2 = 1. Furthermore, µk
and σ2k are the mean and variance of each Gaussian.
The likelihood function for data coming from two univariate mixture compo-
nents is
p(x|α, µ, σ) =
n∏
i=1
(α1N (xi|µ1, σ1) + α2N (xi|µ2, σ2)) , (3.4)
with N (xi|µk, σk) = 1√
2piσ2k
exp− (xi−µk)2
2σ2k
being the Gaussian density function
and xi with i ∈ {1, . . . , n} being the signal intensity of the ith cell. For more
details see [FR07, Bis07].
In order to find the best model, model parameters αk, µk and σk are
estimated using Expectation-Maximization (EM) to maximize the likelihood.
EM consists of an iteration of two steps:
1. ‘E’-step: estimates the conditional probability that an observation xi
belongs to group k:
p(group = k|xi) = αkN (xi|µk, σ
2
k)
α1N (xi|µ1, σ21) + α2N (xi|µ2, σ2k)
. (3.5)
2. ‘M’-step: computes the maximum likelihood parameter estimates given
the probabilities from the ’E’-step:
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Raw data infected non-infected
HCV 5.5± 2.4 · 10−5 6.32± 1.4 · 10−4
DENV 6.71± 2.5 · 10−4 7.14± 2.6 · 10−4
Table 3.1: Mean and standard error of bimodal Gaussian mixture components
for infected and non-infected cells of the raw data of the HCV and DENV screen.
µk =
1
Nk
n∑
i=1
p(group = k|xi)xi (3.6)
σ2k =
1
Nk
n∑
i=1
p(group = k|xi)(xi − µk)2 (3.7)
αk =
Nk
n
, (3.8)
where Nk =
∑n
i=1 p(group = k|xi) and i ∈ {1, . . . , n}.
Initial estimates are obtained by splitting data into 0.5-Quantiles. So data
has been sorted according to increasing signal intensities and then, 50% of the
cells with smallest intensities are used to define group k = 1, and 50% of the
cells with highest intensities form group k = 2. Now, the initial µk, σ
2
k can be
computed directly by calculating the mean and standard deviation of the cell
intensities given in each group and αk = 0.5 in the initial estimation. Using
these values, the EM begins with its first ‘E’-step. It has been shown that
this yields good results for maximum likelihood estimations of mixture models
in practice [FR02]. Each update of the parameters increases the likelihood
function until the algorithm converges (see [Bis07] for details).
When using different initial estimates for the EM this can result in different
mixture components of the Gaussian distributions. However, since this clus-
tering is only used to support the idea of having two different groups of cells
(infected versus non-infected) and since we are not using the clustering for the
later data analysis, we are not further optimizing initial estimates.
Results
The results of these calculations are summarized in Table 3.1 for the log-
transformed raw virus signal intensities of the HCV and DENV screening data.
The Table shows that the two Gaussian distributions of infected and non-
infected cells have well separated means.
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In Figure 3.7 the distribution of the raw signal intensities of all cells of the
HCV screen is demonstrated. In addition, it illustrates the distribution of
simulated data. For the data simulation, we generated data points with two
(k ∈ {1, 2}) Gaussian distributions with µk, σ2k and Nk as computed with the
Gaussian mixture model. The Figure demonstrates that the mixture of the
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Figure 3.7: The black (straight) line shows the signal distribution of raw log
GFP signal intensities of all cells in the HCV screen. The red (dotted) line
represents the distribution of simulated data generated with the parameters as
computed with the Gaussian mixture model.
two Gaussians fits the data well. The same holds for the DENV data (not
shown explicitly). The discrepancies between the two distributions may be
due to noise of the data.
3.5.2 Normalization
Cell Context
According to Snijder and colleagues [SSR+09], each cell’s population context
greatly influence the phenotypic response. We assume that different viral sig-
nal intensity distributions between different spots are due to different amounts
of infected versus non-infected cells of individual spots. However, since cells
within individual spots of our data are not showing homogeneous signal in-
tensities (compare Figure 3.5 in Section 3.5.1), these effects are supposed to
be mainly due to population context parameters like described by Snijder et
al.. Therefore, we use a similar procedure like Snijder and colleagues to study
the population effect on virus replication in RNAi data of the HCV and the
DENV screen.
For this, each cell is described with six different population features. They are
calculated based on the DAPI and GFP channels extracted with the image
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recognition software implemented by Petr Matula [MKW+09] (compare also
Section 3.2.2). The six features are:
1. Nucleus Size: Size of the nucleus.
2. Cell Size: Size of the cell.
3. Cell shape: Circularity of the cell nucleus.
4. Cell number : Number of cells per spot.
5. Cell Density : Density of surrounding cells.
6. Population Border : Location (center or border) of the cell in a local cell
population.
The feature “nucleus size” is equal to the number of pixels after nuclei segmen-
tation given by the image-analysis software like discussed in 3.2.2 for each cell.
There is no stain for the cell cytoplasm and therefore, the size of the nucleus is
used to approximate feature “cell size” by dilating the cell nucleus mask. For
this, a ring around the nuclei of fixed size (six pixels to and six pixels out of the
nuclei center) is used. The “cell size” is given by the number of pixels of the
ring. According to this, the features “nucleus size” and “cell size” are highly
redundant with the “nucleus size” being the one having higher precision since
it is directly based on the DAPI channel. That is why the feature “cell size” is
several times replaced by the feature “nucleus size” in the following analysis.
The third feature is a descriptor of the shape of a cell, namely the inverse of
the cell circularity C = 4piA
P 2
where P is the perimeter and A the area of the
cell nuclei after segmentation. Thus, the feature is defined with:
cell shape =
P 2
4piA
. (3.9)
The inverse is used to transform the values into a range between zero and one
with being equal to one for perfectly circular objects and bigger than one for
more complex shapes.
Although there are no significant differences in cell counts for control spots
(compare Section 3.5.1) we showed in Section 3.3.2 that there is a dependency
of signal intensities and cell numbers per spot in both data sets. Therefore,
feature four -“cell number”- is given by the number of objects identified
as cells after cell nuclei segmentation within the spot area. It accounts for
different signal intensity levels due to different cell counts.
A Gaussian kernel density estimator [BA97] based on nuclei centers (X- and
Y- coordinates) is used to approximate the local cell density in feature number
five.
Finally, using the coordinate information given for each cells nuclei center
42 CHAPTER 3. RNAI DATA ANALYSIS
within a spot, the sixth feature defines whether a cell is located in a local
population or not. Since there are on average 261.33 (σ = 159.68), respectively
252.55 (σ = 124.19) cells per spot in the HCV, respectively the DENV screen,
we split each spot into a 15x15 grid. In each rectangle at least one cell
is located in an average spot. We count how many cells are positioned in
each single rectangle. Based on this, we define cells located in a rectangle
neighboring to at least one empty rectangle to be at the border of a local
population. This feature is binary with each cell being either at a population
border or not. To measure the influence of the grid size on the results, we use
additionally a 10x10 and a 20x20 grid in every spot. Both different grid sizes
do not change final results of the HCV and the DENV host dependency factors.
There are several possible features which can be additionally quantified us-
ing microscopic images. Example are the cell-cycle status, apoptotic cells and
cell elongation [FPK+10, NWH+10, WKIKG09, JCL+09, SSR+09]. However,
for high-throughput data as presented here we have several hundreds of cells
per spot, 384 spots per plate, and seven different plates repeated on twelve
(HCV) and six (DENV) replicates. This results in millions of individual cell
measurements for each feature and thus in a high dimensionality. Therefore,
we focus in this thesis on the features named above to make the analysis also
useful for large-scale screens such as whole-genome arrays. Nevertheless, the
inclusion of many more features for the data analysis is generally possible and
may be advantageous.
Technical Features
Apart from the population context features, we use four features to account
for technical (spatial or between-plate) artifacts:
1. Spot Border : Location of the cell in spot (center or border of spot).
2. Row : Row signal intensity median.
3. Column: Column signal intensity median.
4. Plate: Overall plate signal intensity median.
For the calculation of the first technical feature, the grid of rectangles like for
the calculation of feature “population border” is used. If a cell is within a
rectangle which is located at the border of the spot, the cell is defined to be at
the spot border and centered otherwise. The location of each cell is calculated
by the coordinates of its nuclei. We use this feature to show whether there are
phenotypic effects based on the position of cells within a spot. It is a binary
feature like the “population border” feature.
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The next two features estimate the individual row and column effects for each
plate and therefore, they address the spatial variation within plates. They are
calculated by taking the median of the signal intensities of all cells given in
the spot of the corresponding row or column per plate. For this, we are not
doing any correction for different cell numbers of spots within a single row or
column. This factor is addressed already using the cell context feature “cell
number”.
The last technical feature takes the median of all signal intensities of all cells
for each plate. This is an estimator for overall plate effects and accounts for
between-plate variation.
Estimation of Within-Bin and Between-Bin Variability
To estimate the effects on viral infection of the features named above, we
calculate a variability-ratio. For this purpose, we first reduce the huge dataset
size (similar to the procedure given in Snijder et al.), for a better data
handling by defining groups of cells with similar properties. The data in each
feature is divided into 5%-quantiles. Clearly, we use only two bins for the two
binary features which account for the effect whether a cell is at the border of
a bunch of cells or at the border of a spot.
We calculate the standard deviation of the viral cell signal intensities within
each bin i ∈ {1, . . . , n}. The average of these standard deviations is used to
estimate the within-bin variability (σwithin) for each feature:
σwithin =
1
n
n∑
i=1
σi, (3.10)
where σi denotes the standard deviation in the ith bin.
To calculate the between-bin variability (σbetween) we compute the standard
deviation between the means of different bins for each feature:
σbetween = σ(µ1, . . . , µn), (3.11)
where µi with i ∈ {1, . . . , n} denotes the mean of the signal intensities in the
ith bin.
The variability-ratio (Ratiovar) is now calculated for each feature by divid-
ing the between-bin variability through the within-bin variability:
Ratiovar =
σbetween
σwithin
. (3.12)
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Feature HCV screen DENV screen
Nucleus Size 12.96 16.24
Cell Size 12.42 16.3
Cell shape 1.81 5.62
Cell number 7.58 13.89
Cell Density 2.32 3.22
Population Border 6.57 9.72
Spot Border 4.9 7.84
Row 4.45 10.86
Column 4.29 11.91
Plate 14.35 38.9
Table 3.2: Percental variability-ratios of each of the cell features in the HCV
and the DENV screen.
We used, additionally to the 5%-quantiles, which results in 20 bins, different
bin sizes of 10, 50 and 100 corresponding to 10%-, 2%- and 1%-quantiles,
respectively, to measure whether this significantly influences the variability-
ratio. We calculated for each feature the CV (see Section 2.3.1) of the
variability-ratios of all bin sizes and observed CVs much smaller than 1
every time (CVmax = 0.24, CVµ = 0.05, CVσ = 0.08 for the HCV data;
CVmax = 0.32, CVµ = 0.05, CVσ = 0.1 for the DENV data). Thus, the
variations of the results are not significant.
To compare how largely the individual features influence viral infection
in comparison to the total variation observed in a population, we calculate
percental variability-ratios (Ratiovar ∗100 with Ratiovar like given in Equation
3.12) of raw data. The results are listed in Table 3.2 for HCV and DENV data,
showing considerable variability for individual features in both screens. For a
better comparison of the percental variability-ratios of individual features, we
visualized the results for both screens additionally in Figure 3.8 (feature “cell
size” has been replaced by “nuclei size” due to the reasons explained above).
The Figure clearly illustrates, that the highest influence on viral infection in
both screens is due to a technical feature, namely feature “plate effects”, with
a percental variability-ratio of 14.35% for HCV and 38.9% for DENV (compare
Table 3.2).
This is not surprising, since technical variability occurs in most screens and has
been reported several times before [BSF+09, MHC+06]. However, the second
most important parameter is the population context feature describing the cell
size. This confirms findings by Snijder and co-authors [SSR+09] who showed
that the cell context highly influences viral infection.
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Figure 3.8: Percental variability-ratio of cell context and technical features
of the HCV and the DENV data. Shown are the ratios of the between-bin
standard deviation to the average within-bin standard deviation, as a measure
of the fraction of the variation explained by the cell population or technical
feature under consideration. This quantifies the explained standard deviation
of the features with respect to single-cell viral infection efficiency. Blue bars:
HCV screen, red bars: DENV screen.
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Nevertheless, we observed considerable differences concerning the main con-
tributing factors of population features for DENV in comparison to Snijder
and colleagues. They measured six features for each cell: the size of the pop-
ulation to which it belongs, its local cell density, its position on a cell cluster
edge, its cell size, and its mitotic and apoptotic state. They showed that the
location of a cell at the edge or in the middle of a cell cluster is the most
important feature, followed by the local cell density. The cell size, which is
the most important cell context feature in our analysis, is the least important
factor in the study performed by Snijder et al. (see [SSR+09] for details).
This difference may be due to varying experimental conditions: First, both
studies use different cell lines for the experiments (Huh7.5 (screen presented
here) versus HeLa (Snijder et la.)). Second, Snijder and co-authors used 96
well-plates whereas we use chambered coverglass slides (LabTeks). As al-
ready reported in Section 2.2, this results in quantitative differences of seeded
cells (around 400-10.000 cells/well on well-plates in comparison to 100-400
cells/spot on LabTeks). Furthermore, individual wells are physically separated
using well-plates but not when using LabTeks. Third, the data measured by
Snijder and colleagues did not consider any knockdowns.
We suppose that due to at least one of these differences the cellular behavior
and thus, the viral signal is influenced in a different way within the two studies.
As a consequence of this, Snijder et al. identified not the same factor having
the biggest influence on virus infection like we do.
Figure 3.9 is illustrating the relative importance of the five population
context features (again “cell size” was replaced by “nuclei size”) for the HCV
and DENV screen in comparison to the total variability of the cell context
features. We note that the percentage of each population context is calculated
when assuming that all population features sum up to 100. However, this
is most probably not the case since not all features are supposed to be
independent from each other. The “cell size” for instance can be influenced by
the “cell number” or the “cell density”. Nevertheless we use this notation to
indicate once more that “cell size” is the most important feature (42% HCV,
33% DENV), followed by “cell number” (24% HCV, 28% DENV) and then
by the position of a cell in a local population (21% HCV, 20% DENV). Local
“cell density” and “cell shape” are the least contributing factors, however,
they nevertheless influence viral infection with 7% (both viruses) and up to
12% (DENV), respectively.
In Figure 3.10 the mean and standard deviation of the two most important
population context features “cell number” and “cell size” for the 20 individual
bins are shown for the HCV and DENV data to show how these features
influence the viral signal intensities. The feature “cell size”, for example,
shows a small decrease of the log signal intensities for low bin numbers, so for
small cells. Then, it increases and finally decreases again. This behavior is
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Figure 3.9: Relative explained standard deviation for cell context features
for HCV and DENV in comparison to the total variability due to cell context
features.
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(c) HCV: Cell Size
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(d) HCV: Cell Number
Figure 3.10: Mean and standard deviation of two selected features of the two
screens for the 20 individual bins. Low bins correspond to low cell sizes/cell
numbers.
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similar also for the different bin sizes of n = {10, 50, 100} (see Appendix A).
To test whether the data is linear or not we used the Harvey-Collier test
for linearity. This test performs a t-test on the recursive residuals [HC77] com-
puted with a linear regression model on the log signal intensities and the raw
features (without binning). We did not use binned features since the binning
has been used to allow a better data visualization and to identify most im-
portant features by the calculation of the variability-ratio. For the later data
normalization we use the full range of individual measurements to ensure the
most sophisticated analysis as possible.
The null hypothesis of the Harvey-Collier test states that the true relationship
is linear which means that the mean of the recursive residuals equals zero.
Based on a significance level of α = 0.05 the null hypothesis is rejected for
both the HCV and DENV screen (p-values≤ 2.2 · 10−16) for all features of the
DENV and HCV screen, except for the “spot border” feature of HCV (p-value
≤ 2.987·10−7) and the “column feature” of DENV (p-value ≤ 1.22·10−4) which
demonstrates the non-linearity. Due to these non-linear effects of the popu-
lation context and technical features, we use use a non-linear normalization
strategy.
Non-linear Normalization Strategy: MARS
For normalization of the single cell intensity values against the ten features
we use multivariate adaptive regression splines (MARS) developed by Jerome
H. Friedman in 1991 [Fri91]. MARS is a non-parametric regression technique
producing continuous models in a greedy heuristic approach.
The method assumes that a response variable y is dependent on predictor vari-
ables x = (x1, . . . , xn), given N measurements for all variables i ∈ {1, . . . , n},
so y = (y1, . . . , yN) and xi = (xi1, . . . , xiN). Furthermore, the system that has
generated the data is described by
y = f(x1, . . . , xn) + ε. (3.13)
The parameter ε is the error term and models the dependency of y to factors
apart from the given predictor variables, and which are not observed or
measured. We assume ε to be zero. Function f captures the joint predictive
relationship of y on x.
The aim of MARS is to build a function fˆ(x) that approximates f(x) based
on the given data. For this purpose MARS uses a weighted sum of multivariate
spline basis functions Bm(x):
fˆ(x) = a0 +
M∑
m=1
amBm(x), (3.14)
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where a0 is the coefficient of the constant basis function B1 and each am
for m ∈ {1, . . . ,M} is the coefficient of the basis function Bm given by the
best fit of the data. The number M of basis functions and the parameters
associated with them are directly determined by the data using residual sum
of squares (RSS) (for details see [SH06]) and a modification of generalized
cross-validation (GCV) [Fri91]. To ensure that the resulting function fˆ is
continuous at all points, each basis function Bm consists of the product of one
or several truncated cubic functions characterized by three “knots”. For more
details see [FR95, Fri91].
In the case of RNAi data the response variable is defined by the single cell
intensity measurements and the predictor variables by the ten features.
To normalize against the features, we subtract from each intensity measure-
ment yj for j ∈ {1, . . . , N} its fitted value after having calculated the best fit
fˆ(x) of the viral signal intensities:
y′j = yj − fˆ(x1j, . . . , xnj), (3.15)
where y′j is the jth corrected intensity value which estimates the residuals
accounting for population and technical artifacts.
To show that the normalization minimizes the effects of the individual
features on viral infection, we calculated the percental variability-ratios
(Equation 3.12) of the normalized data and compared it with those of the
raw data for HCV and DENV. Results are shown in the Tables 3.3 and 3.4,
respectively. The Tables demonstrate that MARS decreases the variability-
ratios considerably. In general, the variability-ratios are up to 14.39% (HCV)
and 38.9% (DENV) before we normalized the data and they are decreased to
a minimum of 4.89% (HCV) and 9.84% (DENV) after normalization.
There are two features (“spot border” and “cell density”) in the DENV data
which show slightly higher variability-ratios after than before normalization
(after: 9.84%, before: 7.84% for “spot border” and after: 3.23%, before:
3.22% for “cell density”). We assume that this can be explained by the
general high variability (compare Section 3.3) of the DENV data and the
very high feature space of the huge data set. Due to this, MARS is not able
to perfectly fit the data since it also aims at avoiding overfitting by using a
generalized cross-validation [FR95].
To study whether the assumption stated above that a non-linear regression
will result in a better fit than a linear one, we calculated the goodness-of-fit
(R2) of the MARS and of a linear regression. The results listed in Table 3.5
show that MARS has higher R2-values at least for the HCV data. For the
DENV data both values are equal.
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Feature before normalization after normalization
Nucleus Size 12.96 1.21
Cell Size 12.42 1.31
Cell shape 1.81 1.27
Cell number 7.58 0.56
Cell Density 2.32 2.28
Population Border 6.57 1.52
Spot Border 4.9 4.89
Row 4.45 0.42
Column 4.29 0.47
Plate 14.35 0.94
Table 3.3: Percental variability-ratios for each feature in the HCV screen before
and after normalization.
Feature before normalization after normalization
Nucleus Size 16.24 3.38
Cell Size 16.3 1.82
Cell shape 5.62 1.12
Cell number 13.89 1.24
Cell Density 3.22 3.23
Population Border 9.72 0.81
Spot Border 7.84 9.84
Row 10.86 0.89
Column 11.91 0.8
Plate 38.9 1.7
Table 3.4: Percental variability-ratios for each feature in the DENV screen
before and after normalization.
linear MARS
HCV 0.0344 0.0354
DENV 0.1464 0.1464
Table 3.5: R2 values of the linear and the MARS regression for the HCV and
DENV data.
3.5.3 Gene Set Enrichment Analysis Approach
In Section 3.5.1 we showed that the raw log virus signal intensities of the
HCV and the DENV data can be clustered into two Gaussian distributions of
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Normalized data infected non-infected
HCV −0.5± 3.63 · 10−5 0.34± 1.24 · 10−4
DENV −0.72± 1.71 · 10−4 0.21± 1.71 · 10−4
Table 3.6: Mean and standard error of bimodal Gaussian mixture components
for infected and non-infected cells of the normalized data of the HCV and DENV
screen.
positive control negative control
HCV 0.61± 0.002 0.4± 0.001
DENV 0.42± 0.002 0.21± 0.001
Table 3.7: Mean and standard error of mixture coefficients of the uninfection
cell component probability for positive and negative controls in the HCV and
DENV screens.
clearly separated means. This holds also for the normalized data. To verify
this we applied the model-based clustering using a Gaussian mixture model
of two components on the normalized HCV and DENV signal intensities. The
average and standard error of the resulting two Gaussian distributions are
given in Table 3.6 for both screens. The two population means of infected and
non-infected cells (-0.5 versus 0.34 for HCV and -0.72 versus 0.21 for DENV)
are clearly distant from each other.
Furthermore, Figure 3.6 in Section 3.5.1 indicates that the raw signal
intensities of cells within one spot have a bimodal distribution (infected versus
non-infected cells) with different mixture components (mean and standard
variation) of the two Gaussian distributions for positive and negative controls.
Table 3.7 lists the mean mixture coefficients of the uninfection cell component
probability αnon−infected for the positive and negative controls in both screens.
Since, the probability that an observation is coming from the population of
the uninfected cells is higher (HCV: 0.61, DENV: 0.42) for positive than for
negative controls (HCV: 0.4, DENV: 0.21) in both screens, we conclude that
knockdowns of genes required for viral infection or replication (virus host
dependency factors (HDF)) have a higher proportion of cells with weak signal
intensities.
To identify virus HDFs we want to find knockdowns which result in a shift
of the distribution away from the distribution of negative controls, towards
an increased number of non-infected cells showing only background signal.
Therefore, we use the distribution of the cells within one spot to assign each
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knockdown with a significance value.
For this, we apply the approach of gene set enrichment analysis (GSEA) to
test whether cell intensities after normalization given in one spot are enriched
to the infected or non-infected population.
GSEA
The idea of GSEA, which is one of the most popular strategies for detecting
differentially expressed gene sets, has been first introduced in the field of gene
expression analysis by Mootha et al. [MLE+03]. The GSEA used in this work
is based on the methods proposed by Sweet-Cordero [SCMS+05]. This is the
standard Kolmogorov-Smirnov test (e.i. [SH06]) applied on two running sums
which denote the number of sorted differentially expressed genes which are,
or which are not in the given gene set.
Using GSEA in the context of RNAi screens requires basically one change of
the original usage. Unlike in the analysis of gene expression data, the sets
are defined not by genes but by cells. These sets can be specified based on
different biological concepts, for instance, cells coming from one spot, one
siRNA or one gene.
GSEA starts with a list D with N samples and computes a statistical score
based on the correlation of the measurements (gj) to the phenotype of interest
for all j ∈ {1, . . . , N}. A variety of statistical scores, e.g., the t-score or signal-
to-noise-ratio can be used in this step ([AS09]). Based on this score, the list
D is sorted and a running sum statistic RS is calculated for each predefined
collection of genes G1, G2, · · · , Gm. The sorted list is processed from top to
bottom and the two running sums RSGk and RSG¯k are calculated. RSGk is
increased every time a sample belongs to Gk and RSG¯k each time a sample
belongs to the complementary set G¯k:
RSGk(i) =
∑
gj∈Gk
j6i
1
NGk
(3.16)
RSG¯k(i) =
∑
gj /∈Gk
j6i
1
N −NGk
, (3.17)
where NGk is the number of gj ∈ Gk.
Finally, an enrichment score ESGk for each Gk is defined as the maximal
deviation from zero of DIF, where DIF is the difference of the running sum Gk
3.5. DATA ANALYSIS USING THE CELL-BASED APPROACH 53
and its complementary set G¯k:
DIFi(Gk, G¯k) = RSGk(i)−RSG¯k(i) (3.18)
ESGk = DIFj(Gk, G¯k) where j = arg max
i
|DIFi(Gk, G¯k)|. (3.19)
GSEA and RNAi Data
In the case of RNAi experiments, cells within each single spot k are considered
as predefined sets Gk and the accumulation on top or bottom of the sorted
list of all cell intensities in the total screen is evaluated. The running sums are
calculated based on the ranked normalized viral signal intensities measured
in the GFP channel. Virus host dependency factors which decrease the viral
signal are characterized by a positive ES (enriched to the left and thus to the
population of infected cells).
To assess the significance of the obtained ES we use permutation testing.
We randomly permute the assignment of the cells with a specific spot, in
each plate. Then we calculate an ES of the permuted cells (ESperm) for
each spot and each plate. Thereafter, we take the average of the computed
ESperm of all plates. The distribution of the resulting averaged ESperm values
is used to calculate significance levels for the observed (unpermuted) data.
The bonferroni method accounts for multiple testing. We use a significance
level of α = 0.05 on the corrected p-values and a positive ES ≥ 1.5 times the
standard deviation of the combined ESperm to define hits.
In Figure 3.11 the DIF of the sorted cell intensity values for negative and
positive controls of a randomly chosen plate of the HCV screen is shown. The
remaining plates, and those of the DENV screen behave similar. Importantly,
the Figure visualizes that the DIF is different for the positive and the negative
controls. The DIF value is increasing until a maximum of about 0.2 is reached
and then decreasing again for positive controls. In contrast, the DIF of the
negative controls is fluctuating around zero. High positive ES values are an
indicator for virus HDF and values around zero indicate that the respective
knockdown is not influencing viral replication or infection.
Figure 3.12 shows the histogram of the median ES for each siRNA in the
HCV and DENV screen. Positive and negative controls are marked explicitly.
Interestingly, the positive and negative controls are perfectly separated for
the HCV data, but not for the DENV data where some positive controls are
not working properly. Most probably this is due to the higher variability of
the DENV data (see Section 3.3). However, since other quality measures like
other controls on the same plates or correlation between replicates were fine,
we decided to not remove the plates of the affected controls.
54 CHAPTER 3. RNAI DATA ANALYSIS
Figure 3.11: Computed DIF values for the four positive and seven negative
controls of a randomly selected plate of the HCV screen.
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Figure 3.12: Distribution of the median ES of all plates of the HCV and DENV
screens. The location of positive and negative control scores are indicated by
blue diamonds and red circles, respectively.
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In Figure 3.12 we observe furthermore, that there are three peaks of the
histograms in both screens. This tri-modality effect can also be seen in Figure
3.13, which illustrates each summarized ES per siRNA in the whole HCV
screen. The red curves visualizes the ES sorted by increasing order. The
Figure 3.13: Median ES over replicates of each siRNA in the HCV screen.
The siRNAs are plotted in the sequence as spotted on the plates and the red
line shows the siRNAs sorted by increasing ES.
tri-modality is caused by the computation of the median siRNAs of replicated
plates. Since we have an even number of replicates (twelve for HCV and six
for DENV) the median is around zero if exactly one half of the replicates has
positive and the other half has negative ES values. This reflects the peak in
the middle of both screens which is located around zero and corresponds to
siRNAs not having an effect on the phenotype. The siRNAs which have the
majority of replicates with positive or negative ES values occur in the right
or left peak, respectively. This tri-modality effect does not occur when using
the mean which, however, is less robust to outlier siRNAs.
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3.6 Hepatitis C Virus Host Dependency Fac-
tors
Using the CELL-BASED approach like presented above for normalization
and hit-scoring results in a hit list of 54 HDF which are significantly reducing
HCV replication (see Appendix B.1). We compared our results with results
derived with the AVERAGE and RIPLEY methods described in Sections 3.3
and 3.4, respectively. We computed pairwise Pearson correlation coefficients
between the z-scores, clustering scores and the enrichment scores calculated
with the AVERAGE, RIPLEY and CELL-BASED method, respectively.
Whereas the scores of the CELL-BASED and RIPLEY method are anti-
correlated (PCC=-0.48), the results of the AVERAGE and RIPLEY as well
as the AVERAGE and CELL-BASED method do not show any correlation
(PCC=0.02 and PCC=0.002, respectively).
Defining appropriate thresholds is a crucial step in defining relevant hits
and different filters may impose biases [Gof08]. Obviously, this is especially
true for the three scores compared in this study, which have been computed
differently. The z-score has been calculated based on how many standard
deviations the mean virus signal intensity per spot is above or below the
average of zero. The enrichment score is based on whether the virus signal
intensities of cells given for an individual spot are enriched in the set of
infected or non-infected cells. And finally, the clustering score indicates
whether infected cells show a local cell clustering within a spot.
Thus, especially for the results where individual scores are not correlated,
overlaps between individual hit lists may depend on the score thresholds.
Therefore, we decided to uniquely use the significance level of 5% for hit
identification as well as a score threshold of 1.5 times the standard deviation
of the underlying score distribution for all methods. For the analysis using
the RIPLEY method however, this would result in a hit list of only 14 genes
which is considerably less than for the other two approaches. Therefore, we
used all genes which have a p-value smaller than 0.05 and a negative clustering
score like proposed in the original publication [SRM+10].
Figure 3.14 shows the overlap of the hit lists, with only six genes being
significant HDFs found by all three methods. The overlapping genes are
the positive controls HCV321 and HCV138 which directly target the viral
RNA genome as well as CD81 which is the main entry receptor of HCV.
Moreover, the remaining overlapping genes are phosphatidylinositol 4-kinase
alpha (PI4KA) and casein kinase II subunit alpha (CSNK2A1) which have
already been reported to play a role in the HCV replication cycle (see
[LBN+09, VPC+09, BTP+09, TBP+09, TLDR+09, BCH+09], respectively
[KLC99]) and fms-related tyrosine kinase 4 (FLT-4) which has been suggested
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Figure 3.14: Venn-Diagram of the hits at the gene level using CELL-BASED,
AVERAGE and RIPLEY analysis methods.
to be related to HCV in earlier publications [AS09, SRM+10].
Furthermore, 44 genes have been identified using the AVERAGE approach.
Among them, 34 genes are also found using the CELL-BASED method which
results in an overlap of 68% and indicates high agreement between the two
methods. Interestingly, this is in contrast to the small Pearson correlation
coefficients (PCC=0.002) computed on the scores of both methods. Out of
the 30 genes identified with RIPLEY only 10 (33%) could be confirmed by the
other two methods, although the Pearson correlation coefficients on the scores
of RIPLEY and CELL-BASED was highly anti-correlated (PCC=-0.48).
RIPLEY and AVERAGE show an overlap of only eight genes (18%).
The small overlap of the RIPLEY method with the other two approaches
may be explained by the fact that the data is not normalized, neither against
technical, nor against cell context parameters. However, as shown in Section
3.5.1 theses parameters can highly influence the virus signal intensities.
Although, RIPLEY is considering the local cell neighborhood and does not
summarize virus signal intensities of individual cells like in the AVERAGE
approach, it is just a first step towards the analysis of RNAi data based on
single cell measurements. We assume that the method can be immensely
enhanced by considering normalization procedures like MARS presented
above.
The AVERAGE method, on the other hand, normalizes against technical fea-
tures or cell numbers. Individual cell measurements, however, are completely
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neglected. In the CELL-BASED approach we therefore combined both ideas
and normalized against technical and population context parameters by using
single-cell measurements.
3.6.1 Sensitivity and Specificity of Controls
We assume to produce more reliable hits when using individual cell data.
To evaluate this we calculate whether our approach identifies positive and
negative controls. We compute sensitivity and specificity values on controls
for different p-values and scores used for hit-calling. Then, receiver operator
characteristic (ROC) curves (see for example [SH06, Faw06]) are produced
and the area under the curves (AUC) is calculated for the three methods. We
note that in the two-class problem (positive and negative controls) random
guessing would correspond to a diagonal line in the ROC plot and an AUC of
0.5.
In Figure 3.15 the ROC curves for AVERAGE, CELL-BASED and
RIPLEY are shown. Although all ROC curves are much better than random
guessing, the CELL-BASED curve lies above the others and thus, outperforms
AVERAGE and RIPLEY.
This is furthermore represented in the AUC values which is best for CELL-
BASED with 0.99 in comparison to 0.95 and 0.87 for AVERAGE and
RIPLEY, respectively. For the AVERAGE method a loess normalization
was used to normalize for general trends between the mean viral signal
intensities and the number of cells within one spot. Furthermore, b-score
normalization was applied to normalize against spatial plate effects. The
AUC values show, that the AVERAGE method cannot minimize the in-
troduction of false positive and false negative for controls on a single spot
level as good as the CELL-BASED method by purely normalizing against
technical artifacts and cell counts. Thus, our approach is superior in terms
of both, sensitivity and specificity of identifying positive and negative controls.
Since our analysis approach consists basically of two independent methods
(normalization against the features using MARS and the statistical test based
on the idea of GSEA) we analyze which of the two methods contributes more
to the increased performance of classifying controls. Therefore, we use each
of the two methods independently on the HCV data. For the first method
(MARS-ONLY) we take raw log virus signal intensity values and normalize
them against the features. Then, we use RNAither [RKEK09a] to average the
cell intensities of one spot and compute z-scores for each spot. By applying a
threshold of 1.5 times the standard deviation of the z-scores of each replicate
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Figure 3.15: Receiver operator characteristic analysis of identified positive and
negative controls in the HCV screen. Sensitivity and specificity of controls is
computed for different thresholds on computed z-scores, ES values and cluster-
ing scores using AVERAGE, CELL-BASED and RIPLEY methods, respectively.
For all three methods additionally a significance level of 5% is used.
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we define hits on an individual spot level. We note, that the calculation of
significance levels for each spot is not possible in this method.
For the second method (GSEA-ONLY), we calculate ES on the raw log
virus signal intensities and use the nonparametric statistical test based on
permutations to calculate p-values for each spot. We use bonferroni corrected
p-values ≤ 0.05 and ES ≥ 1.5 times the standard deviation of median
summarized replicate ES for finding individual spots which significantly
decrease viral replication.
We perform for both methods a ROC analysis on individual control spots
and compute AUC values. MARS-ONLY results in an AUC of 0.971 and
GSEA-ONLY in an AUC value of 0.987. We note, that the GSEA-ONLY
method is applied on the raw intensities of the individual cell measure-
ments. In contrast, the single-cell data has been summarized for each spot
after the normalization in the MARS-ONLY method. Nevertheless, both
individual methods are able to yield better results in comparison to the
AVERAGE (AUC=0.95) and RIPLEY (AUC=0.87) approach. Yet, the
combination of MARS-ONLY and GSEA-ONLY in our CELL-BASED anal-
ysis approach gives the best result when compared to the stand-alone methods.
In addition, we summarize replicate measurements of MARS-ONLY by
taking their median and use a two-sample, two-sided Welch’s t-test to define
significance values for the individual siRNAs. We use an alpha threshold
of 0.05 on uncorrected p-values and 1.5 times the standard deviation of
z-scores to define significant siRNAs. The same is done for GSEA-ONLY,
although p-values for individual siRNAs are calculated based on the ES
using the nonparametric test. The overlapping genes of the resulting hits for
Figure 3.16: Venn-Diagram of the hits at the gene level using CELL-BASED,
MARS-ONLY and GSEA-ONLY analysis methods.
GSEA-ONLY, MARS-ONLY and CELL-BASED are 35 (see Figure 3.16).
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Among the 54 hits found using the combined CELL-BASED method 47 (87%)
are also found with the two independent methods.
To further compare the CELL-BASED method with the other approaches,
we compute the robustness of results over individual replicates for all of them.
We calculate average pairwise Pearson correlation coefficients of the scores over
the twelve individual replicates in the HCV screen. Similar results are obtained
for CELL-BASED, MARS-ONLY, GSEA-ONLY, and AVERAGE with 0.26±
0.004, 0.26 ± 0.004, 0.29 ± 0.005 and 0.28 ± 0.004 (mean ± standard error),
respectively. RIPLEY performs worst with 0.11±0.007 which is even less than
Pearson correlation coefficients of raw data (0.2± 0.008).
3.6.2 Validation screen
Published by Reiss and co-authors [RRB+11] a secondary validation screen
has been done on hit genes identified by the AVERAGE analysis method. We
use this validation screen to perform a more detailed evaluation of our method.
Here, we compute the sensitivity and specificity on the subset of genes tested
in the validation screen for varying z-score thresholds for the validation results
and varying ES score thresholds and adjusted p-values ≤ 0.05 for hits of
the CELL-BASED and varying p-values and negative clustering scores for
the RIPLEY method. We could not evaluate the AVERAGE method on the
validation screening data because this approach was used to select genes for
validation. Since no negatives were chosen for validation no true and false
positives can be calculated and therefore, no sensitivity and specificity values.
Figure 3.17 visualizes the AUC values for CELL-BASED and RIPLEY
over different increasing z-score thresholds on the validation data. The Figure
clearly demonstrates that for each z-score value in the validation screen the
area under the ROC curve value is much better for the CELL-BASED than
for the RIPLEY method. Therefore, CELL-BASED method is again showing
superior performance concerning sensitivity and specificity in comparison to
RIPLEY.
3.7 Pathway Analysis and Functional Annota-
tion of Host Dependency Factors
Using the CELL-BASED analysis approach we identified 54 HDFs for HCV
and 57 HDFs for DENV. The DENV hit list is tabulated in Appendix B.2.
For both screens we mapped the corresponding hits to KEGG [KG00] (see
Section 4.1.3) and Biocarta [Bio11a] using the functional enrichment analysis
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Figure 3.17: Area under the ROC curve values using CELL-BASED and
RIPLEY approaches over different z-score thresholds on an HCV validation
screen. Here, the intersection of predicted hits on the primary screen using
CELL-BASED and RIPLEY approaches with genes screened in the validation
screen is used to compute ROC curves and AUC values for varying ES values
and clustering scores, respectively.
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provided by DAVID [6.711] to select significantly enriched pathways. Results
of both screens are shown in Appendix B.3.
We identified 29 pathways being involved in HCV using the hits of the
CELL-BASED approach. Among them, 20 are significant with a p-value
≤ 0.05. In contrast, using the hits identified with the RIPLEY method
not a single pathway could be identified. Using the hits of the AVERAGE
method only two pathways are found and both of them have p-values ≥ 0.05:
Axon guidance (p-value = 0.061) and Purine metabolism (p-value = 0.082).
Purine metabolism has also been identified with the CELL-BASED method
(p-value = 0.04). Axon guidance plays a role in the formation of the
neuronal network and thus, it does not seem to be directly linked to HCV
signaling. Downstream signaling of this pathway, however, induces changes in
cytoskeletal organization which has already been reported to be involved in
HCV [RRB+11]. The hit genes found in the Axon guidance pathway are LIM
domain kinase 2 (LIMK2), Cofilin (CFL) and proto-oncogene tyrosine-protein
kinase Met (MET). LIMK2 and CFL play a role in the regulation of the actin
cytoskeleton and MET in mechanisms like endocytosis or focal adhesion.
All three processes have been identified using the hits derived with the
CELL-BASED method.
Beside the already mentioned endocytosis, focal adhesion, and regulation
of the actin cytoskeleton, enriched processes for HCV using the CELL-BASED
hits include signaling in the immune system, and the ErbB and MAP kinase
signaling. All have previously been reported to play a role in HCV signaling
by Reiss et al. [RRB+11] where they pooled their screen with other screens
published earlier. Notably, using the CELL-BASED method presented here
we identified the same pathways without the additional information of other
screens. This indicates once more the high sensitivity of our approach. A
further evidence of our results is, for example, the ErbB and the MAP kinase
signaling pathways, which have been reported to be of importance for HCV
and flaviviruses in general in 2009 [LBN+09].
Several additional pathways are identified, including regulation purine
metabolism, TLR signaling and several cancer-related pathways. To conclude,
this clearly shows that our approach results not only in an increased sensi-
tivity and specificity on an individual siRNA level, but also in an increased
sensitivity on a pathway level.
Using the hits of the DENV screen, we identified in total 20 enriched
pathways and 14 of them have a p-value ≤ 0.05. Enriched processes include
again focal adhesion, immune signaling, and the ErbB and MAP kinase
pathways. Thus, although the overlap of HCV and DENV HDFs is small
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at the gene level (7 genes) the enriched pathways are showing a significant
overlap (13 pathways (65%)), reflecting the close evolutionary relationship of
both viruses (compare Section 2.1.2).
3.8 Population Context of Non-Virus Screens
In viral RNAi screens, cells are not only transfected with a certain siRNA but
also infected with a virus. To test whether the high influence of population
context parameters on the phenotypic read-outs is true also for non-virus
RNAi screens, we use an image-based screen of an innate immune signaling
pathway using liposomal reagents.
Cells have been reverse transfected with siRNA on spots of LabTek chamber
slides. The signaling of the pathway under investigation has been triggered
by transfection of the cells with a defined stimulus. A few hours later, the
pathway activation in individual cells has been assessed by microscopy of a
fluorescent reporter.
Across the whole screen (about 2.4 Mio. cells have been analyzed) a strict
correlation between population context and the rate of pathway activation has
been detected. This is due to the vastly different susceptibility for liposomal
transfection among cells growing in different micro-contexts. Especially the
correlation between each cells local density is observable by eye-inspection.
To quantify this, we calculate the explained standard deviation of the rate
of pathway activation by the population context features for each plate.
The mean and standard deviation across replicated plates of the individual
population features are for Cell Size: 8.1 ± 2.57, Density: 9.24 ± 3.5, Cell
Number: 8.8 ± 2.4, Cell Shape: 8.16 ± 2.75 and for Population Border:
8.9 ± 8.3. Thus, the population context features show high effects on the
phenotype and thus, they have to be normalized to perform hit-calling.
Moreover, technical features average to 6.1±1.9 (Row), 4.4±2.1 (Column)
and 4.5 ± 2.71 (Spot Border). Analysis has been done on individual plate
level and thus, for the feature addressing the plate effect (Overall) no binning
has been performed. We calculate AUC values for the positive and negative
controls given in the screen after normalizing against the population context
and against the technical features and applying our approach for statistical hit
scoring. We received increased performance (AUC=0.66) in comparison to an
analysis without normalizing against the features (AUC=0.58).
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3.9 Discussion
In this Chapter we introduced a new approach for the analysis and statistical
processing of high-content, high-throughput microscopic screens. We used
individual cell measurements to remove the observed phenotypic effects
on viral infection and replication. Individual cell fluorescence intensities
have been normalized against population context and technical artifacts,
to reveal the true biological signal. We furthermore developed a statistical
testing procedure which uses a modified version of functional enrichment
analysis to assign each knockdown with a significance value. Based on two
large-scale RNAi virus infection screens we showed superior performance
concerning sensitivity and specificity of our method in comparison to two
other approaches recently published.
An evaluation based on individual cell measurements can exploit the
information contained in hundreds to thousands of cells in one spot. Thereby,
the biological variability of cells being in different states is taken into account.
Obviously, the cells within one spot are treated in the same way and are
not technical replicates. Thus, they are not independent from each other.
Nevertheless, we identified two clearly separated distributions of cells within
one spot. This shows that there are phenotypic differences of individual
cells even if they are treated in the same way. Our results show that the
integration of multidimensional phenotypes from high-content screens can
make data analysis and hit scoring much more specific. Taking the individual
cell measurements within each spot into account highly improves sensitivity
and specificity values. The number of false positives and false negatives
on single spot level is limited to a minimum resulting in an almost perfect
classification.
Previous infection screens targeting the same virus showed a very low
overlap of identified hits [Che09, Gof08]. Although this is improved when con-
sidering overlaps at pathway level, there is still a surprisingly high variability
in results. This finding has been also confirmed in our comparative analysis
using the AVERAGE, RIPLEY and CELL-BASED approaches, showing
significant differences in resulting hit lists of the same HCV screen. Since we
reported large influences of the cell population context on viral infection, and
this has been also described previously by Snijder and co-authors [SSR+09],
we conclude that the population factors contribute at least partially to this
problem.
Looking at the enriched pathways identified with the hit lists using the AV-
ERAGE and CELL-BASED approach, our results clearly show an increased
sensitivity. We found substantially more pathways than when using the
AVERAGE method (with the RIPLEY approach no pathways at all could be
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identified). Several of the discovered pathways have already been associated
with HCV and some are newly discovered.
Whereas Snijder et al. reported the location of a cell at the edge or in the
middle of a local cell cluster is the main contributing factor influencing DENV
infection, our results indicate that the size of the cell is the most important
cell context feature for DENV as well as for HCV. The difference may be
due to different experimental conditions like using different cell-lines (Huh7.5
versus HeLa), different platforms (LabTeks versus well-plates) and RNAi data
versus cellular data without any siRNA transfections.
Our results on a non-viral screen strongly indicate that the population
context not only influences RNAi infection screens. However, virus screens are
more complicated since the infection itself can induce virus phenotypic effects.
These cytopathic effects may directly influence a population context feature.
An infection may lead for example to larger cell sizes of infected cells. Normal-
ization against the cell size would then destroy the effects of the perturbations.
Since in the HCV and DENV there are no control spots without infections,
we cannot test whether the cells in our screens suffer from cytopathic effects.
However, the analysis with GSEA-ONLY, where we do not normalize against
cell population effects, results in similar sensitivity and specificity values on
controls, with the CELL-BASED method being even slightly better. This,
as well as the increased sensitivity of the CELL-BASED analysis on pathway
level, indicates that we do not destroy effects when normalizing against cell
context features, but allow a more sophisticated and improved analysis.
To conclude, high-content screening offers a powerful tool to further elucidate
virus host interactions in the future, with significant advantages over high-
throughput screens with low-dimensional, non-microscopy based readouts.
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Part II
Network Inference
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Chapter 4
Networks in Biology
This Chapter is part of the second part of this thesis where we describe how
RNAi data is used to infer signaling networks. RNAi experiments and sub-
sequent data processing allow the identification of genes related to a specific
phenotype. However, their spatial and temporal ordering within the biological
processes remain unknown. To understand the behavior of biological systems
in more detail, it is necessary to elucidate how individual genes interact with
each other. Graphs are an often used tool for the analysis and modeling of
such interactions. Therefore, we start this Chapter with giving a general back-
ground on graphs in Section 4.1. Then, Section 4.2 discusses the challenge of
inferring signaling networks from high-throughput gene perturbation data and
already published network inference strategies are explained. Furthermore, we
outline the advantages and drawbacks of each method.
4.1 Background
4.1.1 Graphs
Graphs provide an easy way to visualize and interpret the structure of related
entities. A graph G consists of a set of nodes V and a set of edges E that
connect the nodes, so graph G = (V,E). The edges can be directed (with a
parent and a child node) or undirected . Additionally, they can be allocated
with certain attributes, for instance numbers indicating the strength of the
relationship between the two nodes they connect. This is called edge weight
wij of the edge between node i and j with i, j ∈ E. If the graph is binary,
edges are either present (wij = 1) or absent (wij = 0).
A self-loop is an edge which connects a node with itself and a cycle allows a
walk from node v0 via an alternating sequence of edges and nodes back to
node v0. The degree of node v is equal the number of edges connected to
it. For directed graphs the in-degree, respectively the out-degree is defined
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to distinguish between the number of incoming, respectively, the number of
outgoing edges of a node.
A graph is connected if there is a walk between each pair of nodes, otherwise
it is disconnected. Furthermore, directed graphs can have root nodes (nodes
which have only outgoing edges) and leaves (nodes which have only incoming
edges).
There are several special types of graphs for example directed acyclic graphs
(DAGs) which are directed and without cycles or transitively closed graphs
where for each pair of nodes which are connected by a directed path a directed
edge exists between them. So if there is a path from node i to node j then
there is also an edge from i to j for all i, j ∈ E of graph G = (V,E). For more
details about graphs see for example [GCD+05].
4.1.2 Bayesian Networks
Bayesian networks are often used to infer signaling networks
[MBS05, Mar06, FSA+09, KDZ+09], see also Section 4.2.3.
Bayesian networks are DAGs whose nodes represent random variables and
whose edges the conditional dependencies. Unconnected nodes represent
variables which are conditionally not dependent on each other. A probability
function for each node defines the probability of its variable. The function
takes as input the values of the variables of the parent nodes.
Formally speaking, let G = (V,E) be a DAG with n ∈ N nodes, and X
be a set of random variables assigned to each of them. Then, X is a Bayesian
network with respect to G if its joint probability density function is given as
the product of the individual density functions, which are conditional to their
parent variables:
P (X1, ..., Xn) =
n∏
i=1
P (Xi|pa(Xi)), (4.1)
where pa(Xi) is the set of parents of node i ∈ {1, ..., n}. If a node has no
parent nodes, its probability distribution is an independent distribution. For
details about Bayesian network learning see for instance [NBBW07, Hec96].
4.1.3 Graphs in Biology
In biology, graphs provide an easy tool to understand, represent and model
data. There are various different applications of graphs in biology [GCD+05,
ZZC08], however, we focus here only on two of them, namely Gene Ontology
and biomolecular pathways.
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Gene Ontology Graphs
The Gene Ontology (GO) [Ash00] project is a bioinformatics initiative which
addresses the need of a standard representation of genes and their products
across different species and databases. The GO Consortium includes gene
product annotation data and enables its fast access and easy processing.
Furthermore, it provides a structured vocabulary of terms (which are identified
with an unique GO label) for describing gene products according to three
different ontologies:
• Molecular function:
Defines the elemental activities of a gene product at the molecular level.
• Biological processes:
Molecular events with a defined beginning and ending.
• Cellular component:
Part of the cell or its extracellular environment where a gene is acting.
The vocabulary terms are represented as nodes arranged in a DAG and
the relationships between them are defined as directed edges. The nodes are
arranged hierarchically, which means child terms being more specific than its
parents. Moreover, each edge is categorized by one of different types of rela-
tions such as “is a”, “part of” or “regulates”.
Biomolecular Pathways
Various different models of molecular networks have been constructed so far.
Examples are protein-protein interaction (PPI) networks, gene co-expression
networks or signaling networks [Alb05].
In PPI networks nodes represent proteins and their interactions are modeled
by undirected edges. Most often, edges are further specified for instance by
confidence scores about the reliability of the interaction. Large PPI networks
offer an expanded insight into the organizational principles and topological
properties. An example for this is network centrality, which is used to find
hub-genes. These genes are highly connected and essential for certain pro-
cesses [SWL+05, WWW+07].
Gene co-expression networks model highly correlated genes [BTS+00,
CBGB04, ZH05]. Nodes correspond to genes, and edges are significant pairwise
correlations of gene expressions measured for instance with DNA microarrays.
It is assumed that correlated genes are co-expressed and that co-expression is
a result of co-regulation and co-functioning [AKB04]. Therefore, co-expression
networks allow to draw hypotheses of the function of yet unknown genes. Fur-
thermore, they offer the possibility to compare processes across different species
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or different cell lines. For this appropriate tools to query the networks to find
cluster or sub-networks of conserved genes are given [ZZC08].
Signaling networks describe the interplay of different molecules to coordinate
biological activities within a cell. These activities can describe for example
gene regulations, responses to external stimuli or enzymatically catalyzed re-
actions. To store, publish and furthermore work with the different types of net-
works in a formal, ontology-based manner, they are integrated into databases.
KEGG (Kyoto Encyclopedia of Genes and Genomes) [KG00] is one example
of a public database resource. It consists of 16 main databases such as the
“KEGG PATHWAY” database. Biological systems within KEGG are repre-
sented via graphs where the set of nodes are KEGG objects (database entries)
and the edges are biological relationships. Similar to GO, each object is spec-
ified using an unique identifier. KEGG PATHWAY is a collection of manually
drawn molecular interaction/reaction graphs of metabolism and other cellular
processes arranged hierarchically. Various signaling networks are listed for a
wide range of biological phenomena, such as cell growth, apoptosis or differ-
entiation.
4.2 Networks and RNAi Data
While RNAi is a powerful tool to identify genes involved in a specific biological
process, the network inference out of RNAi data is a challenging task [MS06].
One of the problems is that the dimensionality of the network inference is
increasing exponentially with the number of nodes. For a directed graph of
n ∈ N nodes there are 2n(n−1) possible undirected network topologies without
self-activating edges [HP73]. Thus, a complete enumeration of the solution
space is not possible for large problems.
The combination of the RNAi technology with mRNA or protein expres-
sion measurements is an often used strategy to study the effect of individual
gene knockdowns on other genes. Thereby, it is learned how genes interact
with each other [FFS+07, FSA+09, MBS05].
Several authors use perturbation data in combination with database and lit-
erature knowledge to infer the network topology. Ourfali et al. [OSI+07]
formulated an integer programming approach to infer an integrated network
of protein-protein and protein-DNA interactions. For this, they use effects of
knockout data on gene expression levels and database information. A similar
approach has been published by Lan and co-authors [LSR+11]. They con-
struct signaling and regulatory networks by linking genetic and transcriptomic
screening data with data of known molecular interactions. However, both ap-
proaches are only possible if information of the respective proteins or genes are
already given. In contrast to these methods, several approaches do not need a
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pre-given interaction network and the signaling network is inferred purely from
the data. In the following, we discuss some of these approaches in detail and
explain whether they can deal with large-scale problems of high dimensionality
or not.
4.2.1 Nested Effects Model
Markowetz and co-authors [MBS05] developed a method called Nested Effects
Model (NEM) to infer networks from perturbation data. It is a computational
framework based on the nested structure of affected downstream genes which
scores network hypotheses in a Bayesian manner. Within their model they
distinguish two kinds of genes: S-genes and E-genes . S-genes (“S” stands
for “silenced” or “signaling”) are the candidate pathway genes silenced by
RNAi while the pathway is stimulated. The effects of the perturbed genes are
measured with the E-genes (“E” stands for “effect”) using DNA microarray
gene expression data. E-genes are downstream genes which are not part of
the model and considered only as reporters of the signal flow in the pathway.
Genes which show a high expression change are classified to be E-genes.
Assuming that the E-genes are transcriptional phenotypes regulated by the
S-genes on the second level, interventions to the S-genes interrupt the signal
flow throughout the pathway and can be directly measured using the E-genes.
Thus, given a candidate network topology of S- and E-genes and the position
of interventions, its agreement to the downstream response of experimental
data can be distinguished.
The work flow of NEMs starts with an adaptive data discretization:
The continuous microarray data is transformed to binary values using the
mean of positive controls for distinguishing between signal is interrupted or
not (corresponding to 1 or 0, respectively). Therefore, state 0 is naturally
given for all genes in a stimulated, unperturbed pathway. If the signal flow
cannot reach a node due to an intervention at some node upstream in the
pathway, its state is assumed to become 1.
Let µ+i and µ
−
i be the mean of the positive and the negative controls for E-gene
Ei with i ∈ {1, ..., |E|}, then the binary data Eik is defined as:
Eik =
{
1 if Cik < κ ∗ µ+i + (1− κ) ∗ µ−i ,
0 otherwise,
(4.2)
where Cik is the continuous expression level of Ei in experiment k
(k ∈ {1, ..., n}, with ideally n ≥ 5) and κ ∈ [0, 1] a parameter to con-
trol the false negative rate. This results in a binary matrix D = (eik) with
eik = 1 if Ei is showing an effect in experiment k.
The S-genes take the value 1 or 0 depending on whether the signaling has been
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interrupted or not. The S-genes which are in state 1 after the perturbation
of the S-gene S form the influence region of S. Furthermore, the set of all
influence regions are summarized in a silencing scheme Φ. Assuming each
E-gene has only one parent in S, its state is 1 if the parent gene is 1, and 0
otherwise.
The parameters Θ = {θi}mi=1 with θi ∈ {1, . . . , n} and m = |E| are used to
show if Ei is attached to Sj by setting θi = j. For computing the likelihood
P (D|Φ,Θ) the distribution of Eik is determined by using the silencing scheme
Φ and the error probabilities α and β. These error probabilities are estimated
from the positive and negative controls, where type I error α and type II error β
are the number of positive controls discretized to 1 and the number of negative
controls discretized to 0, respectively.
Since the silencing scheme Φ and the model parameters Θ are not known, the
authors make three assumptions:
1. Parameter independence:
P (Θ|Φ) =
m∏
i=1
P (θi|Φ). (4.3)
2. Uniform prior:
P (θi = j|Φ) = 1
n
for all i and j. (4.4)
3. The observations in D are sampled independently and identically dis-
tributed given the silencing scheme Φ and the model parameters Θ:
P (D|Φ,Θ) =
m∏
i=1
P (Di|Φ, θi). (4.5)
Using these assumptions the marginal likelihood P (D|Φ) of a silencing scheme
can be calculated with:
P (D|Φ) = 1
nm
m∏
i=1
n∑
j=1
l∏
k=1
P (eik|Φ, θi = j). (4.6)
To evaluate how good a silencing scheme Φ fits the data, Bayes’ formula is used
to score the silencing schemes by computing the posterior probability with:
P (Φ|D) = PD|Φ)P (Φ)
P (D)
, (4.7)
where P (D) is a normalizing constant which is the same for all silencing
schemes. The prior P (Φ) can be chosen to incorporate prior knowledge and
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the marginal likelihood is computed as shown above.
If a silencing scheme Φ is given, the posterior probability for an edge be-
tween Sj and Ei can be easily calculated with:
P (θi = j|Φ, D) = 1
Z
l∏
k=1
P (eik|Φ, θi = j), (4.8)
using a uniform prior for the E-gene position. Z is a normalizing constant
chosen that all probabilities for Ei sum up to 1 over all S-genes.
Different topologies can result in the same downstream effects and there-
fore, they are summarized into the same silencing scheme. The schemes are
sorted according their scores to find pathways which have maximum posterior
probabilities and thus, which best represent the data.
The authors applied their method on simulated data and on real biological
data studying the Drosophila immune response. The simulation studies show
that correct topologies can be reconstructed more easily if there are more
replicate measurements available. Having five replicates and low noise levels,
more than 90% of the networks could be reconstructed.
For the Drosophila data, a top scoring silencing scheme was computed for
four different S-genes, which fits perfectly to the assumed true topology. This
shows, that NEMs can be used to model and infer networks based on gene
expression data after RNAi gene perturbations.
However, there are several limitations of the model:
• The approach can be used only if the number of perturbations is much
smaller than the number of measured downstream effects.
• Several topologies may explain the data equally well and no unique so-
lution can be stated.
• Continuous expression data has to be transformed into binary values,
which results in a loss of information.
• For high number of S-genes (more than five) heuristics have to be used
to search the model space for the best-fitting topology.
• Only features of a pathway can be reconstructed from the indirect ob-
servations allowing only a rough recovery.
• No distinction between activating and deactivating edges is done.
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Apart from these disadvantages, the method which is presented in this thesis
is designed for another scenario. Instead of having only a small number of
perturbations which monitor indirect, high-dimensional downstream effects,
we aim at inferring networks from many interventions. These interventions
can come from single, double or even multiple knockdowns. Whereas in NEMs
each node correspond to one perturbation experiment, we consider each node
to be a single protein which may be influenced by others. In addition, we
want to learn activating as well as deactivating edges, and the data is allowed
to have missing values as well as nodes without any measurements.
Improvements of NEMs
There exist several improvements and extensions of the NEM approach:
• The original version of NEMs [MBS05] has been improved two years later
by Markowetz et al. [MKTS07] which makes the method feasible also for
larger number of perturbed genes. The authors use a divide-and-conquer
approach to infer the topology of all genes by constructing it from sub-
models which consist of only pairs or triples of genes. The authors show
on simulated data that they can accurately reconstruct network mod-
els by using smaller sub-models. Furthermore, using two real data sets
studying the response to microbial challenge in Drosophila melanogaster
and the compendium of expression profiles of Saccharomyces cerevisiae,
the authors show that their results reflect the functions of the involved
genes.
This approach is developed only for binary effects and it cannot distin-
guish between activation and deactivation.
• In 2007, Froehlich et al. [FFS+07] proposed three further extensions of
NEMs originally introduced by Markowetz et al. [MBS05]. First, they
show how to omit the data discretization step by using p-values which
define the likelihood of an E-gene being differentially expressed after a
certain perturbation.
Furthermore, the basic assumption of the model prior P (Φ) being uni-
form over all possible models is enhanced. This allows the integration
of prior knowledge. The scoring scheme introduced by Froehlich et al.
incorporates prior assumptions for each individual edge. In order to
avoid overfitting by simply believing in the data and biasing network
scores towards the prior, regularization techniques like the Akaike
information criterion (AIC) [HTF01] are used.
The last, and most important, enhancement makes the method also
applicable to high-order networks. For this, the authors present two
different approaches: a stochastic sampling approach called simulated
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annealing (SA) [KGV83] and a divide-and-conquer method called mod-
ule networks. In the module network approach complete networks are
recursively reconstructed from smaller sub-networks (modules) similar
to the improvement by Markowetz et al. proposed in 2007 [MKTS07]
discussed above.
Froehlich and colleagues applied their method on artificial data as well
as on the data already used in [MBS05] where they showed identical
results. Furthermore, they used data from the Human ER-α pathway to
show performance of their approach on a higher scaled inference problem
of 13 genes. The learned network topology was in good agreement with
literature knowledge.
• Tresch and partners extended in 2008 [TM08] the original definition of
NEMs in four ways. First, they use a different likelihood function of a
NEM which makes it applicable not only for binary data, but also for
p-values or other statistics which can be converted into a likelihood ratio.
Second, Tresch et al. show that this new likelihood formulation allows
to efficiently traverse the model space. Third, the authors show that the
maximum likelihood estimator recovers the true structure of the graph
if the data has a sufficient number of replicate measurements and thus,
that under mild conditions the model is identifiable. Fourth, it is shown
how prior knowledge can be incorporated and how measurement noise
can be decreased by feature selection and regularization.
The original NEM version [MBS05] can learn only transitively closed
graphs. In the formulation given by Tresch and colleagues this is ex-
panded to all directed graphs which reduces model bias. Based on the
data studying the Drosophila immune response, which has also been used
in [MBS05], the expanded version leads to results which are closer to ex-
isting biological knowledge than in the original publication. In addition,
simulation studies are used to show that the version published by Tresch
et al. reliably reconstructs interaction graphs.
• Anchang et al. [ASJ+09] proposed in 2009 a statistical method called
Dynamic Nested Effects Model (D-NEM) . This enhances the approach
of NEMs by taking temporal gene expression data into account. Fur-
thermore, it allows the modeling of the temporal interplay in the cell
signaling, and gene expression after observed time delays. The authors
could identify a feed-forward loop dominated network important during
embryonic stem cell self-renewal, showing high biological significance.
• Recently, Froehlich and colleagues [FPT11] presented “dynoNEMs”.
This is an extension of NEMs which enable the analysis of perturba-
tion time series data. It is complementing the attempt of the D-NEMs
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d
Figure 4.1: Example network topology with four nodes. The existence of the
red edge can be inferred only if there exists a double knockdown of nodes b and
c. See text for details.
and allows for the resolution of feedback loops as well as for the dis-
crimination of direct and indirect signaling. In dynoNEMs the signal
flow is unrolled over time. The authors applied their method on the
same dataset like Anchang and colleagues which studies the molecular
mechanisms of self-renewal in murine embryonic stem cells. Their results
were in a good agreement to the results of D-NEMs and with biological
literature.
Beside the drawbacks already mentioned, the improvements and extensions
of the NEMs discussed above have still a severe limitation. They do not use
perturbation data of multiple genes at the same time. This kind of data, how-
ever, can be essentially to distinguish between some topologies without using
time-resolved data. Assume for example a network of four nodes as given in
Figure 4.1. It can be seen immediately, that the existence of the red edge from
node a to c can be learned only if the double knockdown of the nodes b and c
or time-resolved data is given.
Although it is generally possible to include double and multiple knockdowns
into NEMs, it has not been implemented so far. Instead, they have been ex-
tended to D-NEMs and dynoNEMs which use time-resolved data. This makes
them not usable for our scenario: we aim at inferring networks purely from
steady-state data since time-course data are not always available. In addi-
tion, we want to reconstruct a network without the measurement of additional
E-genes. Furthermore, the approach shall be able to deal with large-scale
problems with twenty, thirty or more nodes, and to learn activating as well as
deactivating interactions.
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4.2.2 A Model using Probabilistic Boolean Threshold
Networks
Kaderali et al. presented in 2009 a Bayesian network approach for inferring net-
works out of gene knockdown data [KDZ+09]. Nodes are modeled as Boolean
random variables which can take two states: “on” or “off”. Assuming discrete
time steps t, the probabilities of the states are calculated as sigmoid functions.
These functions take the weighted sum of regulations from the parent nodes
at the previous time point as input:
p{xi(t) = 1|x(t− 1)} = 1
1 + exp(−λ(w0i +
∑n
j=1wj,ixj))
, (4.9)
where the Boolean random variable xi ∈ {0, 1}, i ∈ {1, . . . , n} corresponds to
a protein which can be activated or inactivated (1 and 0, respectively). The
model parameter wj,i ∈ R represents the strength of the effect of protein j on
protein i. The strength is zero if there is no effect and greater, respectively,
smaller than zero if there is an activation, respectively, a deactivation. The
parameters w0i ∈ R model the behavior of a protein i if no other proteins
regulate it. The stochasticity of the network with given w and w0 is controlled
by parameter λ.
The more parent nodes are activated, the higher is the probability of the
child node to be activated. Activation of a node can result in both, enhancing
and inhibiting effects on child nodes, depending on the sign of the regulation
weight. Obviously, the probability of a protein i being inactive at time point
t is given by:
p{xi(t) = 0|x(t− 1)} = 1− p{xi(t) = 1|x(t− 1)}. (4.10)
If parameters w and w0 are known, a state transition probability matrix M ∈
R2n×2n is defined with
Mi,j = p
{
x(t) = η(j)|x(t− 1) = η(i)} (4.11)
=
n∏
k=1
p
{
xk(t) = active(k, η
(j))|x(t− 1) = η(i)} , (4.12)
where x(t) = η(i) indicates that the system is in state η(i) at time t and
active(k, η(i)) is an indicator function which is 1 if xk(t) is active in state η
(i)
and 0 if it is inactive.
Assume an initial distribution p0 = p(η(0)) at time 0 and M to be given. The
probability distribution p(η(T )|M, p0) over the states of the system at time
T > 0 can be computed with:
p(η(T )|M, p0) = p′0MT δ(η(T )), (4.13)
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with p′0 being the vector transpose of the column vector p0 of the initial state
distribution and δ(η) ∈ R2n is defined with δi(η) = 1 if η = j and δi(η) = 0
otherwise.
In terms of RNAi data, the silencing of a protein k results in the deactiva-
tion of the corresponding node in the network. Then, xk is fixed to be 0 and an
updated matrix M−k can be computed by removing all rows corresponding to
states where k is active and by marginalizing over the corresponding columns.
Given the information of systematic single or multiple gene knockdowns and
initial state distributions, the network topology which fits the data most likely
can be determined using a Maximum likelihood approach:
p
{
D|w,w0, T} = K∏
k=1
p
(
η(k)(T )|M−k, p0
)
, (4.14)
where
{
η(k)(T )
}K
k=1
are the observed states of the system with η(k)(T ) being
the observed state of the system at time T after knockdown k.
The authors use Bayes’ theorem to infer the model parameters given the
observed data by computing the posterior distribution:
p{w,w0, T |D} = p{D|w,w
0, T}pi(w,w0, T )
p(D)
, (4.15)
where p{D|w,w0, T} is the likelihood, pi(w,w0, T ) is a prior distribution
on the model parameters and p(D)is a normalizing factor. Mode hopping
Markov chain Monte Carlo is used to evaluate the posterior distribution over
the model parameters. For small networks the exact likelihood is computed
whereas for larger networks it is approximated using stochastic simulation.
The prior distribution on model parameters is calculated using the Lq norm.
This forces the network topology to be sparse, which is commonly assumed to
be true for biological networks. For more details see [KDZ+09].
Evaluation of the proposed method has been done on simulated data
for five genes. The authors could identify the true as well as an alternative
topology even for parameter perturbations of up to 50%. In addition,
the Janus Kinases and Signal Transducers and Activators of Transcription
(JAK/STAT) pathway has been used to assess the performance on a real
biological data set. Kaderali and partners were able to correctly reconstruct
the core topology of the JAK/STAT pathway as given in [Pla05].
Similar to NEMs (Section 4.2.1) one of the disadvantage of this approach is
that data needs to be discretized to distinguish whether a node is activated or
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not. Moreover, this approach suffers from a high run time and computational
complexity. Therefore, it is only feasible for small-scaled networks even if
stochastic simulations are used for likelihood computations, which makes the
method not useful for the network inference on large-scale data, which is the
objective in the work presented in this thesis.
4.2.3 Deterministic Effects Propagation Networks
Deterministic Effects Propagation Networks (DEPNs) are a special Bayesian
network approach which allows the network inference from multiple interven-
tion data. The method was introduced by Froehlich and colleagues in 2009
[FSA+09]. Effects of perturbations of one or multiple genes at the same time
are studied by using protein expression level measurements from Reverse
Phase Protein Arrays (RPPAs) [TQL+06].
For the network inference three things are necessary: First, each protein of
interest is perturbed at least once. Second, the intervention effects on all other
proteins are directly measured, and third, there is one experiment where no
protein has been perturbed. If these conditions are fulfilled, the most likely
network topology can be reconstructed.
Even if there are latent nodes (correspond to proteins where no measurements
are available, but which have been perturbed), possible network topologies
can be inferred. Furthermore, the approach of DEPNs can deal with missing
data points.
In DEPNs, each protein corresponds to a node in the network graph Φ
with two possible states: perturbed and unperturbed. Measured effects x
(t,p)
i of
interventions p on individual nodes i after time point or experimental condition
t are modeled as two Gaussian distributions (perturbed/unperturbed) with
unknown mean and variance:
x
(t,p)
i |t, pa(i), p ∼
{ N (µti, σt2i ) p ⊆ pa(i) ∪ {i}
N (µ˜ti, σ˜t2i ) otherwise,
(4.16)
where p(a) corresponds to the set of parents of node i.
For each perturbation experiment the effects are calculated by defining a node
i to be perturbed if itself or its parents are perturbed. Thus, perturbations
are assumed to be deterministically propagated from top to bottom through
the network, where always transitively closed graphs are learned.
Furthermore, each protein measurement can be classified in being perturbed
or unperturbed, based on the control experiment with no gene perturbations.
And finally, the parameters (µti, σ
t2
i ) and (µ˜
t
i, σ˜
t2
i ) of the two distributions (per-
turbed and unperturbed) can be estimated, based on the measurement classi-
fications if the network structure Φ is known, in two ways:
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1. Maximum likelihood estimate: µti = m
t
i and σ
t2
i = s
t2
i where m
t
i and s
t
i
are the empirical mean and standard deviation, respectively.
2. Bayesian estimate: it is supposed that µti|σt2i ∼ N (µ0, σt2i /λ0) and σt2i ∼
Inv-χ2(α0, β0) where µ0, λ0, α0 and β0 are chosen in dependency of the
perturbation state. The marginal posterior distributions for µti and σ
t2
i
are calculated in analytical form:
µti|x(t,p)i ∝ tαn(µn, βn/λn) (4.17)
σt
2
i |x(t,p)i ∼ Inv-χ2(αn, βn), (4.18)
where tαn(µn, βn/λn) denotes the Student-t distribution with αn degrees
of freedom, location µn and scale βn/λn. The remaining parameters are
given by:
µn =
λ0
λ0 + ni
µ0 +
ni
λ0 + ni
mi (4.19)
λn = λ0 + ni (4.20)
αn = α0 + ni (4.21)
βn =
1
αn
(
α0β0 + (ni − 1)s2i +
λ0ni
λ0 + ni
(mi − µ0)2
)
, (4.22)
with ni being the number of observations which are used to compute the
conditional density for x
(t,p)
i . Furthermore, Inv-χ
2 is the scale inverse
of the χ2 distribution, and the posterior modes of µti|x(t,p)i are µn and
αn
αn+2
βn.
If a certain network topology is given, the above calculated parameters are used
to determine how likely it is that this is the true topology. Assume a data set
D = {x(t,p)i } with measurements of all proteins at all time points T under
perturbations P , and the vector of all estimated posterior mode parameters Θ
to be given. Then, the likelihood of a network hypothesis is calculated as:
p(D|Φ,Θ, P ) =
T∏
t=1
n∏
i=1
∏
p∈P
r∏
j=1
p(x
(t,p)
i |t, pa(i),Θi, p), (4.23)
where n is the number of nodes and r the number of replicate measurements.
Froehlich et al. employed the method on simulated as well as on real
biological data studying the ErbB receptor-regulated G1/S transition in
HCC1954 human breast cancer cells [SFL+09]. They showed that their
method can correctly reconstruct most interactions like given in the literature.
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Although the DEPNs do currently not distinguish between activating and
inactivating edges, they are designed for network inference problems similar to
those used in this thesis. They can deal with single as well as with multiple
knockdowns, they do not require time-resolved data and they can be applied
to problems which have up to dozens of nodes.
Dynamic Deterministic Effects Propagation Networks
Just recently, Bender and co-authors published an advanced DEPNs ap-
proach called dynamic deterministic effects propagation networks (DDEPN)
[BHF+10]. DDEPNs use time-resolved data to model the time-dependent
behavior of biological systems explicitly. The method seems to be promising
on simulated data with sensitivity and specificity values larger than random
guessing as well as on real breast cancer data studying ErbB signaling where it
predicts several already known signaling cascades. Nevertheless, it is designed
for a different scenario than for the model developed in this thesis since it
needs time-resolved data.
Chapter 5
Optimization Problems and
Solvers
The model to infer signaling networks from RNAi data introduced in this
thesis is formulated as a linear optimization problem. Therefore, we introduce
optimization problems and their solvers in this Chapter. We note, that the
Chapter is mainly based on [Hau03] and addresses the interested reader only.
Those who are already familiar with optimization problems and solvers, we
advice to directly go on to Chapter 6.
In the first Section of this Chapter, optimization problems are introduced in
general. Then, linear programming and the simplex algorithm which is used
to solve linear optimization problems are explained in more detail.
5.1 Optimization Problems
An optimization problem consists of:
1. The set L of feasible solutions, described by several equalities or inequal-
ities.
2. A real-valued objective function z which is minimized or maximized in
L.
That means, we are looking for:
x ∈ L : z(x) ≤ z(y) or z(x) ≥ z(y) ∀ y ∈ L, (5.1)
for minimization or maximization problems, respectively. In linear Optimiza-
tion, the objective function is a linear function and L is described with linear
equalities and inequalities. The solutions of linear optimization problems
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are in most cases non-integers. Linear optimization problems are solvable in
polynomial time [Sch99].
Integer linear programming means linear optimization with the restriction
that the solution has to be integer. Integer linear programming is NP -hard
[GJ79, Sch99, Hau03].
5.2 Linear Optimization Problems
The idea of linear programming (LP) has been first developed in the 1820’s
by Fourier. Later, in the 1940’s, its fundamental importance and usage was
shown by the work of Dantzig, Kantorovich, Koopmans, and von Neumann
(see [Sch99]).
Standard Form
LPs aim at the optimization of the objective function given by z. In general
every linear problem can be expressed in a standard form:
Definition 5.1:
Assume A ∈ Rm×n, b =
 b1...
bm
 ∈ Rm, c =
 c1...
cn
 ∈ Rn are given, then a
standard-maximum-program aims at finding x ∈ Rn which
maximizes z(x) := cTx (5.2)
s.t. Ax ≤ b
x ≥ 0.
An x∗ ∈ Rn is feasible for an LP if it satisfies Equation 5.2 and x∗ ∈ Rn is
optimal if it is feasible and optimizes the objective function z over feasible x.
Remark 5.1:
A standard-minimum-program is equivalent to a standard-maximum-program,
since cTx maximal ⇔ −cTx minimal.
Remark 5.2:
Every linear optimization problem can be formulated in the standard form
using the following transformations:
1. Inversion of an inequality by multiplication with −1.
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2. Replacement of an equation f(x1, . . . , xn) = d by the two inequalities
f(x1, . . . , xn) ≥ d and f(x1, . . . , xn) ≤ d.
3. Conversion of strict inequality restrictions “less than” or “greater than”,
i.e. f(x1, . . . , xn) < d or f(x1, . . . , xn) > d, respectively, to “less or equal
to” or “greater or equal to” by adding or subtracting extra non-negative
variables (slack variables ξ), i.e. f(x1, . . . , xn) + ξ ≤ d or f(x1, . . . , xn)−
ξ ≥ d, respectively. The cost of slack variables is zero in the appropriate
position in the linear program objective function (i.e. z(x) = cTx+ 0ξ).
4. Replacement of non-restricted variables (thus, neither xj ≤ 0 nor xj ≥ 0
is required) by xj = x
′
j − x′′j with the restrictions x′j ≥ 0 and x′′j ≥ 0.
Canonical Form
Definition 5.2:
Given is A ∈ Rm×n, b ∈ Rm, c ∈ Rn. A canonical maximum program searches
an x ∈ Rn which
maximizes z(x) := cTx (5.3)
s.t. Ax = b
x ≥ 0.
Similar, a canonical minimum program is defined for an x ∈ Rn which
minimizes z(x) := cTx (5.4)
s.t. Ax = b
x ≥ 0.
Remark 5.3:
Each canonical maximum program can be transfered into a minimum program
by exchanging c by −c.
Remark 5.4:
Each standard maximum program of the form given in Definition 5.1 can
be converted into a canonical maximum program by introducing additional
variables (slack-variables) (ξ1, ..., ξm) = ξ
T :
maximize z(x) := cTx+ 0T ξ (5.5)
s.t. Ax+ ξ = b
x ≥ 0
ξ ≥ 0.
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Analogously, each canonical maximum program like given in 5.3 can be trans-
formed into an equivalent standard maximum program by defining two in-
equalities instead of each equality:
maximize z(x) := cTx (5.6)
s.t. Ax ≤ b
−Ax ≤ −b
x ≥ 0.
Solution Space
To define the solution space in more detail, further definitions are required.
Definition 5.3:
K ⊆ Rn is called convex, if ∀ x1,x2 ∈ K and ∀ λ ∈ [0, 1] the following holds:
λx1 + (1− λ)x2 ∈ K. (5.7)
Definition 5.4:
The convex hull of K is the smallest convex set containing K and is denoted
with:
conv(K) = {λ1x1, . . . , λtxt|t ≥ 1;x1, . . . , xt ∈ K; (5.8)
λ1, . . . , λt ≥ 0;λ1 + · · ·+ λt = 1}.
Definition 5.5:
Let conv(K) be the convex hull of K, then p ∈ conv(K) is called an edge of
K if p = λx1 + (1− λ)x2 with x1, x2 ∈ conv(K) and λ = 1 (p = x1) or λ = 0
(p = x2).
Remark 5.5:
The set of edges can be finite, infinite (i.e. if K ⊂ Rn is circular) or empty
(i.e. if K = Rn).
Definition 5.6:
Let L be the non-empty set of feasible solutions of the canonical optimization
program
Ax = b, x ≥ 0 (5.9)
z(x) = cTx minimal,
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with A being a (m,n)-matrix with m < n and rank(A) = m. Then, AB =
{ak|k ∈ B} is called the set of column vectors belonging to x ∈ L, if∑
k∈B
akx =
n∑
j=1
ajx = Ax = b, (5.10)
where B ⊆ {1, . . . , n} is the set of indices k with xk > 0 (so xj = 0 for
j ∈ {1, . . . , n} \B).
Theorem 5.1:
Let L be the set of feasible solutions of an LP and Lopt the optimal solutions.
If L is non-empty, then L has a finite number of edges. There is an optimal
solution if and only if there are feasible solutions and if the set of feasible solu-
tions has an upper or lower bound for minimization or maximization problems,
respectively.
Proof. See [Hau03] Chapter 2.5.
Theorem 5.2:
Assume x ∈ L, then x is an edge of L if and only if the set of column vectors
belonging to x are linearly independent.
Proof. See [Hau03] Chapter 2.5.
Definition 5.7:
Given are Ax = b and AB as in Definition 5.6.
(a) If AB is non-singular, then AB is called a basis of A.
(b) If AB is a basis, then the variables which belong to the columns of
the basis are called basis variables and the others non-basis variables.
(c) The basis solution of Ax = b is the distinct vector xB, which basis
variables are defined by xB = A
−1
B b and all non-basis variables are
zero. The basis solution is therefore a feasible solution of Ax = b.
(d) A basis solution belonging to x with basis AB is called non-
degenerated edge if there are m entries unequal to zero (so xB =
A−1B b ≥ 0), and degenerated edge otherwise. Non-degenerated edges
have exactly one basis, which is exactly the set of column vectors.
Theorem 5.3:
A basic solution xB = A
−1
B b is a feasible solution of Ax = b with at most m
non-zero entries. If all elements of xB are non-zero, then x is also an optimal
solution of the respective LP.
Proof. See [Hau03] Chapter 2.5.
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5.2.1 LP-Solver: the Simplex Algorithm
The simplex method was first introduced by George Dantzig in 1947 and al-
gebraically formulated in 1951 [Dan51]. Geometrically, the feasible region of
Ax = b, x ≥ 0 is a (possibly unbounded) convex polyhedron, whose dimension
is limited by the number of variables. The extreme points are exactly the
edges of the polyhedron. If a linear program in standard form has a minimum
value on the feasible region, this is one of the edges. Thus, the optimization
problem can be solved by going along the lines of the polyhedron and finding
neighboring (more optimal) edges until the global optimal edge is found. Since
the polyhedron is convex, a finite extreme point which is not optimizing the
objective function is connected to an edge which has a better solution of the
objective function. Otherwise, the objective function is unbounded. There are
three cases of solutions:
• LP is not feasible, which means the polyhedron is empty.
• LP is unbounded, which means solutions can be infinitely high/small for
maximization/minimization programs.
• There is exactly one, or infinitely many solutions which are all lying on
a common line of the polyhedron.
In short, the simplex algorithm simply walks along the edges until the
optimum or an unbounded edge is found. However, the number of edges can
increase exponentially with the number of variables. Thus, the number of
extreme points can be huge even for small linear programs. For more details
see [Gro¨04, Hau03, Sch99].
More formally, assume a canonical minimization program as in Definition
5.4 to be given. The simplex consists of two phases:
1. Phase I:
Find a starting extreme point (edge) x0.
2. Phase II:
Use the basic feasible solution x0 as starting point. If it is optimal, the
algorithm is finished. Otherwise, find x1 ∈ E(L) with z(x1) < z(x0), or
there is no optimal solution and the linear program is called infeasible.
Phase I
Finding an edge x0 of L depends on the optimization problem. Two scenarios
are possible:
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1. Problem is defined as a standard maximization program:
Ax ≤ b, x ≥ 0 (5.11)
z(x) = cTx maximal.
WLOG assume b ≥ 0. Introduce slack variables ξ = ξ1, . . . , ξm that
(A|Im)
(
x
ξ
)
= b,
(
x
ξ
)
≥ 0 (5.12)
(−cT |0T )
(
x
ξ
)
minimal,
where Im is the m-dimensional identity matrix. Then x
0 =
(
0
b
)
is a
feasible solution since the column vectors belonging to x0 consist of Im
and thus are linearly independent. Therefore, x0 is an edge of L.
2. The program is already in the form of a canonical minimization problem:
Ax = b, x ≥ 0 (5.13)
z(x) = cTx minimal.
WLOG assume b ≥ 0. Then, solve
(A|Im)
(
x
ξ
)
= b,
(
x
ξ
)
≥ 0 (5.14)
0x1 + · · ·+ 0xn + ξ1 + · · ·+ ξm minimal,
where Im is the m-dimensional identity matrix. Then x
0 =
(
0
b
)
is a
feasible solution since the column vectors belonging to x0 consist of Im
and thus, they are linearly independent. Therefore, x0 is an edge of L.
The objective function of 5.14 is in the set of feasible solutions restricted
to zero and thus, there exists an optimal solution in the edge
(
x˜
ξ˜
)
of L.
If ξ˜ 6= 0, the objective function of 5.14 is greater than zero and there is
no possible solution for 5.13. If ξ˜ = 0, then x˜ ∈ L and x˜ is an edge of
the polyhedron of 5.13, since
b = (A|Im)
(
x˜
ξ˜
)
= (A|Im)
(
x˜
0
)
= Ax˜, (5.15)
and
(
x˜
0
)
is an edge of 5.14 with linearly independent columns of A.
For details see [Hau03].
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Phase II
Assume x0 = (x01, . . . , x
0
n)
T ∈ L being an edge. Let furthermore B ⊆ {1, . . . , n}
be the set of indices i with x0i > 0 and B¯ ⊇ B, |B¯| = m, with {as|s ∈ B¯}
being a basis of x0. Then,
aj =
∑
s∈B¯
τsja
s, ∀j ∈ {1, . . . , n}, (5.16)
with τss = 1 and τsj = 0 if s, j ∈ B¯ and j 6= s. For any x ∈ L, the following
holds:
b =
∑
s∈B¯
x0sa
s =
n∑
j=1
xja
j =
n∑
j=1
(∑
s∈B¯
τsja
s
)
=
∑
s∈B¯
(
n∑
j=1
τsjxj
)
as. (5.17)
Since as is a basis of x0, a comparison of the coefficients is possible:
x0s =
n∑
j=1
τsjxj =
∑
j /∈B¯
τsjxj + xs, (5.18)
for s ∈ B¯. This can be reformulated with
xs = x
0
s −
∑
j /∈B¯
τsjxj. (5.19)
This can be used to define the objective function with:
z(x) =
n∑
j=1
cjxj (5.20)
=
∑
s∈B¯
csxs +
∑
j /∈B¯
cjxj
=
∑
s∈B¯
csx
0
s −
∑
s∈B¯
cs
∑
j /∈B¯
τsjxj +
∑
j /∈B¯
cjxj (see Equation 5.19)
=
∑
s∈B¯
csx
0
s −
∑
j /∈B¯
(∑
s∈B¯
csτsj − cj
)
xj
= z(x0)−
∑
j∈B¯
(dj − cj)xj,
where
dj =
∑
s∈B¯
τsjcs, for j /∈ B¯. (5.21)
There are three possibilities:
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1. ∀ j /∈ B¯, dj ≤ cj, and thus, ∀x ∈ L, z(x) ≥ z(x0).
Thus, x0 is an optimal solution.
2. ∃ i /∈ B¯, di > ci and ∀ s ∈ B¯, τsi ≤ 0. If all feasible solutions xδ hold
that z(xδ) < z(x0), then the objective function is not lower bounded.
Thus, there is no optimal solution (for more details see [Hau03]).
3. ∃ i /∈ B¯, di > ci and ∀ k ∈ B¯, τki > 0, then there exists δ =
min{x0l /τri|l ∈ B¯, τli} where xδ is a solution of Ax = b, xδ ∈ L and
z(xδ) < z(x0). Based on Theorem 5.1 the algorithm terminates after a
finite number of steps with the optimal solution, or it terminates with
the result that there is no optimal solution (solution space not bounded).
For more details see [Gro¨04, Hau03, Sch99].
Complexity
Like mentioned at the beginning of this Chapter, the number of edges of a
polyhedron can increase exponentially with the number of variables and in-
equalities. Klee and Minty showed in 1972 that the worst-case complexity of
the simplex algorithm is therefore also exponential (O(2n)) [KM72]. In de-
generated linear programs (there exist two bases with the same basic feasible
solution), there can be the problem of cycles, where always the same edge is
calculated. Thus, the algorithm cannot terminate. However, in 1955 Dantzig,
Orden and Wolfe developed a generalized simplex method where cycling can
be avoided (see [DOW55]).
Borgwardt was able to show in 1982 that the average run time of the sim-
plex algorithm is only polynomial with performing O(n3m
1
n−1 ) many changes
of the basis [Bor82]. In practice, the simplex algorithm has proven itself to
be even more efficient than the ellipsoid method developed in 1979 by Leonid
Khachiyan, which is like the Karmarkar algorithm [Kar84], a polynomial al-
gorithm. However, both methods are not discussed here, for more details see
for example [Sch99].
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Chapter 6
A Linear Model for Network
Inference
To learn the signaling network of genes it is necessary to find how they
interact with each other. In terms of a network graph, this results in finding
the weights of the edges. Since there can be more than one possible networks
which best represent the data, the model presented here in detecting the
simplest and thus, the minimal one.
We assume that the signal transduction within the network is given as an
information flow. The flow begins from one or several source nodes S and it
is then propagated down through the network until it reaches one or several
sink nodes F . Thus, a protein a influences other proteins which are further
down in the network topology i.e. b, if there exists a path from a to b.
After the knockdown of a certain gene, its child nodes is supposed to show a
phenotypic effect. Therefore, we classify all genes in the study whether they
are active or inactive after each knockdown. Furthermore, the model assumes
that nodes are active, if the sum of incoming edge weights from parent
nodes are higher than a pre-given threshold and inactive otherwise. Based
on these assumptions, we formulate the network inference problem as an
optimization problem which uses the observed data to find a network topology
that minimizes the edge weights and fits the data best. It is flexible since
additional constraints can be easily formulated and only little restrictions are
imposed on the network structures such as the exclusion of self-regulating
edges. Cycles are allowed.
This Chapter starts with a Section where the linear model for the inference
of signaling networks from perturbation data is described. The second Section
describes how the theoretical and empirical sensitivity, specificity and precision
values are calculated.
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6.1 Linear Programming Model
Given are n ∈ N different genes and K ∈ N different knockdowns of one or
several genes at the same time. The model presented here can deal with data
where each gene has been silenced at least once, so K = n, but also missing
data with K < n or data with additional double or multiple knockdowns
(K > n) is possible. The Model is developed for the use with RNA interference
data, however, all kinds of perturbations can be used as long as the phenotypic
response of the remaining genes can be quantified in an observation matrix :
Definition 6.1:
An observation matrix X is defined as the measurements of genes i ∈
{1, . . . , n} after knockdowns k ∈ {1, . . . , K} with xik ∈ R≥0, ∀{i, k} where:
xik
{ ≥ δi if gene i is inactive after knockdown k
< δi otherwise,
(6.1)
and δi is calculated from the data.
The δi are for example chosen as the mean of δik for all k knockdowns of
gene i. Another possibility is to use a reference value for each gene where no
genes have been perturbed. We note that the δi can be different for different
genes i.
Definition 6.2:
An activation matrix B is defined with bik ∈ {0, 1} where
bik =
{
0 if gene i has been inactivated in knockdown k
1 otherwise.
(6.2)
Double or even multiple knockdowns can be easily handled by setting the
respective entries of B to zero.
The signaling network is represented as a weighted directed graph
G(V,W ) where the vertex vi ∈ V represents a gene and the edge wij ∈ W the
connection of gene i to gene j. If i and j are connected wij 6= 0 and wij = 0
otherwise. If the edge weight wji > 0 node j activates i and if wji < 0 node j
deactivates i. The larger |wij| the higher the evidence that gene i influences
gene j.
Remark 6.1:
The observations of all nodes are assumed to be in steady state, so xik(t+1) =
xik(t), ∀{i, k}. Moreover, there are no self-regulating edges, so wii = 0, ∀i.
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The LP Model
Assume we are looking for a network topology which has at least one given
source node S and one given sink node F (the case if no source and/or sink
node are given is discussed in Section 7.2.2). The LP model is defined as:
Definition 6.3:
min z∗(w+ji, w
−
ji, w
0
i , ξl) :=
(∑
i,j
(w+ji + w
−
ji) +
∑
i
w0i +
1
λ
∑
l
ξl
)
(6.3)
s.t. if xik ≥ δi and bik = 1 : w0i +
∑
j 6=i
(w+ji − w−ji)xjk ≥ δi (6.4)
if xik < δi and bik = 1 : w
0
i +
∑
j 6=i
(w+ji − w−ji)xjk ≤ 0 + ξl (6.5)
if i ∈ V \ S :
∑
j∈V,j 6=i
(w+ji + w
−
ji) ≥ δi (6.6)
if i ∈ V \ F :
∑
j∈V,j 6=i
(w+ij + w
−
ij) ≥ δi, (6.7)
where the objective function z in equation 6.3 is minimized, to keep the
network sparse with most edge weights being zero. This minimization is
done over three terms: the first term accounts for the absolute edge weights
wji = w
+
ji + w
−
ji with w
+
ji, w
−
ji ∈ R≥0 for i, j ∈ {1, . . . , n} modeling whether
there is a gene-gene connection between i and j (wji 6= 0) or not (wji = 0).
The second term optimizes offset variables w0i ∈ R≥0 with i ∈ {1, . . . , n}
which denote the baseline activity of the genes. The third term enables to
deal with noisy data by using slack variables ξl ∈ R≥0 with l ∈ {1, . . . , |Ξ|},
where Ξ = {xik|xik = 0, ∀{i, k}}.
The “penalty” parameter λ ∈ R≥0 is defined as a non-negative parameter to
control the introduction of the slack variables ξ. Intuitively, if λ = ∞ slack
variables can be infinitely high, and if λ = 0 slack variables are not allowed.
To determine parameter λ we use Leave-One-Out Cross-Validation (LOOCV).
For this, every single observation xik ∀i, k is removed once. The remaining
data is then used to infer a network topology with the LP model. Using the
learned topology, the state of the removed gene is predicted by using one
of two Gaussian distributions. The choice of the distribution depends on
whether the state is assumed to be active or inactive. Then, the mean squared
error (MSE) between the prediction and the real observation is computed for
100 predictions in each cross validation step.
To restrict the range for the parameters λ, we define an upper bound on λ. It
is not allowed to be larger than |Ξ| ∗ σ2(xik) with σ2(xik) being the variance
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of the observations xik, ∀{i, k}. This bound is chosen based on the worst case
where are all |Ξ| slack variables are unequal to zero. The introduction of slack
variables is necessary whenever there are contradictory equations which are
most probably due to noisy data. Thus, the higher the variance of the data
the higher the slack variables can become.
The constraints 6.4 and 6.5 specify the effects of the knockdowns. We
assume that the activity of each gene i is given by the sum of its baseline
activity (w0i ), and the activity of its parents (xjk, j 6= i). The activities of the
parents are multiplied with the corresponding edge weights (w+ji − w−ji) after
knockdown k. If gene i is observed to be active after the knockdown k, so
xik = 1 (and it has not been silenced, so bik = 1), the sum of all incoming edges
and its baseline activity has to be greater or equal to δi (constraint 6.4) and
smaller or equal to zero otherwise (constraint 6.5). Since we want to model ac-
tivating, inactivating and no gene interactions (so edge weights being positive,
negative or zero), the edge weights wji have been replaced by w
+
ji − w−ji with
w+ji, w
−
ji ∈ R≥0 according to Section 5 Remark 5.2 in the constraints 6.4 and 6.5.
The inequalities given in 6.6 and 6.7, respectively, force each node which
is not a source or sink node to have at least one incoming and one outgoing
edge, respectively. Since the edge weights can be positive or negative, the
variables w+ji and w
−
ji have to be added like in the optimization function z, to
ensure that the absolute values of wji are considered.
Both constraints (6.6 and 6.7) are necessary to avoid lose ends. By lose ends
we mean for example a node which is not a source node but has no incoming
information flow, or a node which is not an sink node but has no outgoing
information flow. Although these inequalities help, they do not ensure that
the resulting network topology is connected. For example if cycles are learned
(i.e. node a activates node b, which activates node c, and c activates a in
turn) each node might have an incoming and outgoing edge but nevertheless,
they are not connected to the source and sink nodes. This problem cannot
be solved using a linear model approach as presented here, since it would
make edge weights dependent on each other. Consider for example a network
with four nodes a,b,c and d, where a is a source and d a sink node. Then,
there are three possible network topologies (irrespective whether an edge is
activating or deactivating) which do not have lose ends (see Figure 6.1). The
edge between a and b can be zero if and only if there is a connection from a
to c and from c to b (Figure 6.1, second topology). Otherwise, the network
topology has to be like the first or the third topology given in Figure 6.1.
Hence, the connection from a to b depends on the other inferred connections
and therefore, the inference of edges of a network where lose ends are not
allowed is dependent on a given topology. Thus, to force the inference of
connected networks it is necessary to explore the whole search space. This,
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a b c d1.
a c b d2.
a d3. b
c
Figure 6.1: Possible connected networks with four nodes. There are three
possible network topologies, where the assumption that node a is a source and
node d a sink node holds, and where no lose ends (so all nodes are connected
with the source and sink node) are given.
however, we avoid as we aim at inferring signaling networks in a fast and
efficient manner. This makes our model useful for large-scale problems of
dozens of nodes.
We note, that in contrast to DEPNs [FSA+09] the model presented here
does not require a reference experiment with no knockdown. In addition, it is
not necessary that each gene of interest has been silenced at least once.
6.2 Performance Evaluation
To quantify the performance of a model on simulated data, sensitivity,
specificity and precision values are calculated. The model presented here
is able to infer three types of edge weights: negative, positive and zero.
Therefore, the classical two class receiver operating characteristic (ROC)
[SH06, Faw06] can be extended to the three class problem .
For the calculation of the performance analysis we first define how predicted
edges are classified (along the lines of [MRRK09]). A predicted edge is
defined to be a true positive (TP) if it is actually existing in the underlying
true network which has been used to simulate the data, and if its sign is
correct (so positive if it is actually an activating edge and negative if it is
an inactivating edge). True negatives (TN) are given by non-existent edges
of the learned network which are also not present in the true topology.
Furthermore, we denote false negatives (FN) as falsely predicted non-existent
edges (independent whether they are activating or inactivating in the true
topology). Finally, false positives (FP) are all edges which are predicted with
a wrong sign or which are predicted to exist when they are non-existent in
the true topology. This can be summarized in a confusion matrix given in
Table 6.1.
After calculating the TP, FP, TN and FN values, they are used to compute
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Predicted
positive edge negative edge non-existent edge
positive edge TP FP FN
True negative edge FP TP FN
non-existent edge FP FP TN
Table 6.1: Confusion matrix of the three-class classification problem.
the performance measurements with:
Specificity =
TN
TN + FP
(6.8)
Sensitivity =
TP
TP + FN
(6.9)
Precision =
TP
TP + FP
. (6.10)
This allows the calculation of the ROC of an inferred network. Furthermore,
it enables the computation of the area under the curve (AUC) value for a
ROC-curve as well as for a precision to recall curve (PR-curve), where recall
is equal to sensitivity.
For the calculation of the AUC values for random networks which have
the same properties (number of positive and negative edges) like the true
underlying topology, we permute the edges of a given network and assign
them to nodes chosen randomly among the network nodes. This is repeated
1000 times and every time the AUC is computed for the random topologies.
The average AUC of the 1000 runs represent the performance of randomly
generated networks.
6.2.1 Implementation and used Hardware and Software
All calculations of this thesis have been carried out using a Linux cluster with
dual-processor 3.1 GHz XEON quadcore machines with 16 GB RAM. R version
2.12.1 has been used to implement all functions necessary for the LP model
given in 6.1 and the cran [R D09] package “lpSolve” version 5.6.5 [Bo10] has
been used to solve the LP models. lpSolve is an interface to the open source
linear and integer programming solver lp solve version 5.5. which uses the
simplex algorithm for calculating the optimal solution of LPs.
Chapter 7
Applications on Simulated and
Real Data
In this Chapter, we evaluate the performance of our LP model based on dif-
ferent types of simulated data. We compare results with those derived with
the already published method DEPN [FSA+09] and random guessing. First,
we simulate data for a small-scale artificial five-node network to test the per-
formance of different settings of noise and missing data in Section 7.1. Then,
networks of different sizes are extracted from existing interaction pathways
given in KEGG [KG00] in Section 7.2. Based on these networks, data is simu-
lated and the DEPN approach and the LP model are to infer the true topologies
from this data. We show that the LP model outperforms the DEPN approach
in terms of prediction performance and computation time (Section 7.3). A real
data set studying ErbB signaling is used to apply the LP model on a biological
problem in Section 7.4. We identified several already known interactions of the
ErbB signaling pathway as well as identify new ones. Finally, the Section 7.5
presents a discussion of this Chapter.
7.1 Five-Node Example Network
Assume the artificial network topology of Figure 7.1 to be given. For this
network we simulated experimental measurements for five single, and one
double knockdown as well as for one reference experiment as listed in the
perturbation matrix (Table 7.1).
For each of these experiments we computed the expected downstream effects.
This results in an observation matrix where the observations are coming
from two Gaussian distributions, one for activated and one for inactivated
genes. A node i is assumed to be active if i is not perturbed and if among its
parents more activating than inhibiting parents are active, so if its “inflow”
is activating and node i is assumed to be inactive otherwise. Root nodes are
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2 3
1
4
5
Figure 7.1: Five-node example network topology. Arrows indicate activation
and between the node 3 and the node 4 an inactivation is shown.
gene i
knockdown k 1 2 3 4 5
1 0 1 1 1 1
2 1 0 1 1 1
3 1 1 0 1 1
4 1 1 1 0 1
5 1 1 1 1 0
6 1 0 0 1 1
7 1 1 0 1 1
Table 7.1: Perturbation matrix B of the five-node example, where bik = 0
if gene i has been silenced in knockdown experiment k with i ∈ {1, . . . , 5}
and k ∈ {1, . . . , 6}. The sixth row corresponds to the double knockdown of
gene 2 and 3, and the last row represents a reference experiment without any
knockdown.
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assumed to be active if they are not perturbed.
For nodes which are determined to be active after a perturbation, we
model their activity to come from the distribution N (0.95, σ), and from
the distribution N (0.56, σ) for inactive ones. These distributions are cho-
sen in agreement to the average of the activation and the inactivation,
respectively, as determined for the real data (Section 7.4). Furthermore,
σ ∈ {0, 0.01, 0.1, 0.2, 0.27, 0.3, 0.4, 0.5} is used to simulate different amounts
of noise level in the data. The parameters δi are defined to come from a
Gaussian with N (0.755, σ), where 0.755 is determined by taking the average
of the means of the activating and the deactivating state distributions. In the
following we show network inference results of data simulations for noisy and
incomplete data.
7.1.1 Noisy Data
To simulate noisy data we generate 100 times a dataset with three replicate
measurements using the activation and deactivation conditions as explained
above. For the network inference, we first use the LP model on each generated
data. Replicates are summarized by taking the average. The corresponding
LPs have been solved with λ being 0 ≤ λ ≤ |Ξ| ∗σ2(xik) (step size of 0.1). For
each λ, we perform LOOCV and compute the MSE. The λ which minimizes
the MSE is chosen for the corresponding LP model. Since in each cross
validation step, different weights for individual interactions can be learned,
we compute the median and the median absolute deviations (MAD) of all
edge weights learned in the LOOCV. If the absolute value of the computed
median is higher than the respective MAD, the edge weight is assumed to
be reliable and to be not due to noise in the data. In this case, we use the
learned median edge weight as the final interaction strengths. Otherwise, we
define the edge weight to be zero, since it cannot be distinguished from noise
and thus, it is unreliable.
Our LP model assumes that the source and sink nodes are known in advance.
Since this is not always given for applications of real data, we secondly applied
our LP model on the generated data without an a priori definition of the
source and sink nodes (LP-SE). This implies that the constraints 6.6 and
6.7 cannot be formulated. Therefore, they are not used to infer the network
topology for the LP-SE model.
In addition, we use a third approach called DEPN which has been recently
published by Froehlich et al., to learn the network topology used to generate
the data. To assign each edge with a weight we use greedy hillclimbing and
bootstrapping (resampling with replacement) with 100 bootstrap samples as
proposed in the DEPN implementation [FMT+].
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For each of the 100 generated data sets, we therefore infer network
topologies using the three methods (LP model, LP-SE model and DEPN).
We make ROC curves of the learned interactions. Each time we calculate the
AUC values. Since the DEPNs are not able to learn negative interactions
we treat our LP and LP-SE model like in a typical two-class ROC analysis
(see Section 6.2). For this, we ignore the signs of the learned interactions by
taking the absolute values.
In Figure 7.2 the area under the ROC- (AU-ROC) and un-
der the PR-curve (AU-PR) are plotted for increasing noise (σ ∈
{0, 0.01, 0.1, 0.2, 0.27, 0.3, 0.4, 0.5}) for the three methods. Moreover, the
Figure shows AUC values for randomly generated networks computed like
explained in Section 6.2. As we use a two-class ROC analysis for the DEPN,
the LP and the LP-SE model, we take only positive interactions for the
random guessing AUC value computations, too. The Figure demonstrates
that there are only little differences between the LP and the LP-SE model
for computed AU-ROC and AU-PR values. Both methods perform well with
AU-ROC values larger than 0.8 and AU-PR values larger than 0.6 up to a
noise of σ around 0.1. Then, both AUC values decrease until they approach
the random guessing line at a noise of σ around 0.5.
The DEPN approach performs better with its AU-PR values being each time
bigger than those for the other two methods. The AU-ROC values of DEPNs
are up to a noise level of around σ = 0.1 slightly worse and then slightly
better than the LP and LP-SE model.
To assess whether our approach can infer also the sign of the edges with
a good performance, we computed AUC values for the three-class problem
additionally. The Figure 7.3 shows AU-ROC and AU-PR results exemplarily
for the LP model (LP-SE model behaves similar) as well as for random guessing
values in a two- and a three-class analysis. Not surprisingly, random guessing
is more difficult if the edge signs of the interactions are taken into account.
Thus, both, the random guessing AU-ROC and the random guessing AU-PR
values, are smaller in the three-class analysis than in the two-class analysis.
In contrast, our LP model performs similar in both cases. This indicates that
the LP method is not able to identify whether the connection is activating or
deactivating.
If we do not explicitly note, that we use a three-class classification, we restrict
the AU-ROC and AU-PR computations of all problems to the classical two-
class ROC analysis in the following. This allows a direct comparison of the
results with those derived with the DEPN approach.
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Figure 7.2: Area under the ROC- and PR-curve for increasing noise σ ∈
{0, 0.01, 0.1, 0.2, 0.27, 0.3, 0.4, 0.5} of the LP model, LP-SE, DEPN and random
guessing.
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Figure 7.3: Area under the ROC- and PR-curve for increasing noise σ ∈
{0, 0.01, 0.1, 0.2, 0.27, 0.3, 0.4, 0.5} of the LP model using a two-class and a three-
class classification analysis. The dotted lines represent random guessing values
for the two- and three-class classification. The red (dash-dotted) lines, respec-
tively, the straight (black) lines correspond to results of the three-class, respec-
tively, the two-class classification analysis of the results derived with the LP
model.
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7.1.2 Missing Data
In real biological experiments data is often not only noisy, but may also be
incomplete due to measurement errors, missing reagents or simply to save
costs. To compare the performance of the three approaches explained in the
Section 7.1.1 on incomplete data, we simulate data with different noise levels
(σ ∈ {0.01, 0.1, 0.27, 0.5}) and randomly selected missing data points. Again,
we generate 100 times data of three replicates. We define 10%, 25%, 50% and
75% of the data values to be not given. The missing data points are randomly
chosen from the data.
For learning the network topology with the LP and the LP-SE model, we
summarize replicates using the average. Then, we solve the corresponding
problems with 0 ≤ λ ≤ |Ξ| ∗ σ2(xik) (step size of 0.1) to find the λ which
is minimizing the MSE of the LOOCV. We use the median of the edge
weights of all cross validation steps, which has an absolute values larger
than the computed MAD as the final interaction strength. In addition, we
inferred the network with the DEPN approach using greedy hillclimbing and
bootstrapping (100 bootstrap samples). Each time we make the corresponding
ROC curves and calculate the AUC values.
The AUC values for the ROC- and PR-curve, respectively, of each different
noise level are presented in the Figures 7.4 and 7.5, respectively. Not surpris-
ingly, the three methods perform worse the more data points are missing and
the higher the noise. Again, the LP and LP-SE model perform similarly. The
DEPN approach cannot infer networks if there are 75% missing data points.
In contrast to the DEPN approach, the LP model learns whether an edge is
activating or deactivating. Therefore, we additionally assess the performance
of the LP model on noisy data by using a three-class classification analysis on
the learned interactions (see Section 6.2). The AU-ROC and the AU-PR values
are similar to those of the two-class classification (see Appendix C). Thus, the
LP model learns the sign of an interaction with the same performance as it
learns the existence of the edge.
7.2 Real Networks from KEGG
Whereas the previous Section evaluated the performance of the LP and the
LP-SE model as well as the DEPN approach on a small artificial five-node
network, we now use real existing networks in this Section. For this, we
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Figure 7.4: Mean area under the ROC-curve using the LP, the LP-SE and
the DEPN model on missing data over 100 repetitions of four different noise
settings. (a) noise: σ = 0.01 (b) noise: σ = 0.1 (c) noise: σ = 0.27 (d) noise:
σ = 0.5. The dotted lines represent random guessing values.
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Figure 7.5: Mean area under the PR-curve using the LP, the LP-SE and the
DEPN model on missing data over 100 repetitions of four different noise settings.
(a) noise: σ = 0.01 (b) noise: σ = 0.1 (c) noise: σ = 0.27 (d) noise: σ = 0.5.
The dotted lines represent random guessing values.
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randomly extracted sub-networks of different sizes from eleven different
KEGG [KG00] signal transduction networks of varying total size (KEGG
IDs: hsa05212, hsa05210, hsa04630, hsa04370, hsa04350, hsa04310, hsa04210,
hsa04115, hsa04110, hsa04012, hsa04010). Only gene-gene interactions are
considered as edges.
We assume a perturbation matrix for these networks with single knock-
downs for each gene i ∈ {1, . . . , n} with n ∈ N to be given. Furthermore, we
assume that there are perturbation experiments of n/2 double knockdowns,
where the genes are pairwise randomly chosen among the given genes. In
addition, one experiment is modeled without any perturbation. Using this,
we generate data of three replicates for each type of experiment. Each
observation is assumed to come from two normal distributions (active or
inactive) after a given perturbation as described for the five-node example.
An activated node is simulated from the normal distribution N (0.95, 0.01)
and from N (0.56, 0.01) if it is inactivated. The parameter δi is generated
using the normal distribution N (0.755, 0.01).
We assume that source and sink nodes are not given and therefore, network
topologies are inferred using the LP-SE model. To find the best parameter
λ with 0 ≤ λ ≤ |Ξ| ∗ σ2(xik) (step size: 0.1), and to compute a range of
possible weights for each edge, we use LOOCV. The median of the learned
edge weights of each cross validation step is used as the final connection
strength, if its absolute value is bigger than the MAD. In the following we
present results of simulations for ten-node and large-scale networks.
7.2.1 Ten-Node Networks
We extract ten different networks with n = 10 nodes each from KEGG as
explained above. The networks have a varying number of edges: five networks
have 7 interactions and the remaining networks have 5, 8, 10, 12 and 13 nodes,
respectively. Each connection is positive, so there are no inhibitions.
To compare our approach with the DEPNs we apply additionally the DEPN
approach on the simulated data for each network. We make ROC curves and
calculate AUC values on the learned edges with the DEPNs and the LP-SE
model. Since DEPNs cannot learn negative interactions we use absolute values
of our learned interactions, to make ROC results of both methods comparable.
The results are shown as boxplots over all ten extracted networks in Figure
7.6. Additionally, the Figure shows random guessing AUC values calculated
for each of the ten networks as explained in Section 6.2. Obviously, the LP-SE
model performs better than random guessing for both, the AU-ROC and the
AU-PR results. The random AU-PR values are small, because most of the se-
lected sub-networks are very sparse with seven of them having less interactions
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Figure 7.6: AUC values of (a) the ROC and (b) the PR curves of the network
inference using the LP-SE model, the DEPNs and random guessing values on
ten-node sub-networks randomly selected from KEGG.
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than nodes.
Figure 7.6 clearly shows the increased performance of our LP-SE model in
comparison with DEPNs, although DEPNs performed better at the same noise
levels for the AU-PR values in the five-node example network. This shows the
increased performance of our model on large-scale networks in comparison to
the DEPN approach.
7.2.2 Large-Scale Networks
To evaluate the performance of the LP-SE model and DEPNs on large-scale
problems, we extract five networks of large sizes with n ∈ {16, 26, 28, 44, 52}
nodes. Again, the networks have only positive interactions with 17, 27, 31, 43
and 51 edges, respectively.
For each of the five networks we simulate 25, 40, 43, 67 and 79 perturbation
experiments, respectively. These experiments consist of single knockdowns
of each of the n nodes, n/2 double knockdowns randomly chosen, and one
experiment without any knockdown.
As already mentioned, the run time increases exponentially with an in-
creasing number of nodes and perturbation experiments. Since LOOCV is
very time consuming (each measurement is left out once and the network is
learned for the remaining data), it slows down our network approach. There-
fore, we use for this data 100 times a stratified k-fold cross validation of ten
folds. This reduces the number of times the training process is repeated and
thus, the total run time is decreased.
Taking the λ which minimizes the MSE, we compute AUC values of the me-
dian of all edge weights computed in the individual cross validation steps. The
results are shown in Figure 7.7 as well as results derived when using DEPNs
as well as with random guessing values.
The Figure shows that in this large-scale example the performance of our
LP-SE model is again much better than the DEPN approach which is only
slightly better than random guessing.
7.3 Run Time
The dimensionality of possible networks increase exponentially with an increas-
ing number of nodes. To assess whether this is true also for the computation
time, we measure the used run time of each network inference process. All
calculations are carried out as described in Section 6.2.1.
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Figure 7.7: AUC values of (a) the ROC and (b) the PR curves of the network
inference using the LP-SE model, the DEPNs and random guessing values on
large-scale sub-networks randomly selected from KEGG.
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7.3.1 Run Time of the Five-Node Network
For the data generated with varying noise and varying missing values Table
7.2 summarizes the computation times. Results are represented for all three
methods (DEPN, LP and LP-SE model) used for the network inference. The
run times are averaged over the generated 100 different data sets for different
noise and for different number of missing data points, respectively. The Table
Run time in seconds
# nodes # exp. LP model LP-SE model DEPN
noisy data: 5 7 3.08± 1.79 3.69± 1.76 94.25± 7.53
missing data: 5 7 3.54± 1.52 3.39± 1.45 200.11± 132.96
10-node kegg: 10 16 - 471.6± 287.4 3283.8± 1058.4
largefold kegg: 16 25 - 2996.4 26247.04
largefold kegg: 26 40 - 14279.6 214617.398
largefold kegg: 28 43 - 41798.61 465184.138
largefold kegg: 44 67 - 292748.26 -
largefold kegg: 52 103 - 300906.93 -
Table 7.2: Number of nodes, number of experiments and the mean and stan-
dard deviation of the computation time over each run carried out for the net-
work inference with noisy data, missing data and the sub-networks extracted
from KEGG. If no standard deviation is shown, the respective network has been
inferred only once from the respective data.
shows that the run time is very small for the network inference with the LP
and the LP-SE model with taking on average only around three seconds. In
contrast, DEPNs take much longer with up to 200 seconds. To conclude, the
DEPN approach take on average up to 100 times longer than our models.
7.3.2 Run Time of the Ten-Nodes and the Large-Scale
Networks
Similarly to the artificial five-node example given above, we compute the run
time the LP-SE model and the DEPN approach need to infer the underlying
network topology of the sub-networks extracted from KEGG. The results are
represented in Table 7.2.
Whereas the network inference takes only several seconds for the LP-SE
model on five nodes, it takes already on average 7.86 ± 4.79 minutes for the
ten-node data sets with the 16 simulated perturbation experiments. This
reflects the increasing dimensionality of the network inference problem for an
increasing number of nodes. The DEPN approach takes even longer than the
LP-SE model, and it takes almost one hour (54.73 ± 17.64 minutes) to infer
the network topology. Nevertheless, the performance of DEPNs is worse than
the LP-SE model in terms of AU-ROC and AU-PR values. This large increase
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of computation time when increasing the number of nodes has already been
reported for the DEPN approach in [FSA+09].
The run time of our LP-SE model for the large-scale networks is 0.83, 3.97,
11.61, 81.32 and 83.59 hours, which means that it takes now considerably
longer to infer the network topology than for small examples. However, it
is still feasible and much faster in comparison to the DEPN approach which
takes 7.2, 73.5, 129.22 hours for the first three networks. For the large-scale
problems with 44 and 52 nodes the DEPN approach was not able to finish the
network inference process within 1000 hours.
To summarize, Figure 7.8 gives the run times which are needed by the
DEPN and the LP-SE model to infer the network topologies of the different
data sets. The time is plotted in seconds on a log-scale against the number of
nodes (for exact numbers see Table 7.2). Obviously, the DEPN approach takes
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Figure 7.8: Run time in seconds on log-scale to infer the underlying networks of
different sizes with the DEPN approach (green circles) and the LP-SE approach
(red dots). The green and red lines connect the individual measurements. The
green star denotes the time point (1000 hours) at which the network inference
with the DEPN approach has been aborted for the network with 44 nodes.
longer than the LP-SE model. The last two networks, with 44 and 52 nodes,
cannot be reconstructed by the DEPN approach in a reasonable time at all.
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The star in Figure 7.8 indicates the time point, where the DEPN approach has
been aborted without finishing the network inference process for the large-scale
network of 44 nodes. The LP-SE model is performing much better, as it can
infer the underlying network topology within 81.32 hours.
7.4 Real Data Studying ErbB Signaling
In network inference it is difficult to quantify the performance of a proposed
method on real biological data since, the underlying true network topology
(gold standard) is rarely fully understood. The ErbB signaling pathways are
one of the best studied signaling networks. It is known that they regulate
diverse physiological responses such as cell division, motility and survival
[CY06]. Therefore, we use a recently published data set on ErbB signaling for
an evaluation of our LP model on real data.
7.4.1 ErbB Signaling
The ErbB protein family (or epidermal growth receptor (EGFR) family) con-
sists of four structurally related receptor tyrosine kinases (ERBB1-ERBB4).
They have the ability of forming homodimers and heterodimers upon activation
by epidermal growth factors such as EGF. Thereby, they activate intracellu-
lar signaling transduction pathways. The ErbB family is highly involved in
human diseases like multiple sclerosis or the Alzheimer disease where ErbB
signaling is insufficient due to inactivated ErbB receptors [BY07]. In contrast,
excessive ErbB signaling is associated with the development of many human
cancers such as breast or lung cancer [SFL+09, BY07].
ErbB proteins are extensively studied to find potential candidates for thera-
peutical targets. Trastuzumab for example is used to target the ERBB2 recep-
tor in breast cancer cells which are showing ERBB2 overexpression. ERBB2
has no known direct activation ligand but forms activated heterodimer pref-
erentially with ERBB3 but also with ERBB1 [ZBB05], activated by EGF.
In normal and cancer cells, ERBB2 controls G1/S cell cycle transition by
modulating G1 regulators resulting in an oscillating activity of the tumor
suppressor retinoblastoma protein pRB. This protein allows the expression
of genes required for S-phase entry [LBM+00]. For a detailed description of
the ErbB signaling to regulate of G1/S cell cycle transition see for example
[ZBB05, LBM+00, SFL+09].
Cancer cells treated with trastuzumab show an interrupted downstream sig-
naling of ERBB2 followed by a G1/S cell cycle arrest leading to a reduction of
the abnormal cell growth and proliferation during cancer formation [SFL+09].
Due to the capability of cancer cells to acquire resistance, for example by
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receptor-independent activation of downstream signaling molecules, the re-
sponse rate of trastuzumab is only low and many patients are de novo resis-
tant [SFL+09, BY07]. ErbB signaling pathways have been extensively stud-
ied, nevertheless, it remains poorly understood how the signaling is affected in
treatment resistant cells. Accordingly, ongoing work has to be done to iden-
tify new additional targets which are showing a higher response rate and are
guaranteeing cell cycle arrest in cancer cells.
7.4.2 ErbB Signaling Data
Froehlich et al. studied 16 proteins (ERBB1, ERBB2, ERBB3, IGF1R, ER-
alpha, pAKT1, pERK1/2, MYC, Cyclin D1, p27, p21, Cyclin E1, CDK6,
CDK4, CDK2 and pRB1) which are involved in the ErbB receptor-regulated
G1/S cell cycle transition network of human cells. For a detailed description of
the experimental setup see [FSA+09]. In short, the authors used RNAi knock-
downs followed by a quantification of effects on the remaining network proteins
using reverse phase protein arrays (RPPA) [TQL+06, CTS+02]. They per-
formed 13 single-knockdowns (ERBB1, IGF1R, ER-alpha, pAKT1, pERK1/2,
MYC, Cyclin D1, p27, p21, Cyclin E1, CDK6, CDK4, CDK2) and three
double-knockdowns (ERBB1+ERBB2, ERBB2+ERBB3, ERBB1+ERBB3)
with chemically synthesized siRNAs as well as one experiment with MOCK
transfected cells which serves as a negative control. RPPA measurements have
been done before, and twelve hours after EGF stimulation for ten intermediates
of the network, namely ERBB1, ERBB2, pAKT1, pERK1/2, Cyclin D1, p27,
p21, CDK4, CDK2 and pRB1, to quantify their protein expression after each
individual perturbation. This has been repeated in four technical and three
biological replicates which have been integrated using quantile normalization.
The remaining proteins could not be quantified due to lacking antibodies suit-
able for RPPA.
Additionally, we process the data further by summarizing replicate measure-
ments using averages.
7.4.3 Results
We solve the LP model corresponding to the ErbB signaling data with
δi = MOCKi at time zero (without EGF stimulation) for each gene
i ∈ {1, . . . , 16} and with given source (ERBB1, ERBB2 and ERBB3) and sink
(pRB1) nodes. Using LOOCV we identify parameter λ = 1.83 to be the one
with minimal MSE with 0 ≤ λ ≤ |Ξ| ∗ σ2(xik) and a step size of 0.01.
The median edge weight of all LOOCV-steps is taken as the resulting learned
interaction. The results are illustrated in Figure 7.9 where the inferred
edges are color coded with purple corresponding to no interaction (zero edge
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Figure 7.9: Imageplot of median of inferred edge weights wij of the ErbB
signaling data of all LOOCV-steps with i corresponding to genes of the ith
column and j to genes of the jth row.
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weight), blue to positive and yellow to negative interactions. Tables of the
exact numbers of the inferred median edge weights can be found in Appendix
D.
In total, we learned 43 interactions, where 34 connections are activating
and 9 are deactivating. After removing the interactions which have a MAD
higher than its absolute median, 35 interactions (31 activations and 4
deactivations) remain. At first, we start to evaluate the negatively learned
interactions. The most pronounced deactivation with a median edge weight
of -1.07 is from p21 to CDK2. This inhibition has already been reported in
the literature [HEK+95]. Next, with median edge weights of -0.6 and -0.36
we inferred deactivations of pERK1/2 by pRB1 and CDK2 by Cyclin D1.
Both inhibitions seem biologically plausible feedback loops, to control the
G1/S cell cycle transition, although they have not been directly reported in
literature yet. However, there is some evidence that CDK2 is co-precipitated
with Cyclin D1 [BBM+94].
Furthermore, there is a deactivation with median edge weight of -0.2, namely
the inactivation of p21 by ERBB1. This interaction can be found in the
literature as an indirect path which goes via pAKT1 and MYC [FSA+09].
The remaining inhibitions have median edge weights smaller than -0.04 or
a MAD higher than its absolute median and thus, are not pursued further.
We note, that the DEPN approach cannot infer negative edge weights and
therefore, they are not able to learn deactivations. Nevertheless, the above
mentioned interactions have been inferred using the DEPN approach, except
for the interaction learned between pRB1 and pERK1/2.
The interaction which has been learned with the highest positive median
edge weight of 1.62 is the activation of pERK1/2 by p21. This strongly
indicates that there is a positive feedback loop controlling the G1/S cell cycle
transition. However, this has not been shown in the literature yet. The median
edge weight of 1 has been inferred for the activation of CDK2 by ERBB2.
Although the direct connection of these proteins has not been reported in the
literature, there exist two indirect signaling paths: ERBB2→pAkt1→MYC
→Cyclin E1 →CDK2 and ERBB2→pERK1/2→MYC→Cyclin E1→CDK2
[FSA+09] which support our results.
There are five interactions which have been learned with a median edge weight
of 0.95: MYC activates CDK6, IGF1R activates Cyclin E1 and vice versa,
CDK6 activates ERalpha and ERalpha activates MYC. The last activation
is known from literature [SPWM98]. The connection between IGF1R and
Cyclin E1 is known by an indirect path via pERK1/2 and MYC [FSA+09].
The two other interactions between MYC and CDK6, and between CDK6
and ERalpha are newly predicted activations. Using the DEPNs on the same
data an indirect path has been learned from MYC to CDK6: MYC → p27 →
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CDK4 → Cyclin D1 → CDK6 [FSA+09].
Among the remaining learned activations with lower edge weights the acti-
vation of ERBB1 by ERBB2 and vice versa are worth mentioning, since the
two kinases are known to form heterodimers (see for example [CY06, CSJ+09]).
To evaluate the results further, we use a reference network extracted
from the String database [Str11]. For this, we use all interactions of the 16
proteins under study which have a combined confidence score higher than
0.85. Since the interactions given in String are undirected and unsigned, we
remove the edge weights of our inferred network topology as well as the signs.
Based on this reference network, we compute sensitivity, specificity, precision
LP model DEPN random
TP 9 7 13.11
TN 72 73 59.11
FP 15 14 27.9
FN 32 34 27.9
SP 0.83 0.84 0.68
SN 0.22 0.17 0.32
PR 0.38 0.33 0.32
AC 0.63 0.63 0.56
Table 7.3: Computed evaluation values of the ErbB data after network in-
ference using the LP model, the DEPN approach and random guessing. TP=
true positives, TN= true negatives, FP= false positives, SP= specificity, SN=
sensitivity, PR= precision, AC= accuracy (see Section 6.2).
and accuracy (see Section 6.2) of our results. In addition, we calculate the
evaluation values for a “random” network where we randomly permute the
given interactions of the String reference network 100 times and take the
average of the computed values. Furthermore, we present results of the
network inferred by the DEPN approach as published in [FSA+09].
The evaluation results are shown in Table 7.3. The accuracy of both inference
methods, DEPN and the LP model behave similar with an accuracy of 0.63.
This is better than random guessing where an accuracy of 0.56 is achieved.
In conclusion, we learned several already known activations and inactiva-
tions as well as inferred potential new interactions of the ErbB signaling. The
most interesting new predictions are those which indicate negative or positive
feedback loops since they allow to regulate and control the the G1/S cell cycle
transition. This seems to be biological plausible, since Chen et al. reported,
for example, that the ErbB response is silenced by negative feedback from
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active ERK [CSJ+09] which is thus supporting the idea of feedback loops in
the ErbB signaling.
7.5 Discussion
We formulated the network inference task as a linear optimization program
which can be solved efficiently even for large network sizes where other meth-
ods suffer from the exponentially increasing dimensionality. Our model can
use measurements from single as well as from double or multiple knockdowns
at the same time. In addition, prior knowledge for example from databases,
protein-protein interactions or expert knowledge can be easily integrated into
the linear program by formulating additional constraints. The model presented
here infers not only the existence of an edge, but also its sign, so whether there
is an activation or a deactivation between two nodes.
One drawback of the LP model is that time-series data cannot be integrated
up to now. We are using steady-state data and thus, loops within the network
topology can be resolved only up to a certain level by using double or multiple
knockdowns.
Using the formulation of a linear optimization problem allows an efficient cal-
culation of the topology which best fits the given data. However, there might
be topologies which are closer to biology although they are not minimizing the
given LP. To overcome this problem and to compute a range of edge weights
between the genes, we use LOOCV for the small, and a stratified k-fold cross
validation for the large-scale problems.
We showed based on simulated data for a five-node example that the LP and
the LP-SE models are able to deal with noisy as well with incomplete data with
a similar performance like the DEPN approach. However, our linear models
are much faster in computing the results than the DEPNs. Using sub-networks
extracted from signaling pathways given in KEGG, we showed that our LP-SE
model is not only much faster than the DEPN approach but has in addition
a better performance. The LP-SE model is clearly outperforming the DEPNs
on the large-scale networks, and it is much better than random guessing. Our
model is immensely speeding up the network inference task with producing
even better results than the DEPNs.
Using RNAi in combination with RPPAs studying the ErbB receptor-regulated
G1/S cell cycle transition network of human cells, we applied our LP-SE model
on a real biological problem. Among the inferred interactions several have been
reported in the literature before and inferred using the DEPN approach. We
use a reference network extracted from String to compare our results with the
current level of biological knowledge of the ErbB signaling. Our results achieve
an accuracy better than random guessing. The newly identified connections
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indicate that there are negative and positive feedback loops within the ErbB
signaling pathway. This may be important to regulate or control the signaling
process in some way, however, to validate this, new experiments are necessary.
Chapter 8
Conclusion and Further
Extensions
In this thesis a novel approach for the reconstruction of signaling networks
from high-throughput perturbation data has been introduced. The pertur-
bations can be caused for example by RNA interference. RNAi is especially
well suited to identify the effect of gene knockdowns on a certain phenotype.
However, biological experiments are always suffering from noise due to
technical problems or to biological variations for example when measured cells
are in different states of the cell cycle. For inferring signaling networks from
real data, the number of false positives has to be decreased to a minimum. We
proposed in this thesis a novel network inference model. This model allows
a fast and efficient reconstruction of gene signaling pathways from RNAi
data. Furthermore, we developed strategies for an optimal data analysis and
statistical hit scoring of cellular based RNAi screening data. This allows to
reveal the real biological signal and to diminish the effects purely due to noise.
8.1 Single-Cell Data Analysis
The technology of producing RNAi screening data has immensely improved
during the last years. This allows the quantification of several phenotypic
effects for individual cells of a screen at the same time. Using two high-
content high-throughput virus infection RNAi screens, we studied a Hepatitis
C and a Dengue virus data set. We assigned each cell of the given data
with four technical, and six cell context features. We showed that the viral
phenotype after individual perturbations is, beside the technical variability,
highly dependent on cell context features.
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Cell Context Features
For both screens, the size of the cell has been identified as the most con-
tributing biological factor influencing virus infection. This is in large contrast
to a recently published study performed by Snijder and colleagues [SSR+09].
The authors showed that the infection of cells with Dengue virus is mostly
influenced by the location of a cell at the middle or at the border of a local
population of cells. The discrepancy with our results may be due to three
factors which are different in the two studies: first, Snijder et al. did not
use RNAi data but cellular screens without any perturbations. Second, they
infected and measured effects on HeLa cells, whereas in our Dengue screen
Huh7.5 cells have been used. The third and last point is given by the two
different platforms used for the experimental setup. In the study performed
by Snijder et al. well-plates were applied, and in contrast, our data has been
generated using chambered coverglass slides.
Each of these factors may cause the different behavior of the cells in our
screen in comparison to the data used in the Snijder et al. publication. The
last point, using different experimental platforms, results in quantitative
differences of the number of cells in each spot/well. Whereas on LabTeks
there are around 100-400 cells per spot, on well-plates up to several thousands
of cells are within each well. Furthermore, using well-plates the individual
experiments are spatially separated. This is not the case on LabTeks where
the risk of cross-contamination can be higher than for well-plates. Thus, both
studies depend already on completely different technical settings.
Although, we could therefore not reproduce the results from Snijder and
colleagues, our results strongly indicate that viral infection in RNAi screening
data is significantly influenced by the cell context. Therefore, analysis and hit
scoring strategies should take this information into account to guarantee an
optimal processing of the data. This hypothesis may be further supported by
already published screens, which do not consider this information and which
are showing only a small overlap of identified hit genes even for the same virus.
Data Normalization
We used multivariate adaptive regression splines [Fri91] to perform a non-liner
normalization of the RNAi data against the measured features. Thereby, the
influence of the individual feature on virus infection has been decreased to a
minimum and the true biological signal has been unraveled.
In the next step, we adapted the idea of gene set enrichment analysis for
the use with RNAi data, to enable the calculation of significance values of
identified hits based on individual cell measurements. This has the advantage
that each cell can be viewed as a “replicate” measurement and the significance
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can be calculated for individual knockdowns, individual siRNAs or genes.
Obviously, individual cells of one spot are not real replicates as such, since they
are treated in the same way. However, as we clearly observed two different
distributions of cell signal intensities within one spot, this indicates that
even the cells which are treated exactly similar, show different phenotypes.
Individual cells can show high variabilities in their behavior if they are for
example in a different state of their cell cycle. Using thus the information of
individual cells is a great advantage especially for smaller screens, where no
replicate plates are available.
Performance Evaluation
For the HCV screen, we evaluated our results using positive and negative
controls. In addition, we used results of a secondary screen to assess the
performance of our results. Published by Reiss and co-authors [RRB+11],
the validation screen has been performed on hit genes identified using a
normal analysis method which does not take the cell context into account.
We calculated significant hits with our method, the one published by Reiss
and colleagues as well as a third one published by Suratanee et al. [SRM+10].
There is only a small overlap of six hits identified with the three competing
approaches. This illustrates, once more, the need of a sophisticated analysis
strategy to diminish the already reported small overlap of identified hits
in different studies. Since our approach showed superior sensitivity and
specificity of the data, this is clearly indicating that the use of individual cell
measurements highly improves the data analysis task.
Our CELL-BASED approach consists basically of two individual methods: the
normalization of the data based on the computed cell context and technical
features as well as the hit scoring using the approach of a GSEA. We applied
both methods, independently of each other, on the HCV data and analyzed
their performance. Both performed better than RIPLEY and AVERAGE
but not as good as the CELL-BASED approach. GSEA-ONLY is the factor
which contributes more than MARS-ONLY to the final good performance of
the combined approach.
In addition, we performed a pathway analysis using DAVID [6.711] on
the identified host dependency factors of the HCV and DENV screen. Using
our CELL-BASED method more than 20 pathways could be identified to be
significantly enriched in HCV processing. Significantly enriched processes for
both screens include endocytosis, focal adhesion, signaling in the immune
system and the ErbB and MAP kinase signaling. All of them have been
already reported in a study considering several RNAi screens at the same
time (see Reiss et al. [RRB+11]. This is a further indication of the increased
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sensitivity when using our analysis and hit scoring approach. Moreover, we
identified several additional pathways such as the regulation of the actin
cytoskeleton, purine metabolism, TLR signaling and several cancer-related
pathways.
The large number of identified pathways with the CELL-BASED method
is in huge contrast to the number of pathways which are predicted using
AVERAGE or RIPLEY. For the AVERAGE method only two pathways have
been identified. One of them has been learned also with the CELL-BASED
method. The RIPLEY method performs even worse and found no pathways
at all, although we used all genes as hits which have a p-value smaller than
0.05 and clustering scores smaller than zero here. For the other methods we
uniquely defined hits based on scores which are larger than 1.5 times the
standard deviation of the underlying score distribution, additionally to the
thresholds on p-values. However, there are only a few genes which would
fulfill this criteria for the RIPLEY approach and results of the performance
analysis would be even worse.
Although there is only a small overlap of identified hit genes for the Dengue
and Hepatitis C data, we identified various enriched pathways which both
viruses have in common and which are demonstrating the close evolutionary
relationship of the two viruses.
Non-Viral RNAi Data and Cytopathic Effects
In addition to the viral infection RNAi screens analyzing Dengue and
Hepatitis C virus we used a non-virus screen to study the cells’ population
context effects on the phenotypic outcome. Results show similar trends as
for the virus screens, with the cell context highly influencing the phenotype.
Moreover, using the CELL-BASED analysis strategy results in an increased
performance on the correct classification of the controls, in comparison to an
approach which does not take the cell context into account.
Clearly, one of the problems in our study is that we cannot exclude that
there are cytopathic effects. Cytopathic effects are virus-induced phenotypic
effects which can result, for example, in an increased cell growing. Normalizing
against cell context features which are due to cytopathic effects may lead to
wrong results. One solution to account for this is using additional controls
where cells have not been infected. Then, these controls can be used to test
whether the cells show different population context effects than when treated
with the virus. In the screens analyzing the Dengue and Hepatitis C virus,
however, such controls are not given.
Since results of the GSEA-ONLY analysis of the HCV data indicate that this
has a higher contribution on the final results than the normalization against
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the population context, and since both methods perform even better than the
stand-alone methods, we conclude that the normalization is not destroying
but revealing the true biology.
Taken together, the increased performance of our analysis highly advocates
that the use of single cell information greatly enhances the identification of hit
genes which are significantly involved in certain processes. However, this is only
a first step towards the development of new strategies which take individual cell
information into account. Further RNAi screening experiments and analyses
on the produced data will allow to gain a better understanding of the ongoing
biology and thereby, to improve the proposed methods.
Moreover, it is possible to extract many more cell context features for each cell
than those presented in this thesis. Additional fluorescence markers during
the experimental setup can be used to visualize, for example, the size of the
cytoplasm or individual proteins. Using microscopy-images, the signal of these
markers can be quantified and therefore, it can be used for the data analysis
and normalization. This allows a more detailed data analysis and thus, it may
lead to improved and more reliable results.
8.2 Network Inference
After the identification of the factors which play a role in specific phenotypes
using perturbation data, we want to learn how theses factors interact with
each other in the underlying signaling cascade. This allows to understand the
biological processes in much more detail. However, the network inference from
RNAi data is a challenging task [MS06]. One of the most pronounced diffi-
culties is the exponentially increasing dimensionality for an increasing number
of elements. This restricts the application of already published approaches
such as NEMs [MBS05] and a probabilistic boolean model [KDZ+09] to only
small-scale networks of up to six nodes.
Advantages
In this thesis, we developed a model which overcomes the limitations due to
a high dimensionality of the problem. The approach has been formulated
as a linear programming problem which can be solved efficiently, even for
large-scale networks, using the simplex algorithm.
The approach of the LP model is based on the assumption that the signaling
of a network is represented as an information flow. Assuming that this
flow starts from one or several source nodes, it is propagated down through
the network, and finally it reaches one or several sink nodes. We assume
furthermore, that the perturbation of a gene influences other genes which are
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further down in the underlying topology in a deterministic way. This is used
to identify genes which show an effect after the perturbation of another gene.
This, in turn, allows to infer interactions between individual genes. In the LP
model, the activity of a gene is given by the sum of the baseline activity of
the respective gene, and the information of the parent nodes. For this, the
incoming flow of the parents is summed up. In addition, slack variables are
used to deal with noisy data. Furthermore, the LP model integrates data of
double or multiple knockdowns at the same time, and a network topology
with activating as well as deactivating connections is inferred. Self-regulating
edges are not allowed, but feedback and feedforward loops are possible.
Since the model is formulated as a LP, additional constraints can be easily
included. This allows the easy incorporation of prior knowledge information.
The prior knowledge can be extracted from different sources such as the
KEGG database, PPI networks, the literature or expert knowledge. For each
known interaction between a pair of genes an equation or an inequality can
be included into the model, as long as they are not contradictory. However,
great care is needed to prevent overfitting. Adding too many additional
constraints reduces the inference from data, and favors the inference from
prior knowledge. If the data is supposed to be reliable, this should be avoided.
On contrast, if the data is noisy or incomplete or both, the inclusion of
additional information using may result in better predictions.
Evaluations on Simulated and on Real Data
For the evaluation of the LP model different types of data have been used.
First, we applied our method on simulated data generated for a small
artificial five-node network. This small network has been used, to analyze
the robustness of the LP model on noisy and incomplete data. To do this,
we simulated data with different levels of noise and with different amounts
of incomplete data. Then the LP model has been used to infer the network
topology using the simulated data. The LP model assumes that the source
nodes and the sink nodes are given. Since this assumptions is not always
fulfilled, we modified the LP model into the LP-SE model. The LP-SE model
can be used if the information about source and sink nodes are not given.
Thus, we use additionally the LP-SE model for the network inference of
the simulated data of the five-node network to quantify differences of the
prediction results. Both methods perform similarly well when comparing
results of the ROC and the PR analysis.
Furthermore, we showed for the LP model and for the LP-SE model that
the network predictions perform much better than random guessing for small
noise levels. Naturally, the results are worsened the higher the noise, and the
more data points are missing.
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In addition, we compared the LP and the LP-SE model with the DEPN ap-
proach. Applying the DEPN method on the simulated data results AU-ROC
and AU-PR values comparable to those given for the LP and the LP-SE
model. The DEPN method seems to perform slightly better than the LP and
the LP-SE model in terms of the AU-PR values for noisy data. However,
DEPNs cannot reconstruct the topology, if more than 75% of the data are
missing. In contrast, this is still possible for the LP and the LP-SE model
with a performance better than random guessing if the noise is not too large.
Since the DEPN approach cannot learn the sign of an edge, we computed
the AU-ROC and the AU-PR values using a standard two-class classification.
However, the LP and the LP-SE model learn a signed network topology. This
results in a three-class classification problem, where an edge can be present,
positive, or negative. To evaluate, how good the LP and the LP-SE model
predict the sign of an edge, we computed the AU-ROC and the AU-PR values
additionally for the three-class classification analysis. The results are similar
in both cases. This indicates, that the LP and the LP-SE model cannot
only distinguish whether an edge exists or not, but also whether the edge is
activating or deactivating.
To assess the performance of the model on real networks given in biology,
we extracted sub-networks of given signaling pathways from KEGG. First,
we used ten different ten-node networks and then five different large-scale
networks with 16 to 52 nodes. Assuming that source nodes and sink nodes
are not known, we used the LP-SE model and the DEPN approach to infer
the network topologies. The results of both methods were quantified by
computing the AU-ROC and the AU-PR values, and this clearly shows
that the LP-SE model performs much better than the DEPN approach.
Furthermore, both methods are better than random guessing for the ten-node
networks. For the large-scale problems however, the DEPN approach behaves
not better than guessing.
Next, we analyzed the run time which is needed to infer the underlying
network topologies with the DEPN and the LP model. Clearly, the LP
model is much faster than DEPNs for all given data sets. For the LP and
the LP-SE model, the network inference takes only several seconds using
the five-node data, whereas the DEPNs need up to one and a half minutes.
For the ten-node networks, both methods need in general longer to learn
the topologies than for the five-node example. However, the LP-SE model
is clearly outperforming the DEPN approach. The LP-SE model takes only
around 8 minutes on average for the ten-node networks in comparison to 55
minutes the DEPN method takes. Certainly, the network inference process
takes longer the more nodes are given since the dimensionality of the problem
increases. This trend is more pronounced for the DEPN approach than for the
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LP model. The DEPN approach for example cannot reconstruct the network
with 52 nodes within a reasonable time. Thus, the inference process has been
aborted after 1000 hours. For this 52-node network, the LP-SE model needs
a long time, too. Nevertheless, the LP-SE model is able to infer the network
and it needs around 84 hours to do this.
Finally, we applied the LP model on a real data set. For this, we used
data studying 16 proteins involved in the ErbB receptor-regulated G1/S cell
cycle transition signaling of human cells. The data included 13 single, and
three double knockdowns, as well as a reference experiment without any
perturbations. We were able to learn several already known positive and
negative interactions. In addition, some of the inferred edges using the LP
model have been reconstructed with the DEPN approach, too. However,
whereas the DEPN approach does not infer the signs of the edges, we correctly
identified whether interactions are activating or deactivating for several of the
already known connections. We compared the results derived with the LP
model with a reference network extracted from the String database [Str11].
We achieved an accuracy of our predictions of 0.63. This is similar to the
accuracy of the ErbB network as published in [FSA+09] which has been
inferred using the DEPN method. Both, the results of the LP model and the
DEPN approach, are better than random guessing (accuracy of 0.56).
Beside the already known edges, the LP model identified yet unknown inter-
actions which are strongly indicating that the ErbB signaling is controlled by
internal feedback loops. Since ErbB signaling is involved in several human
diseases, this may be a first attempt for the development of new drug targets.
Obviously, further experiments are necessary to allow a better judgment of
this indication.
Limitations and Drawbacks
Our LP model infers network topologies by using a linear model. The learned
network topology is the one which minimizes the linear program and thus,
the LP model gives only one final solution. In biology, however, there may
be other solutions which are, although not minimizing the LP, representing
the true underlying biology in a better way. Therefore, we used LOOCV to
compute the range of the edge weights for all possible connections. LOOCV
allows furthermore to find the parameter λ which minimizes the mean squared
error.
Moreover, using the LP approach, it cannot be ensured that the learned
topologies are completely connected. Therefore, we defined specific ranges
for λ, which allowed to control the trade-off between network sparseness
and connectivity. To force a network to be connected, an exploration of
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the full search space of connected topologies would be required. However,
we are aiming at finding suitable networks fast and efficiently. This makes
our approach also useful for large scale networks of up to dozens of genes.
Therefore, we preferred to learn the networks in a feasible time, instead of
demanding them to be connected.
A further drawback of the LP model is the fact that it cannot be applied
on data with different read-outs. Even replicate measurements of the same
perturbation experiment are at the moment summarized for the use with our
LP model. This can result in an information loss and it may be advantageous
to use replicates implicitly in the model. Similarly, it may improve the results
if different read-outs are modeled implicitly during the network inference
process.
Moreover, time-series data cannot be integrated into the inference task as
the LP model assumes steady-state conditions. One possibility to use time
resolved data in our model may be via the modification of the baseline
parameter of each gene. Instead of having only one baseline parameter,
several can be used to model the effect after different time-points. However,
the baseline activity of a later time-point depends on previous time-points,
and as mentioned in Section 6.1 dependencies of the parameters cannot be
modeled using a linear approach without enumerating the full search space.
This, in turn, would result in an increased run time and thus, this would
abate one of the most pronounced advantages of our method.
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Appendix A
Feature Plots of DENV Data
Figure A.1 shows the mean and standard deviation of feature “cell size” of the
DENV screen for different bin sizes with n = {10, 20, 50, 100} bins.
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Figure A.1: Mean and standard deviation of feature “cell size” of the DENV
screen for different bin sizes.
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Appendix B
Hit Lists
B.1 Hit List of the HCV Screen
Table B.1 lists the hits of virus host dependency factors of the HCV screen
after CELL-BASED, AVERAGE and RIPLEY analysis.
Table B.1: Gene hit list of the HCV screen after CELL-BASED, AVERAGE,
RIPLEY, GSEA-ONLY, and MARS-ONLY analysis. Shown are genes which
scored at least in one of the methods to be significantly reducing HCV infection.
For CELL-BASED, respectively, RIPLEY the ES, respectively, the clustering
scores are shown. For AVERAGE, MARS-ONLY and GSEA-ONLY the respec-
tive z-scores are given. If the values are not significant in one type of analysis
they are represented by empty cells. The last column shows whether a gene also
came out as a hit in the DENV (indicated by the ES of the DENV data) or not
(indicated by empty cells).
Gene ENTREZ ID RIPLEY AVERAGE CELL-BASED GSEA-ONLY MARS-ONLY HIT DENV
ACK1 -0.7748348125 0 0.1131170606 0.1077080164 -0.0603939278 0
ACVR1C 130399 0 0 0.1176341058 0 0 0
ADK 132 0 1.8607851501 0.10779213 0.1279761403 -0.0584024124 0
AKAP12 9590 0 1.6605915884 0.136484711 0.171599855 -0.1042494399 0
AKAP8L 26993 0 1.5756255801 0.1377499254 0.153155406 -0.0788223588 0.1171384091
AKT3 10000 0 0 0.119397414 0.1257064011 0 0
ANKK1 255239 -0.644279625 0 0 0 0 0
AURKB 9212 -0.5961612353 0 0 0 0 0
BMPR2 659 -0.6404928667 0 0 0 0 0
CAMK1G 57172 0 4.1367581856 0.313214574 0.3162151265 -0.2462775418 0
CAMK2B 816 0 1.8788602376 0.1343924019 0 -0.0914607818 0
CARKL 0 2.5897285903 0.1469633834 0.1793797178 -0.1155279769 0
CD4 920 0 0 0 0.1155559384 0 0
CD81 975 -2.1275204792 3.0996941663 0.2406700954 0.2777782757 -0.1847533501 0
CDC42BPA 8476 0 1.5619325443 0 0 -0.0941096449 0
CDK2 1017 0 1.9173104848 0.1312752438 0.1315034884 -0.0930829879 0
CDK4 1019 0 0 0.1451628991 0 -0.1043589479 0.1218911378
CDKL2 8999 0 0 0 0.1206765735 -0.1050797967 0
CFL1 1072 0 1.8981202251 0.1330411821 0.1385308148 -0.1012358681 0
CHKA 1119 0 2.1643100012 0.1655656259 0.1710879978 -0.128815603 0
CHKB 1375 0 0 0 0.114662443 0 0
CKI-alpha 0 1.582496722 0 0.1127611138 -0.0599394343 0.1377499254
CKMT1 -0.6091872353 0 0 0 0 0.2521418998
CNKSR1 10256 -0.324138875 0 0 0 0 0
CSF1R 1436 0 0 0.1190093497 0.1184299761 -0.0885108991 0
CSNK2A1 283106 -0.6258927647 2.1655126694 0.1617886468 0 -0.0949020828 0
CXCR4 7852 -0.6284616133 0 0.1533465648 0 -0.076305372 0
Continued on next page
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Table B.1 – continued from previous page
Gene ENTREZ ID RIPLEY AVERAGE CELL-BASED GSEA-ONLY MARS-ONLY HIT DENV
DGKZ 8525 0 0 0 0 -0.0782614223 0
DYRK3 8444 0 2.7161391588 0.1916018688 0.1951528235 -0.1449176879 0
EIF2AK4 440275 -0.7116005882 0 0 0 0 0
EPHA7 2045 0 0 0 0.1444749298 0 0
ERK8 0 1.5476795105 0.1090417486 0 -0.07133 0
ERN2 10595 0 0 0 0 -0.0806014946 0
ETNK1 55500 0 0 0 0.1185938224 -0.0683433953 0
FGFR2 2263 0 1.7174930582 0.1489351892 0.1252106513 -0.1155249481 0
FLJ25006 0 1.5335072739 0 0 0 0
FLT4 2324 -0.5479343571 2.2900936419 0.1352398454 0.1255391104 -0.1239510965 0
FN3K 64122 0 0 0 0.1115682121 0 0
GALK1 2584 0 3.0523974587 0.2441906943 0.2021668493 -0.1888352368 0
GCK 2645 -0.6752924375 0 0 0 -0.0543672622 0
GLYCTK 132158 -0.5697323529 0 0 0.1253687942 0 0
HCV 138 -2.6394967123 3.6479370634 0.2521418998 0.2548755564 -0.2008731061 0
HCV 321 -2.9216648356 3.6368455651 0.261232309 0.2909695944 -0.1994508322 0.1469633834
HIPK4 147746 0 0 0 0.1207865579 0 0
HK2 3099 0 0 0 0.1038299172 0 0
HK3 3101 0 0 0 0 -0.0742196973 0
IHPK2 -0.6379886667 0 0 0 0 0
IRAK1 3654 0 1.571171456 0 0.1500652951 -0.0779952425 0
LAK -0.8162185882 1.6598044635 0 0 0 0
LIMK2 3985 0 2.3567623916 0.1509813226 0.1430903169 -0.1020785759 0
LOC340156 0 0 0 0 -0.0596646094 0
LOC390777 0 0 0.1025662816 0.1267588355 -0.0631485659 0
LOC391533 391533 0 0 0 0.1497439457 -0.0696283635 0
LOC400301 0 0 0 0.1434720999 -0.0900677638 0
LOC442141 0 0 0.1171384091 0.1305503104 -0.0902587809 0
LOC91807 0 1.6231886166 0.1404126556 0.1347382198 -0.103733009 0
LRRK1 79705 0 2.2646624941 0.1475742145 0 -0.124122252 0
MAK 4117 0 2.0078318022 0.1523644514 0 -0.1309117181 0
MAP2K1IP1 0 1.5737926236 0.1444966778 0.1475532346 -0.0881662433 0
MAP2K2 407835 -0.6364224 0 0 0 0 0
MAP2K3 5606 0 0 0 0 -0.0819301918 0
MAP2K4 6416 0 0 0.1027432082 0 0 0
MAP3K14 9020 0 0 0 0 -0.0724596071 0
MAP3K6 9064 0 1.7366747557 0 0.1730559659 -0.1016838038 0
MAP3K7 6885 0 0 0 0.1246736635 0 0
MELK 9833 0 1.932617677 0.1322887231 0 -0.1321649334 0
MET 4233 -0.8306554118 1.5587167624 0 0.1152671985 0 0
MKNK1 8569 0 0 0 0.1177831324 -0.0701719605 0
MPP6 51678 -0.5960231875 0 0 0 0 0
MPP7 143098 0 0 0 0.1339683533 0 0
NME4 4833 0 2.1383455773 0.1451179753 0.1405009476 -0.1362921907 0
NME6 10201 0 0 0.1134694912 0 0 0
OSR1 130497 -0.5213102667 0 0 0 0 0
p24 -0.3435650385 0 0 0 -0.0791475374 0
PAK4 10298 -0.5306489583 0 0 0 0 0
PCM1 5108 0 2.1355771029 0.1228696339 0.1287111492 -0.1013362824 0
PCTK1 0 0 0.1185463341 0 -0.0796580007 0
PCTK3 0 0 0.1147505514 0 0 0
PDGFRA 5156 0 0 0 0.1415938911 0 0
PDK1 5163 0 0 0.116856564 0.1200262806 0 0
PDK4 5166 0 0 0 0 -0.0566570987 0
PDPK1 5170 0 0 0.1154572945 0 0 0
PFKP 5214 0 0 0 0 -0.0544526207 0
PIK3R4 30849 -0.97696 0 0 0 0 0
PIK4CA -3.5110589091 2.9829469232 0.2030196698 0.227870097 -0.1603934059 0
PIK4CB -0.6006052353 0 0 0 0 0
PKN2 5586 -0.6840730625 0 0 0 0 0
PRKCD 5580 0 0 0.1008470858 0.1182278733 -0.0623171886 0
PRKCDBP 112464 0 0 0 0 -0.0610411599 0
PRKCI 5584 -0.3953135 0 0 0 -0.0969059342 0.1312752438
PRKY 5616 0 0 0 0 -0.0561089 0
PRPS1 221823 0 2.2979784971 0.1523630494 0.1616320722 -0.1432502925 0.1916018688
PRPS2 5634 0 0 0 0 -0.0543121159 0
PSKH1 5681 0 2.8671762203 0.2149395892 0.2103765235 -0.1370060224 0
PTK9L 84084 0 0 0 0 -0.0624599794 0
RAB6A 5894 0 0 0.1221191189 0.1565963195 -0.0894259361 0
RAF1 0 0 0.1053950163 0 -0.0529807645 0
RPS6KB1 6198 -0.5494733333 0 0 0 0 0
SBK1 388228 0 0 0 0 -0.0682361747 0
SGKL 0 0 0.1357119648 0 0 0
SIK2 23235 0 0 0 0.1408657236 0 0
SLAMF6 114836 -0.4252741765 0 0 0 -0.0728310483 0
SRMS 6725 0 1.9378112685 0.1761706874 0.21965565 -0.1174763683 0
STK17A 9263 0 1.7576337841 0 0.1278444374 -0.0870925224 0
STK19 8859 0 0 0 0 -0.0710872644 0
STK24 8428 0 0 0 0 -0.0643778089 0
STK4 6789 0 0 0.1218911378 0 0 0
STK6 0 0 0 0.1193660567 0 0
Continued on next page
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Table B.1 – continued from previous page
Gene ENTREZ ID RIPLEY AVERAGE CELL-BASED GSEA-ONLY MARS-ONLY HIT DENV
TAF1 6872 0 1.7357011523 0.1163455498 0.1410310476 -0.0974076802 0
TEX14 56155 0 0 0 0 -0.0685526256 0
TGFBR2 7048 0 0 0 0 -0.0581756092 0
TIE 0 0 0 0 -0.0910392618 0
TLK1 9874 0 1.6030779342 0 0.1006021727 0 0
TXNDC3 51314 0 1.8099067532 0.1200612542 0.1414415843 -0.0891001732 0
TXNDC6 347736 0 1.5038896218 0 0.1222863847 -0.0665637725 0
ULK2 9706 0 0 0 0.1467522055 0 0
VRK3 51231 0 2.0428657479 0.1739949434 0.1652335831 -0.1170016487 0
B.2 Hit List of the DENV Screen
Table B.2 lists the hits of virus host dependency factors of the DENV screen
after normalization and hit scoring using the CELL-BASED analysis method.
Table B.2: Gene hit list of the DENV screen after CELL-BASED analysis.
Shown are ES after normalization.
Gene ENTREZ ID CELL-BASED
AAK1 22848 0.1209106731
ACVR2B 93 0.146984063
ADCK5 203054 0.2593055687
AKAP8L 26993 0.1131147699
C19orf35 374872 0.1674584813
C9orf96 169436 0.1838625724
CDC42SE2 56990 0.1337900039
CDK10 8558 0.1202148192
CDK4 1019 0.1190662535
CKI-alpha 0.1177560653
CKI-delta 0.1302087219
CKMT1 0.1208840862
COASY 80347 0.1643057047
COPB 0.1446878343
CSK 1445 0.1283304096
ERBB4 2066 0.1440386128
GK 2713 0.1314407357
HCV 138 0.1341174024
HCV 321 0.1547687568
IHPK3 0.1409453321
ITPK1 3705 0.1304454772
KDR 3791 0.1410455703
LCK 3932 0.1039074693
LEDGF-p75 0.133982579
LOC340371 0.1359490663
LRRK2 120892 0.1285685923
MAP2K7 5609 0.167248405
MAPK10 5602 0.1575260835
MAPK6 5597 0.1341785924
MAPK8 5599 0.1128646973
MAPKAPK2 9261 0.1319369824
MARK1 4139 0.1156667351
MAST1 22983 0.1313235059
MIDORI 0.1600694441
Continued on next page
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Table B.2 – continued from previous page
Gene ENTREZ ID CELL-BASED
MINK 0.1329031123
NEK6 10783 0.1208132764
NTRK3 4916 0.102864854
PIK3R3 8503 0.1816203592
PKMYT1 9088 0.1093590518
PLXNA3 55558 0.1465929834
PLXNC1 10154 0.135352589
PRKACB 5567 0.1145926292
PRKCB1 0.1186531494
PRKCE 5581 0.1178679489
PRKCI 5584 0.1188402306
PRKCQ 5588 0.1209638557
PRKG2 5593 0.1376981852
PRKY 5616 0.1489939056
PRPS1 221823 0.1319423276
PTK2B 2185 0.1111078258
RAB1A 5861 0.1349586886
RIOK1 83732 0.1635074222
RIPK3 11035 0.1480503226
RPS6KL1 83694 0.2125937692
STK32C 282974 0.1301677447
TEC 7006 0.187453925
TRIB3 57761 0.1311717934
B.3 Pathway Analysis of HCV and DENV
Hits
In Table B.3 and Table B.4 the results of the gene set enrichment analysis of
the HCV screen for KEGG and Biocarta are listed and correspondingly Table
B.5 and Table B.6 show the gene set enrichment analysis results of the DENV
screen.
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The Tables B.7 and B.8 show the enriched KEGG and Biocarta pathways
of the analysis strategy AVERAGE.
Table B.7: Results of gene set enrichment analysis of the HCV screen for
KEGG and Biocarta pathways using the DAVID bioinformatics software on
the hits derived from the AVERAGE analysis. In the column “No.” results are
enumerated to find the respective pathways in the continued Table B.8. Column
“Category” shows whether the hit was found in the KEGG or Biocarta database.
“Term” describes the name of the pathway. “Count” and “%” indicate how
many genes and what percentage of the hit list are in the respective pathway.
The column “Pvalue” shows the significance of the enrichment, “List” is the
total number of genes in the corresponding pathway and “Fold Enrichment”
expresses the enrichment score.
No. Category Term Count % PValue List Total
1 KEGG PATHWAY hsa04360:Axon guidance 3 0.345 0.061 17
2 KEGG PATHWAY hsa00230:Purine metabolism 3 0.345 0.082 17
Table B.8: Results of gene set enrichment analysis of the HCV screen for
KEGG and Biocarta on the AVERAGE hit list, continued from Table B.7 (see
column “No.” to find the corresponding pathways). The columns “Bonferroni”,
“Benjamini” and “FDR” show the p-value after the respective correction for
multiple testing and column “Genes” lists the hit genes found in each pathway.
No. Fold Enrichment Bonferroni Benjamini FDR Genes
1 6.956 0.913 0.913 43.456 LIMK2, MET, CFL1
2 5.865 0.964 0.811 54.046 NME4, ADK, PRPS1
Appendix C
Two-Class and Three-Class
AUC Values
To assess, whether the LP model can infer the sign of an edge with a good
performance, we use a three-class classification to compute AU-ROC and AU-
PR values for the data simulated with missing data points. The results are
represented in Figure C.1 and C.2. Clearly, the performance of the network
inference with the LP model for the two-class classification is similar to the
performance measured with a three-class classification.
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(d) noise: σ = 0.5
Figure C.1: Mean area under the two-class and the three-class ROC-curve for
random guessing as well as for results of the network inference using the LP
model on missing data over 100 repetitions of four different noise settings. (a)
noise: σ = 0.01 (b) noise: σ = 0.1 (c) noise: σ = 0.27 (d) noise: σ = 0.5.
The dotted lines represent random guessing values for the two- and three-class
classification. The red (dash-dotted) lines, respectively, the straight (black) lines
correspond to results of the three-class, respectively, the two-class classification
analysis of the results derived with the LP model.
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Figure C.2: Mean area under the two-class and the three-class PR-curve for
random guessing as well as for results of the network inference using the LP
model on missing data over 100 repetitions of four different noise settings. (a)
noise: σ = 0.01 (b) noise: σ = 0.1 (c) noise: σ = 0.27 (d) noise: σ = 0.5.
The dotted lines represent random guessing values for the two- and three-class
classification. The red (dash-dotted) lines, respectively, the straight (black) lines
correspond to results of the three-class, respectively, the two-class classification
analysis of the results derived with the LP model.
Appendix D
ErbB Signaling Network
Inferred with the LP model
In Table D.1 the median edge weights ± the median absolute deviation (MAD)
of all LOOCV-steps for the inferred network topologies using the LP model on
the ErbB signaling data are represented.
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Notation Index and
Abbreviations
µ Mean, 18
σ Standard Deviation, 18
Im m×m Identity Matrix, 91
AIC Akaike information criterion, 77
ASGP-R Asialoglycoprotein Receptor, 11
AUC Area Under Curve, 59
CSNK2A1 Casein Kinase II Subunit Alpha, 57
CV Coefficient of Variation, 18
D-NEM Dynamic Nested Effects Model, 78
DAG Directed Acyclic Graph, 71
DAPI 4’,6-Diamidino-2-Phenylindole, 16
DAVID Database for Annotation, Visualization and Integrated Dis-
covery, 64
DDEPN Dynamic Deterministic Effects Propagation Network, 84
DENV Dengue Fever Virus, 10
DEPN Deterministic Effects Propagation Network, 82
DNA Deoxyribonucleic Acid, 8
DR Dynamic Range, 17
dsRNA Double-stranded RNA, 6
EGF Epidermal Growth Factor, 116
EGFR Epidermal Growth Receptor, 116
EM Expectation-Maximization, 38
ER Endoplasmic Reticulum, 10
ES Enrichment Score, 53
esiRNAs Endoribonuclease-prepared Short Interfering RNA, 13
FLT-4 Fms-Related Tyrosine Kinase 4, 57
GCV Generalized Cross-Validation, 49
GFP Green Fluorescence Protein, 14
GO Gene Ontology, 72
GSEA Gene Set Enrichment Analysis, 52
HCV Hepatitis C Virus, 11
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HDF Host Dependency Factors, 51
JAK/STAT Janus Kinases and Signal Transducers and Activators of Tran-
scription, 81
kb Kilobases, 10
KEGG Kyoto Encyclopedia of Genes and Genomes, 73
LDL-R Low-density Lipoprotein Receptor, 11
LOOCV Leave-One-Out Cross-Validation, 97
Lowess Locally Weighted Polynomial Regression, 20
LP linear programming, 86
MAD Median Absolute Deviation, 19
MARS Multivariate Adaptive Regression Splines, 48
mRNA Messenger RNA, 7
MSE mean squared error, 97
NEM Nested Effects Model, 74
nm Nanometer, 9
nt Nucleotides, 7
PCC Pearson correlation coefficient, 31
PCR Polymerase Chain Reaction, 8
PI4KA Phosphatidylinositol 4-Kinase Alpha, 57
PPI Protein-Protein Interaction, 72
PR Precision to Recall, 100
RISC RNA-induced Silencing Complex, 7
RNA Ribonucleic Acid, 6
RNAi RNA Interference, 1
ROC Receiver Operator Characteristic, 59
RPPA Reverse Phase Protein Array, 82
RPPA Reverse Phase Protein Arrays, 117
RSS Residual Sum of Squares, 49
RT-PCR Reverse Transcriptase-polymerase Chain Reaction, 14
SA Simulated Annealing, 78
shRNAs Short Hairpin RNAs, 8
SID-1 Systemic RNA Interference Defective, 7
siRNAs Short Interfering RNAs, 6
SR-BI Scavenger Receptor B Type I, 11
TGN Trans-Golgi Network, 10
Index
ES, 53
AUC, 59, 100
AVERAGE method, 25, 29
Basis functions, 48
Bayesian Network, 71
Between-Bin Variability, 43
Biomolecular Pathway, 72
Capsid, 9
Capsomer, 9
Coefficient of Variation, 18
Correlation Coefficient, 18
Kendall’s rank, 18
Pearson’s, 18
Spearman’s rank, 18
Dengue Virus, 10
Deterministic Effects Propagation
Networks, 82
Directed Acyclic Graph, 71
Dynamic Deterministic Effects Propa-
gation Networks, 84
Dynamic Range, 17
E-genes, 74
Expectation-Maximization, 38
Fluorescence Microscope, 16
Gaussian Mixture Model , 35–39
GCV, 49
Gene Co-expression Network, 72
Gene Ontology, 72
Graph, 70
Directed, 70
Undirected, 70
GSEA, 52
Hepatitis C Virus, 10
Host Dependency Factors, 51
LabTek, 13
Leave-One-Out Cross-Validation, 97
Linear Optimization Problem, 86–89
Canonical Form, 87
Standard Form, 86
MAD, 19, 103
Mann-Whitney Test, 22
MARS, 48
Mean squared error, 97
Microwell Plate based Screening, 15
Nested Effects Model, 74
Normalization, 19
B-score, 20
Controls, 19
Lowess, 20
Z-score, 20
Optimization Problems, 85–86
Plate Reader, 16
PPI network, 72
Precision, 95, 99
Precision to Recall, 100
Recall, 100
Retrovirus, 9
Reverse Transfection, 14
Ripley method, 25
RNA Interference, 1, 6–8
RNAi-based Cell Microarrays, 13
ROC
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three-class, 99
two-class, 59, 99
RSS, 49
S-genes, 74
Sensitivity, 95, 99
Signaling Network, 73
Simplex Algorithm, 3, 90–93
Solid-phase Reverse Transfection, 15
Specificity, 95, 99
Standard-Maximum-Program, 86
Standard-Minimum-Program, 86
T-test, 21
One-sample, 21
Standard, 22
Two-sample, 22
Welch, 22
Variability-Ratio, 43
Within-bin Variability, 43
Z’ Factor, 17
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